EP1238114A2 - Methods and compositions relating to electrical detection of nucleic acid reactions - Google Patents
Methods and compositions relating to electrical detection of nucleic acid reactionsInfo
- Publication number
- EP1238114A2 EP1238114A2 EP00993326A EP00993326A EP1238114A2 EP 1238114 A2 EP1238114 A2 EP 1238114A2 EP 00993326 A EP00993326 A EP 00993326A EP 00993326 A EP00993326 A EP 00993326A EP 1238114 A2 EP1238114 A2 EP 1238114A2
- Authority
- EP
- European Patent Office
- Prior art keywords
- microelectrodes
- electrode
- contact
- nucleic acid
- target molecule
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 150000007523 nucleic acids Chemical class 0.000 title claims abstract description 124
- 108020004707 nucleic acids Proteins 0.000 title claims abstract description 120
- 102000039446 nucleic acids Human genes 0.000 title claims abstract description 120
- 238000001514 detection method Methods 0.000 title claims abstract description 57
- 238000006243 chemical reaction Methods 0.000 title claims abstract description 36
- 238000000034 method Methods 0.000 title abstract description 159
- 239000000203 mixture Substances 0.000 title description 13
- 238000009396 hybridization Methods 0.000 claims abstract description 102
- 239000000017 hydrogel Substances 0.000 claims abstract description 63
- 108091034117 Oligonucleotide Proteins 0.000 claims abstract description 51
- 230000004001 molecular interaction Effects 0.000 claims abstract description 39
- 239000000523 sample Substances 0.000 claims description 178
- 239000000758 substrate Substances 0.000 claims description 98
- 125000003729 nucleotide group Chemical group 0.000 claims description 85
- 239000002773 nucleotide Substances 0.000 claims description 79
- 239000008151 electrolyte solution Substances 0.000 claims description 39
- 229910052751 metal Inorganic materials 0.000 claims description 39
- 239000002184 metal Substances 0.000 claims description 39
- 229920002401 polyacrylamide Polymers 0.000 claims description 37
- 239000000499 gel Substances 0.000 claims description 33
- 239000000243 solution Substances 0.000 claims description 21
- 238000000835 electrochemical detection Methods 0.000 claims description 20
- 239000012472 biological sample Substances 0.000 claims description 13
- 230000009467 reduction Effects 0.000 claims description 11
- 238000010348 incorporation Methods 0.000 claims description 10
- 238000007254 oxidation reaction Methods 0.000 claims description 10
- 238000002966 oligonucleotide array Methods 0.000 claims description 9
- 230000003647 oxidation Effects 0.000 claims description 9
- 239000003792 electrolyte Substances 0.000 claims description 8
- 229920000642 polymer Polymers 0.000 claims description 8
- 229920000547 conjugated polymer Polymers 0.000 claims description 6
- 229910052723 transition metal Inorganic materials 0.000 claims description 5
- 150000003624 transition metals Chemical class 0.000 claims description 5
- 238000006722 reduction reaction Methods 0.000 claims 4
- 230000003993 interaction Effects 0.000 abstract description 25
- 238000009739 binding Methods 0.000 abstract description 17
- 108090000765 processed proteins & peptides Proteins 0.000 abstract description 17
- 230000027455 binding Effects 0.000 abstract description 16
- 238000007899 nucleic acid hybridization Methods 0.000 abstract description 16
- 238000003491 array Methods 0.000 abstract description 11
- 102000004196 processed proteins & peptides Human genes 0.000 abstract description 11
- 230000009830 antibody antigen interaction Effects 0.000 abstract description 3
- 238000003205 genotyping method Methods 0.000 abstract description 2
- JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 abstract 1
- BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Chemical compound [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 description 63
- 239000013615 primer Substances 0.000 description 43
- -1 antibodies Proteins 0.000 description 40
- 239000010408 film Substances 0.000 description 38
- 239000002751 oligonucleotide probe Substances 0.000 description 38
- 108020005187 Oligonucleotide Probes Proteins 0.000 description 37
- 229940021013 electrolyte solution Drugs 0.000 description 33
- 239000000463 material Substances 0.000 description 30
- 229920000128 polypyrrole Polymers 0.000 description 29
- 229910052697 platinum Inorganic materials 0.000 description 26
- 239000007787 solid Substances 0.000 description 26
- 230000000295 complement effect Effects 0.000 description 25
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 24
- BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 description 23
- 239000000126 substance Substances 0.000 description 23
- 239000008367 deionised water Substances 0.000 description 22
- 229910021641 deionized water Inorganic materials 0.000 description 22
- 229910052709 silver Inorganic materials 0.000 description 22
- 239000004332 silver Substances 0.000 description 22
- 241000894007 species Species 0.000 description 21
- 239000000853 adhesive Substances 0.000 description 19
- 230000001070 adhesive effect Effects 0.000 description 19
- 239000011521 glass Substances 0.000 description 19
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 19
- 229910052737 gold Inorganic materials 0.000 description 19
- 239000010931 gold Substances 0.000 description 19
- 238000005259 measurement Methods 0.000 description 19
- 108090000623 proteins and genes Proteins 0.000 description 19
- 108020004711 Nucleic Acid Probes Proteins 0.000 description 18
- 238000003556 assay Methods 0.000 description 18
- 239000002853 nucleic acid probe Substances 0.000 description 18
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 16
- 229910052802 copper Inorganic materials 0.000 description 16
- 239000010949 copper Substances 0.000 description 16
- 238000005245 sintering Methods 0.000 description 16
- 108020004414 DNA Proteins 0.000 description 15
- 239000004020 conductor Substances 0.000 description 15
- 239000000919 ceramic Substances 0.000 description 14
- 229910044991 metal oxide Inorganic materials 0.000 description 14
- 150000004706 metal oxides Chemical class 0.000 description 14
- 230000008569 process Effects 0.000 description 14
- 102000004169 proteins and genes Human genes 0.000 description 14
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 13
- 239000000872 buffer Substances 0.000 description 13
- 125000006853 reporter group Chemical group 0.000 description 13
- 125000005647 linker group Chemical group 0.000 description 12
- 206010071602 Genetic polymorphism Diseases 0.000 description 11
- RTAQQCXQSZGOHL-UHFFFAOYSA-N Titanium Chemical compound [Ti] RTAQQCXQSZGOHL-UHFFFAOYSA-N 0.000 description 11
- 229910052799 carbon Inorganic materials 0.000 description 11
- 238000002484 cyclic voltammetry Methods 0.000 description 11
- 150000001247 metal acetylides Chemical class 0.000 description 11
- 230000035772 mutation Effects 0.000 description 11
- 150000004767 nitrides Chemical class 0.000 description 11
- 229910052719 titanium Inorganic materials 0.000 description 11
- 239000010936 titanium Substances 0.000 description 11
- KAESVJOAVNADME-UHFFFAOYSA-N Pyrrole Chemical compound C=1C=CNC=1 KAESVJOAVNADME-UHFFFAOYSA-N 0.000 description 10
- 239000012491 analyte Substances 0.000 description 10
- 150000001768 cations Chemical class 0.000 description 10
- 239000003446 ligand Substances 0.000 description 10
- 238000004832 voltammetry Methods 0.000 description 10
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 9
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 9
- XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical compound [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 description 9
- 229920001577 copolymer Polymers 0.000 description 9
- 238000010304 firing Methods 0.000 description 9
- 150000002739 metals Chemical class 0.000 description 9
- 239000010703 silicon Substances 0.000 description 9
- 229910052710 silicon Inorganic materials 0.000 description 9
- 238000012360 testing method Methods 0.000 description 9
- 241000700605 Viruses Species 0.000 description 8
- 239000002253 acid Substances 0.000 description 8
- 238000009792 diffusion process Methods 0.000 description 8
- 239000003814 drug Substances 0.000 description 8
- 239000002245 particle Substances 0.000 description 8
- 230000035945 sensitivity Effects 0.000 description 8
- 238000004873 anchoring Methods 0.000 description 7
- 239000000427 antigen Substances 0.000 description 7
- 102000036639 antigens Human genes 0.000 description 7
- 108091007433 antigens Proteins 0.000 description 7
- 239000011230 binding agent Substances 0.000 description 7
- 230000008859 change Effects 0.000 description 7
- 230000001419 dependent effect Effects 0.000 description 7
- 239000007850 fluorescent dye Substances 0.000 description 7
- 238000011534 incubation Methods 0.000 description 7
- 238000004519 manufacturing process Methods 0.000 description 7
- 238000002493 microarray Methods 0.000 description 7
- 238000012986 modification Methods 0.000 description 7
- 230000004048 modification Effects 0.000 description 7
- 230000007935 neutral effect Effects 0.000 description 7
- 238000003752 polymerase chain reaction Methods 0.000 description 7
- 239000000843 powder Substances 0.000 description 7
- 238000005406 washing Methods 0.000 description 7
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 6
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 6
- PNEYBMLMFCGWSK-UHFFFAOYSA-N aluminium oxide Inorganic materials [O-2].[O-2].[O-2].[Al+3].[Al+3] PNEYBMLMFCGWSK-UHFFFAOYSA-N 0.000 description 6
- 238000000576 coating method Methods 0.000 description 6
- 230000007423 decrease Effects 0.000 description 6
- 229940079593 drug Drugs 0.000 description 6
- 238000002848 electrochemical method Methods 0.000 description 6
- 238000002847 impedance measurement Methods 0.000 description 6
- 239000012212 insulator Substances 0.000 description 6
- 238000003475 lamination Methods 0.000 description 6
- 238000002844 melting Methods 0.000 description 6
- 230000008018 melting Effects 0.000 description 6
- 239000012071 phase Substances 0.000 description 6
- 229920003023 plastic Polymers 0.000 description 6
- 239000004033 plastic Substances 0.000 description 6
- 239000003981 vehicle Substances 0.000 description 6
- 238000000018 DNA microarray Methods 0.000 description 5
- 102000004190 Enzymes Human genes 0.000 description 5
- 108090000790 Enzymes Proteins 0.000 description 5
- 108091028043 Nucleic acid sequence Proteins 0.000 description 5
- 229910021607 Silver chloride Inorganic materials 0.000 description 5
- HDRRAMINWIWTNU-NTSWFWBYSA-N [[(2s,5r)-5-(2-amino-6-oxo-3h-purin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl] phosphono hydrogen phosphate Chemical compound C1=2NC(N)=NC(=O)C=2N=CN1[C@H]1CC[C@@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O1 HDRRAMINWIWTNU-NTSWFWBYSA-N 0.000 description 5
- ARLKCWCREKRROD-POYBYMJQSA-N [[(2s,5r)-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl] phosphono hydrogen phosphate Chemical compound O=C1N=C(N)C=CN1[C@@H]1O[C@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)CC1 ARLKCWCREKRROD-POYBYMJQSA-N 0.000 description 5
- 230000003321 amplification Effects 0.000 description 5
- 230000008901 benefit Effects 0.000 description 5
- 210000004027 cell Anatomy 0.000 description 5
- 239000011248 coating agent Substances 0.000 description 5
- URGJWIFLBWJRMF-JGVFFNPUSA-N ddTTP Chemical compound O=C1NC(=O)C(C)=CN1[C@@H]1O[C@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)CC1 URGJWIFLBWJRMF-JGVFFNPUSA-N 0.000 description 5
- 229920001971 elastomer Polymers 0.000 description 5
- 229940088598 enzyme Drugs 0.000 description 5
- 239000004744 fabric Substances 0.000 description 5
- 238000003199 nucleic acid amplification method Methods 0.000 description 5
- 239000002777 nucleoside Substances 0.000 description 5
- 230000003287 optical effect Effects 0.000 description 5
- 238000002360 preparation method Methods 0.000 description 5
- 239000002987 primer (paints) Substances 0.000 description 5
- 239000005060 rubber Substances 0.000 description 5
- HKZLPVFGJNLROG-UHFFFAOYSA-M silver monochloride Chemical compound [Cl-].[Ag+] HKZLPVFGJNLROG-UHFFFAOYSA-M 0.000 description 5
- 238000004365 square wave voltammetry Methods 0.000 description 5
- UJOBWOGCFQCDNV-UHFFFAOYSA-N Carbazole Natural products C1=CC=C2C3=CC=CC=C3NC2=C1 UJOBWOGCFQCDNV-UHFFFAOYSA-N 0.000 description 4
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 4
- 239000004593 Epoxy Substances 0.000 description 4
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 4
- 229920000265 Polyparaphenylene Polymers 0.000 description 4
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 4
- 102000011923 Thyrotropin Human genes 0.000 description 4
- 108010061174 Thyrotropin Proteins 0.000 description 4
- ISAKRJDGNUQOIC-UHFFFAOYSA-N Uracil Chemical compound O=C1C=CNC(=O)N1 ISAKRJDGNUQOIC-UHFFFAOYSA-N 0.000 description 4
- XLOMVQKBTHCTTD-UHFFFAOYSA-N Zinc monoxide Chemical compound [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 description 4
- 108010058966 bacteriophage T7 induced DNA polymerase Proteins 0.000 description 4
- 239000008366 buffered solution Substances 0.000 description 4
- 235000014633 carbohydrates Nutrition 0.000 description 4
- 150000001720 carbohydrates Chemical class 0.000 description 4
- 229910017052 cobalt Inorganic materials 0.000 description 4
- 239000010941 cobalt Substances 0.000 description 4
- GUTLYIVDDKVIGB-UHFFFAOYSA-N cobalt atom Chemical compound [Co] GUTLYIVDDKVIGB-UHFFFAOYSA-N 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- 238000003487 electrochemical reaction Methods 0.000 description 4
- 238000005516 engineering process Methods 0.000 description 4
- 150000002148 esters Chemical class 0.000 description 4
- 239000012634 fragment Substances 0.000 description 4
- 230000014509 gene expression Effects 0.000 description 4
- UYTPUPDQBNUYGX-UHFFFAOYSA-N guanine Chemical compound O=C1NC(N)=NC2=C1N=CN2 UYTPUPDQBNUYGX-UHFFFAOYSA-N 0.000 description 4
- 239000010954 inorganic particle Substances 0.000 description 4
- 238000002372 labelling Methods 0.000 description 4
- 150000003833 nucleoside derivatives Chemical class 0.000 description 4
- 239000011368 organic material Substances 0.000 description 4
- 229920001088 polycarbazole Polymers 0.000 description 4
- 229920002098 polyfluorene Polymers 0.000 description 4
- 229920000414 polyfuran Polymers 0.000 description 4
- 238000012545 processing Methods 0.000 description 4
- 238000000083 pulse voltammetry Methods 0.000 description 4
- 230000002285 radioactive effect Effects 0.000 description 4
- 150000003839 salts Chemical class 0.000 description 4
- 238000003950 stripping voltammetry Methods 0.000 description 4
- 230000001225 therapeutic effect Effects 0.000 description 4
- 230000007704 transition Effects 0.000 description 4
- OAKPWEUQDVLTCN-NKWVEPMBSA-N 2',3'-Dideoxyadenosine-5-triphosphate Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@H]1CC[C@@H](CO[P@@](O)(=O)O[P@](O)(=O)OP(O)(O)=O)O1 OAKPWEUQDVLTCN-NKWVEPMBSA-N 0.000 description 3
- OSBLTNPMIGYQGY-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;2-[2-[bis(carboxymethyl)amino]ethyl-(carboxymethyl)amino]acetic acid;boric acid Chemical compound OB(O)O.OCC(N)(CO)CO.OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O OSBLTNPMIGYQGY-UHFFFAOYSA-N 0.000 description 3
- IVRMZWNICZWHMI-UHFFFAOYSA-N Azide Chemical compound [N-]=[N+]=[N-] IVRMZWNICZWHMI-UHFFFAOYSA-N 0.000 description 3
- 241000894006 Bacteria Species 0.000 description 3
- 102000004127 Cytokines Human genes 0.000 description 3
- 108090000695 Cytokines Proteins 0.000 description 3
- 102000053602 DNA Human genes 0.000 description 3
- QTANTQQOYSUMLC-UHFFFAOYSA-O Ethidium cation Chemical compound C12=CC(N)=CC=C2C2=CC=C(N)C=C2[N+](CC)=C1C1=CC=CC=C1 QTANTQQOYSUMLC-UHFFFAOYSA-O 0.000 description 3
- 108060002716 Exonuclease Proteins 0.000 description 3
- 208000026350 Inborn Genetic disease Diseases 0.000 description 3
- 239000008051 TBE buffer Substances 0.000 description 3
- 150000007513 acids Chemical class 0.000 description 3
- 229910045601 alloy Inorganic materials 0.000 description 3
- 239000000956 alloy Substances 0.000 description 3
- 150000007942 carboxylates Chemical class 0.000 description 3
- 230000001413 cellular effect Effects 0.000 description 3
- 239000002299 complementary DNA Substances 0.000 description 3
- ZOMNIUBKTOKEHS-UHFFFAOYSA-L dimercury dichloride Chemical class Cl[Hg][Hg]Cl ZOMNIUBKTOKEHS-UHFFFAOYSA-L 0.000 description 3
- 238000010291 electrical method Methods 0.000 description 3
- 102000013165 exonuclease Human genes 0.000 description 3
- 239000011888 foil Substances 0.000 description 3
- 230000006870 function Effects 0.000 description 3
- 208000016361 genetic disease Diseases 0.000 description 3
- 239000002241 glass-ceramic Substances 0.000 description 3
- 238000010438 heat treatment Methods 0.000 description 3
- 229940088597 hormone Drugs 0.000 description 3
- 239000005556 hormone Substances 0.000 description 3
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 3
- 238000000338 in vitro Methods 0.000 description 3
- 239000000138 intercalating agent Substances 0.000 description 3
- 230000002687 intercalation Effects 0.000 description 3
- 238000009830 intercalation Methods 0.000 description 3
- 239000011159 matrix material Substances 0.000 description 3
- 238000006386 neutralization reaction Methods 0.000 description 3
- 238000007826 nucleic acid assay Methods 0.000 description 3
- 125000003835 nucleoside group Chemical group 0.000 description 3
- TWNQGVIAIRXVLR-UHFFFAOYSA-N oxo(oxoalumanyloxy)alumane Chemical compound O=[Al]O[Al]=O TWNQGVIAIRXVLR-UHFFFAOYSA-N 0.000 description 3
- 230000037361 pathway Effects 0.000 description 3
- 230000010287 polarization Effects 0.000 description 3
- 239000011541 reaction mixture Substances 0.000 description 3
- 102000005962 receptors Human genes 0.000 description 3
- 238000011160 research Methods 0.000 description 3
- 230000027756 respiratory electron transport chain Effects 0.000 description 3
- 230000004044 response Effects 0.000 description 3
- 238000007650 screen-printing Methods 0.000 description 3
- 238000004088 simulation Methods 0.000 description 3
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 3
- 239000001509 sodium citrate Substances 0.000 description 3
- 238000005507 spraying Methods 0.000 description 3
- 238000010408 sweeping Methods 0.000 description 3
- 150000003568 thioethers Chemical group 0.000 description 3
- PRDFBSVERLRRMY-UHFFFAOYSA-N 2'-(4-ethoxyphenyl)-5-(4-methylpiperazin-1-yl)-2,5'-bibenzimidazole Chemical compound C1=CC(OCC)=CC=C1C1=NC2=CC=C(C=3NC4=CC(=CC=C4N=3)N3CCN(C)CC3)C=C2N1 PRDFBSVERLRRMY-UHFFFAOYSA-N 0.000 description 2
- JKMHFZQWWAIEOD-UHFFFAOYSA-N 2-[4-(2-hydroxyethyl)piperazin-1-yl]ethanesulfonic acid Chemical compound OCC[NH+]1CCN(CCS([O-])(=O)=O)CC1 JKMHFZQWWAIEOD-UHFFFAOYSA-N 0.000 description 2
- FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 description 2
- NIXOWILDQLNWCW-UHFFFAOYSA-N Acrylic acid Chemical class OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 2
- ZKHQWZAMYRWXGA-KQYNXXCUSA-N Adenosine triphosphate Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)[C@@H](O)[C@H]1O ZKHQWZAMYRWXGA-KQYNXXCUSA-N 0.000 description 2
- 239000000275 Adrenocorticotropic Hormone Substances 0.000 description 2
- KXDHJXZQYSOELW-UHFFFAOYSA-M Carbamate Chemical compound NC([O-])=O KXDHJXZQYSOELW-UHFFFAOYSA-M 0.000 description 2
- 239000004215 Carbon black (E152) Substances 0.000 description 2
- 102400000739 Corticotropin Human genes 0.000 description 2
- 101800000414 Corticotropin Proteins 0.000 description 2
- 108010014303 DNA-directed DNA polymerase Proteins 0.000 description 2
- 102000016928 DNA-directed DNA polymerase Human genes 0.000 description 2
- AOJJSUZBOXZQNB-TZSSRYMLSA-N Doxorubicin Chemical compound O([C@H]1C[C@@](O)(CC=2C(O)=C3C(=O)C=4C=CC=C(C=4C(=O)C3=C(O)C=21)OC)C(=O)CO)[C@H]1C[C@H](N)[C@H](O)[C@H](C)O1 AOJJSUZBOXZQNB-TZSSRYMLSA-N 0.000 description 2
- 102000003951 Erythropoietin Human genes 0.000 description 2
- 108090000394 Erythropoietin Proteins 0.000 description 2
- 102000012673 Follicle Stimulating Hormone Human genes 0.000 description 2
- 108010079345 Follicle Stimulating Hormone Proteins 0.000 description 2
- 239000007995 HEPES buffer Substances 0.000 description 2
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 2
- 108090000723 Insulin-Like Growth Factor I Proteins 0.000 description 2
- SOWBFZRMHSNYGE-UHFFFAOYSA-N Monoamide-Oxalic acid Natural products NC(=O)C(O)=O SOWBFZRMHSNYGE-UHFFFAOYSA-N 0.000 description 2
- KWYHDKDOAIKMQN-UHFFFAOYSA-N N,N,N',N'-tetramethylethylenediamine Chemical compound CN(C)CCN(C)C KWYHDKDOAIKMQN-UHFFFAOYSA-N 0.000 description 2
- 206010028980 Neoplasm Diseases 0.000 description 2
- PXHVJJICTQNCMI-UHFFFAOYSA-N Nickel Chemical compound [Ni] PXHVJJICTQNCMI-UHFFFAOYSA-N 0.000 description 2
- 229910019142 PO4 Inorganic materials 0.000 description 2
- KDLHZDBZIXYQEI-UHFFFAOYSA-N Palladium Chemical compound [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 description 2
- 206010061902 Pancreatic neoplasm Diseases 0.000 description 2
- 108091093037 Peptide nucleic acid Proteins 0.000 description 2
- 102100022019 Pregnancy-specific beta-1-glycoprotein 2 Human genes 0.000 description 2
- 239000004820 Pressure-sensitive adhesive Substances 0.000 description 2
- 206010060862 Prostate cancer Diseases 0.000 description 2
- 208000000236 Prostatic Neoplasms Diseases 0.000 description 2
- KJTLSVCANCCWHF-UHFFFAOYSA-N Ruthenium Chemical group [Ru] KJTLSVCANCCWHF-UHFFFAOYSA-N 0.000 description 2
- 229910052581 Si3N4 Inorganic materials 0.000 description 2
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
- 108020004682 Single-Stranded DNA Proteins 0.000 description 2
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 2
- MUMGGOZAMZWBJJ-DYKIIFRCSA-N Testostosterone Chemical compound O=C1CC[C@]2(C)[C@H]3CC[C@](C)([C@H](CC4)O)[C@@H]4[C@@H]3CCC2=C1 MUMGGOZAMZWBJJ-DYKIIFRCSA-N 0.000 description 2
- 102000036693 Thrombopoietin Human genes 0.000 description 2
- 108010041111 Thrombopoietin Proteins 0.000 description 2
- 125000000217 alkyl group Chemical group 0.000 description 2
- 229910052782 aluminium Inorganic materials 0.000 description 2
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 2
- 150000001408 amides Chemical class 0.000 description 2
- 150000001412 amines Chemical class 0.000 description 2
- 239000003242 anti bacterial agent Substances 0.000 description 2
- 230000000692 anti-sense effect Effects 0.000 description 2
- 229940088710 antibiotic agent Drugs 0.000 description 2
- QZPSXPBJTPJTSZ-UHFFFAOYSA-N aqua regia Chemical compound Cl.O[N+]([O-])=O QZPSXPBJTPJTSZ-UHFFFAOYSA-N 0.000 description 2
- 230000001580 bacterial effect Effects 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 239000007853 buffer solution Substances 0.000 description 2
- 201000011510 cancer Diseases 0.000 description 2
- 239000006229 carbon black Substances 0.000 description 2
- 229910010293 ceramic material Inorganic materials 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- ZPUCINDJVBIVPJ-LJISPDSOSA-N cocaine Chemical compound O([C@H]1C[C@@H]2CC[C@@H](N2C)[C@H]1C(=O)OC)C(=O)C1=CC=CC=C1 ZPUCINDJVBIVPJ-LJISPDSOSA-N 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 238000010276 construction Methods 0.000 description 2
- 230000001276 controlling effect Effects 0.000 description 2
- IDLFZVILOHSSID-OVLDLUHVSA-N corticotropin Chemical compound C([C@@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC=1NC=NC=1)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CC(N)=O)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC=1C=CC=CC=1)C(O)=O)NC(=O)[C@@H](N)CO)C1=CC=C(O)C=C1 IDLFZVILOHSSID-OVLDLUHVSA-N 0.000 description 2
- 229960000258 corticotropin Drugs 0.000 description 2
- CVSVTCORWBXHQV-UHFFFAOYSA-N creatine Chemical compound NC(=[NH2+])N(C)CC([O-])=O CVSVTCORWBXHQV-UHFFFAOYSA-N 0.000 description 2
- OPTASPLRGRRNAP-UHFFFAOYSA-N cytosine Chemical compound NC=1C=CNC(=O)N=1 OPTASPLRGRRNAP-UHFFFAOYSA-N 0.000 description 2
- 230000032798 delamination Effects 0.000 description 2
- CFCUWKMKBJTWLW-UHFFFAOYSA-N deoliosyl-3C-alpha-L-digitoxosyl-MTM Natural products CC=1C(O)=C2C(O)=C3C(=O)C(OC4OC(C)C(O)C(OC5OC(C)C(O)C(OC6OC(C)C(O)C(C)(O)C6)C5)C4)C(C(OC)C(=O)C(O)C(C)O)CC3=CC2=CC=1OC(OC(C)C1O)CC1OC1CC(O)C(O)C(C)O1 CFCUWKMKBJTWLW-UHFFFAOYSA-N 0.000 description 2
- 238000000151 deposition Methods 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- LIKFHECYJZWXFJ-UHFFFAOYSA-N dimethyldichlorosilane Chemical compound C[Si](C)(Cl)Cl LIKFHECYJZWXFJ-UHFFFAOYSA-N 0.000 description 2
- LOKCTEFSRHRXRJ-UHFFFAOYSA-I dipotassium trisodium dihydrogen phosphate hydrogen phosphate dichloride Chemical compound P(=O)(O)(O)[O-].[K+].P(=O)(O)([O-])[O-].[Na+].[Na+].[Cl-].[K+].[Cl-].[Na+] LOKCTEFSRHRXRJ-UHFFFAOYSA-I 0.000 description 2
- 238000011038 discontinuous diafiltration by volume reduction Methods 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- KPUWHANPEXNPJT-UHFFFAOYSA-N disiloxane Chemical class [SiH3]O[SiH3] KPUWHANPEXNPJT-UHFFFAOYSA-N 0.000 description 2
- 238000006056 electrooxidation reaction Methods 0.000 description 2
- 239000003344 environmental pollutant Substances 0.000 description 2
- 229940105423 erythropoietin Drugs 0.000 description 2
- 238000005530 etching Methods 0.000 description 2
- ZMMJGEGLRURXTF-UHFFFAOYSA-N ethidium bromide Chemical compound [Br-].C12=CC(N)=CC=C2C2=CC=C(N)C=C2[N+](CC)=C1C1=CC=CC=C1 ZMMJGEGLRURXTF-UHFFFAOYSA-N 0.000 description 2
- 229960005542 ethidium bromide Drugs 0.000 description 2
- 230000005284 excitation Effects 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- KTWOOEGAPBSYNW-UHFFFAOYSA-N ferrocene Chemical compound [Fe+2].C=1C=C[CH-]C=1.C=1C=C[CH-]C=1 KTWOOEGAPBSYNW-UHFFFAOYSA-N 0.000 description 2
- 238000001215 fluorescent labelling Methods 0.000 description 2
- 229940028334 follicle stimulating hormone Drugs 0.000 description 2
- 239000010439 graphite Substances 0.000 description 2
- 229910002804 graphite Inorganic materials 0.000 description 2
- 150000002429 hydrazines Chemical class 0.000 description 2
- 229930195733 hydrocarbon Natural products 0.000 description 2
- JYGXADMDTFJGBT-VWUMJDOOSA-N hydrocortisone Chemical compound O=C1CC[C@]2(C)[C@H]3[C@@H](O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 JYGXADMDTFJGBT-VWUMJDOOSA-N 0.000 description 2
- 229910003437 indium oxide Inorganic materials 0.000 description 2
- PJXISJQVUVHSOJ-UHFFFAOYSA-N indium(iii) oxide Chemical compound [O-2].[O-2].[O-2].[In+3].[In+3] PJXISJQVUVHSOJ-UHFFFAOYSA-N 0.000 description 2
- 208000015181 infectious disease Diseases 0.000 description 2
- 230000002458 infectious effect Effects 0.000 description 2
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 2
- 150000002500 ions Chemical class 0.000 description 2
- 229910052742 iron Inorganic materials 0.000 description 2
- DRAVOWXCEBXPTN-UHFFFAOYSA-N isoguanine Chemical compound NC1=NC(=O)NC2=C1NC=N2 DRAVOWXCEBXPTN-UHFFFAOYSA-N 0.000 description 2
- 208000015486 malignant pancreatic neoplasm Diseases 0.000 description 2
- 239000012528 membrane Substances 0.000 description 2
- 108020004999 messenger RNA Proteins 0.000 description 2
- 229910021645 metal ion Inorganic materials 0.000 description 2
- 239000002923 metal particle Substances 0.000 description 2
- 238000004377 microelectronic Methods 0.000 description 2
- CFCUWKMKBJTWLW-BKHRDMLASA-N mithramycin Chemical compound O([C@@H]1C[C@@H](O[C@H](C)[C@H]1O)OC=1C=C2C=C3C[C@H]([C@@H](C(=O)C3=C(O)C2=C(O)C=1C)O[C@@H]1O[C@H](C)[C@@H](O)[C@H](O[C@@H]2O[C@H](C)[C@H](O)[C@H](O[C@@H]3O[C@H](C)[C@@H](O)[C@@](C)(O)C3)C2)C1)[C@H](OC)C(=O)[C@@H](O)[C@@H](C)O)[C@H]1C[C@@H](O)[C@H](O)[C@@H](C)O1 CFCUWKMKBJTWLW-BKHRDMLASA-N 0.000 description 2
- HMMGMWAXVFQUOA-UHFFFAOYSA-N octamethylcyclotetrasiloxane Chemical compound C[Si]1(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O1 HMMGMWAXVFQUOA-UHFFFAOYSA-N 0.000 description 2
- 150000002894 organic compounds Chemical class 0.000 description 2
- 229910052762 osmium Inorganic materials 0.000 description 2
- SYQBFIAQOQZEGI-UHFFFAOYSA-N osmium atom Chemical compound [Os] SYQBFIAQOQZEGI-UHFFFAOYSA-N 0.000 description 2
- 201000002528 pancreatic cancer Diseases 0.000 description 2
- 208000008443 pancreatic carcinoma Diseases 0.000 description 2
- 230000001717 pathogenic effect Effects 0.000 description 2
- 235000021317 phosphate Nutrition 0.000 description 2
- 239000002953 phosphate buffered saline Substances 0.000 description 2
- 150000003013 phosphoric acid derivatives Chemical class 0.000 description 2
- INAAIJLSXJJHOZ-UHFFFAOYSA-N pibenzimol Chemical compound C1CN(C)CCN1C1=CC=C(N=C(N2)C=3C=C4NC(=NC4=CC=3)C=3C=CC(O)=CC=3)C2=C1 INAAIJLSXJJHOZ-UHFFFAOYSA-N 0.000 description 2
- 229960003171 plicamycin Drugs 0.000 description 2
- 238000005498 polishing Methods 0.000 description 2
- 229920003229 poly(methyl methacrylate) Polymers 0.000 description 2
- 102000054765 polymorphisms of proteins Human genes 0.000 description 2
- OXCMYAYHXIHQOA-UHFFFAOYSA-N potassium;[2-butyl-5-chloro-3-[[4-[2-(1,2,4-triaza-3-azanidacyclopenta-1,4-dien-5-yl)phenyl]phenyl]methyl]imidazol-4-yl]methanol Chemical compound [K+].CCCCC1=NC(Cl)=C(CO)N1CC1=CC=C(C=2C(=CC=CC=2)C2=N[N-]N=N2)C=C1 OXCMYAYHXIHQOA-UHFFFAOYSA-N 0.000 description 2
- 238000003825 pressing Methods 0.000 description 2
- 238000011002 quantification Methods 0.000 description 2
- 230000001105 regulatory effect Effects 0.000 description 2
- 239000011347 resin Substances 0.000 description 2
- 229920005989 resin Polymers 0.000 description 2
- 229910052707 ruthenium Inorganic materials 0.000 description 2
- 239000004065 semiconductor Substances 0.000 description 2
- HQVNEWCFYHHQES-UHFFFAOYSA-N silicon nitride Chemical compound N12[Si]34N5[Si]62N3[Si]51N64 HQVNEWCFYHHQES-UHFFFAOYSA-N 0.000 description 2
- 229910052708 sodium Inorganic materials 0.000 description 2
- 239000011734 sodium Substances 0.000 description 2
- 235000017557 sodium bicarbonate Nutrition 0.000 description 2
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- 238000001179 sorption measurement Methods 0.000 description 2
- 238000004528 spin coating Methods 0.000 description 2
- 235000000346 sugar Nutrition 0.000 description 2
- FHCPAXDKURNIOZ-UHFFFAOYSA-N tetrathiafulvalene Chemical compound S1C=CSC1=C1SC=CS1 FHCPAXDKURNIOZ-UHFFFAOYSA-N 0.000 description 2
- 150000003573 thiols Chemical class 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- 230000001052 transient effect Effects 0.000 description 2
- 229910001428 transition metal ion Inorganic materials 0.000 description 2
- WFKWXMTUELFFGS-UHFFFAOYSA-N tungsten Chemical compound [W] WFKWXMTUELFFGS-UHFFFAOYSA-N 0.000 description 2
- 229910052721 tungsten Inorganic materials 0.000 description 2
- 239000010937 tungsten Substances 0.000 description 2
- 241000701161 unidentified adenovirus Species 0.000 description 2
- 241001529453 unidentified herpesvirus Species 0.000 description 2
- 241001430294 unidentified retrovirus Species 0.000 description 2
- 229940035893 uracil Drugs 0.000 description 2
- VBEQCZHXXJYVRD-GACYYNSASA-N uroanthelone Chemical compound C([C@@H](C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O)C(C)C)[C@@H](C)O)NC(=O)[C@H](CO)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@@H](NC(=O)[C@H](CC=1NC=NC=1)NC(=O)[C@H](CCSC)NC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)CNC(=O)CNC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CS)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)CNC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@H]1N(CCC1)C(=O)[C@H](CS)NC(=O)CNC(=O)[C@H]1N(CCC1)C(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CC(N)=O)C(C)C)[C@@H](C)CC)C1=CC=C(O)C=C1 VBEQCZHXXJYVRD-GACYYNSASA-N 0.000 description 2
- 125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 description 2
- 239000011787 zinc oxide Substances 0.000 description 2
- KWTSXDURSIMDCE-QMMMGPOBSA-N (S)-amphetamine Chemical compound C[C@H](N)CC1=CC=CC=C1 KWTSXDURSIMDCE-QMMMGPOBSA-N 0.000 description 1
- VOXZDWNPVJITMN-ZBRFXRBCSA-N 17β-estradiol Chemical compound OC1=CC=C2[C@H]3CC[C@](C)([C@H](CC4)O)[C@@H]4[C@@H]3CCC2=C1 VOXZDWNPVJITMN-ZBRFXRBCSA-N 0.000 description 1
- JCLFHZLOKITRCE-UHFFFAOYSA-N 4-pentoxyphenol Chemical compound CCCCCOC1=CC=C(O)C=C1 JCLFHZLOKITRCE-UHFFFAOYSA-N 0.000 description 1
- STQGQHZAVUOBTE-UHFFFAOYSA-N 7-Cyan-hept-2t-en-4,6-diinsaeure Natural products C1=2C(O)=C3C(=O)C=4C(OC)=CC=CC=4C(=O)C3=C(O)C=2CC(O)(C(C)=O)CC1OC1CC(N)C(O)C(C)O1 STQGQHZAVUOBTE-UHFFFAOYSA-N 0.000 description 1
- 229930024421 Adenine Natural products 0.000 description 1
- GFFGJBXGBJISGV-UHFFFAOYSA-N Adenine Chemical compound NC1=NC=NC2=C1N=CN2 GFFGJBXGBJISGV-UHFFFAOYSA-N 0.000 description 1
- 229920000936 Agarose Polymers 0.000 description 1
- 102100023635 Alpha-fetoprotein Human genes 0.000 description 1
- 239000004382 Amylase Substances 0.000 description 1
- 102000013142 Amylases Human genes 0.000 description 1
- 108010065511 Amylases Proteins 0.000 description 1
- 241000712891 Arenavirus Species 0.000 description 1
- JBRZTFJDHDCESZ-UHFFFAOYSA-N AsGa Chemical compound [As]#[Ga] JBRZTFJDHDCESZ-UHFFFAOYSA-N 0.000 description 1
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 1
- 241000193830 Bacillus <bacterium> Species 0.000 description 1
- 229920002799 BoPET Polymers 0.000 description 1
- 241000588807 Bordetella Species 0.000 description 1
- 241000588832 Bordetella pertussis Species 0.000 description 1
- 229910001369 Brass Inorganic materials 0.000 description 1
- 206010006187 Breast cancer Diseases 0.000 description 1
- 208000026310 Breast neoplasm Diseases 0.000 description 1
- 102400000113 Calcitonin Human genes 0.000 description 1
- 108060001064 Calcitonin Proteins 0.000 description 1
- 201000009030 Carcinoma Diseases 0.000 description 1
- 108010001857 Cell Surface Receptors Proteins 0.000 description 1
- 241000606161 Chlamydia Species 0.000 description 1
- 241000606153 Chlamydia trachomatis Species 0.000 description 1
- 239000004099 Chlortetracycline Substances 0.000 description 1
- VYZAMTAEIAYCRO-UHFFFAOYSA-N Chromium Chemical compound [Cr] VYZAMTAEIAYCRO-UHFFFAOYSA-N 0.000 description 1
- 108090000317 Chymotrypsin Proteins 0.000 description 1
- 108010005939 Ciliary Neurotrophic Factor Proteins 0.000 description 1
- 102100031614 Ciliary neurotrophic factor Human genes 0.000 description 1
- 241000193163 Clostridioides difficile Species 0.000 description 1
- 241000193468 Clostridium perfringens Species 0.000 description 1
- 241000193449 Clostridium tetani Species 0.000 description 1
- 206010009944 Colon cancer Diseases 0.000 description 1
- 208000001333 Colorectal Neoplasms Diseases 0.000 description 1
- 208000035473 Communicable disease Diseases 0.000 description 1
- 108020004635 Complementary DNA Proteins 0.000 description 1
- 241000711573 Coronaviridae Species 0.000 description 1
- 241000709687 Coxsackievirus Species 0.000 description 1
- 241000701022 Cytomegalovirus Species 0.000 description 1
- 108010008286 DNA nucleotidylexotransferase Proteins 0.000 description 1
- 102100033215 DNA nucleotidylexotransferase Human genes 0.000 description 1
- 239000003155 DNA primer Substances 0.000 description 1
- 239000003298 DNA probe Substances 0.000 description 1
- WEAHRLBPCANXCN-UHFFFAOYSA-N Daunomycin Natural products CCC1(O)CC(OC2CC(N)C(O)C(C)O2)c3cc4C(=O)c5c(OC)cccc5C(=O)c4c(O)c3C1 WEAHRLBPCANXCN-UHFFFAOYSA-N 0.000 description 1
- 229920002307 Dextran Polymers 0.000 description 1
- LTMHDMANZUZIPE-AMTYYWEZSA-N Digoxin Natural products O([C@H]1[C@H](C)O[C@H](O[C@@H]2C[C@@H]3[C@@](C)([C@@H]4[C@H]([C@]5(O)[C@](C)([C@H](O)C4)[C@H](C4=CC(=O)OC4)CC5)CC3)CC2)C[C@@H]1O)[C@H]1O[C@H](C)[C@@H](O[C@H]2O[C@@H](C)[C@H](O)[C@@H](O)C2)[C@@H](O)C1 LTMHDMANZUZIPE-AMTYYWEZSA-N 0.000 description 1
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 1
- 241000709661 Enterovirus Species 0.000 description 1
- 241000588724 Escherichia coli Species 0.000 description 1
- 108010068561 Fructose-Bisphosphate Aldolase Proteins 0.000 description 1
- 102000001390 Fructose-Bisphosphate Aldolase Human genes 0.000 description 1
- 229910001218 Gallium arsenide Inorganic materials 0.000 description 1
- 241001556449 Garrha rubella Species 0.000 description 1
- 241001123589 Gorilla papillomavirus Species 0.000 description 1
- 108010010369 HIV Protease Proteins 0.000 description 1
- 241000606790 Haemophilus Species 0.000 description 1
- 102000002265 Human Growth Hormone Human genes 0.000 description 1
- 108010000521 Human Growth Hormone Proteins 0.000 description 1
- 239000000854 Human Growth Hormone Substances 0.000 description 1
- 102000008100 Human Serum Albumin Human genes 0.000 description 1
- 108091006905 Human Serum Albumin Proteins 0.000 description 1
- 206010020460 Human T-cell lymphotropic virus type I infection Diseases 0.000 description 1
- 241000714260 Human T-lymphotropic virus 1 Species 0.000 description 1
- 241000714259 Human T-lymphotropic virus 2 Species 0.000 description 1
- 241000701085 Human alphaherpesvirus 3 Species 0.000 description 1
- GPXJNWSHGFTCBW-UHFFFAOYSA-N Indium phosphide Chemical compound [In]#P GPXJNWSHGFTCBW-UHFFFAOYSA-N 0.000 description 1
- 229930010555 Inosine Natural products 0.000 description 1
- UGQMRVRMYYASKQ-KQYNXXCUSA-N Inosine Chemical compound O[C@@H]1[C@H](O)[C@@H](CO)O[C@H]1N1C2=NC=NC(O)=C2N=C1 UGQMRVRMYYASKQ-KQYNXXCUSA-N 0.000 description 1
- 108090001061 Insulin Proteins 0.000 description 1
- 102000004877 Insulin Human genes 0.000 description 1
- 102000004218 Insulin-Like Growth Factor I Human genes 0.000 description 1
- 108010002352 Interleukin-1 Proteins 0.000 description 1
- 102000015696 Interleukins Human genes 0.000 description 1
- 108010063738 Interleukins Proteins 0.000 description 1
- 229920000271 Kevlar® Polymers 0.000 description 1
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 1
- 102000003855 L-lactate dehydrogenase Human genes 0.000 description 1
- 108700023483 L-lactate dehydrogenases Proteins 0.000 description 1
- 241000713666 Lentivirus Species 0.000 description 1
- 102000016267 Leptin Human genes 0.000 description 1
- 108010092277 Leptin Proteins 0.000 description 1
- NNJVILVZKWQKPM-UHFFFAOYSA-N Lidocaine Chemical compound CCN(CC)CC(=O)NC1=C(C)C=CC=C1C NNJVILVZKWQKPM-UHFFFAOYSA-N 0.000 description 1
- 102000003960 Ligases Human genes 0.000 description 1
- 108090000364 Ligases Proteins 0.000 description 1
- HBBGRARXTFLTSG-UHFFFAOYSA-N Lithium ion Chemical compound [Li+] HBBGRARXTFLTSG-UHFFFAOYSA-N 0.000 description 1
- 241000712079 Measles morbillivirus Species 0.000 description 1
- 241000711386 Mumps virus Species 0.000 description 1
- 241000186362 Mycobacterium leprae Species 0.000 description 1
- 239000005041 Mylar™ Substances 0.000 description 1
- 102100030856 Myoglobin Human genes 0.000 description 1
- 108010062374 Myoglobin Proteins 0.000 description 1
- 241000588652 Neisseria gonorrhoeae Species 0.000 description 1
- 241000588650 Neisseria meningitidis Species 0.000 description 1
- 239000000020 Nitrocellulose Substances 0.000 description 1
- 241000714209 Norwalk virus Species 0.000 description 1
- 239000004677 Nylon Substances 0.000 description 1
- 108010038807 Oligopeptides Proteins 0.000 description 1
- 102000015636 Oligopeptides Human genes 0.000 description 1
- 102000043276 Oncogene Human genes 0.000 description 1
- 108700020796 Oncogene Proteins 0.000 description 1
- 241000150452 Orthohantavirus Species 0.000 description 1
- 241000702244 Orthoreovirus Species 0.000 description 1
- 206010033128 Ovarian cancer Diseases 0.000 description 1
- 206010061535 Ovarian neoplasm Diseases 0.000 description 1
- 208000016222 Pancreatic disease Diseases 0.000 description 1
- 108010002747 Pfu DNA polymerase Proteins 0.000 description 1
- 241000709664 Picornaviridae Species 0.000 description 1
- KMSKQZKKOZQFFG-HSUXVGOQSA-N Pirarubicin Chemical compound O([C@H]1[C@@H](N)C[C@@H](O[C@H]1C)O[C@H]1C[C@@](O)(CC=2C(O)=C3C(=O)C=4C=CC=C(C=4C(=O)C3=C(O)C=21)OC)C(=O)CO)[C@H]1CCCCO1 KMSKQZKKOZQFFG-HSUXVGOQSA-N 0.000 description 1
- 239000004698 Polyethylene Substances 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- 239000004642 Polyimide Substances 0.000 description 1
- 241001505332 Polyomavirus sp. Species 0.000 description 1
- 239000004743 Polypropylene Substances 0.000 description 1
- 239000004793 Polystyrene Substances 0.000 description 1
- 102000003946 Prolactin Human genes 0.000 description 1
- 108010057464 Prolactin Proteins 0.000 description 1
- 102100035703 Prostatic acid phosphatase Human genes 0.000 description 1
- 241000125945 Protoparvovirus Species 0.000 description 1
- 241000589516 Pseudomonas Species 0.000 description 1
- 241000711798 Rabies lyssavirus Species 0.000 description 1
- 241000702670 Rotavirus Species 0.000 description 1
- 241000607142 Salmonella Species 0.000 description 1
- 241000293871 Salmonella enterica subsp. enterica serovar Typhi Species 0.000 description 1
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 description 1
- 241000607768 Shigella Species 0.000 description 1
- 241000580858 Simian-Human immunodeficiency virus Species 0.000 description 1
- 241000700584 Simplexvirus Species 0.000 description 1
- 102000013275 Somatomedins Human genes 0.000 description 1
- 241000191940 Staphylococcus Species 0.000 description 1
- 229910000831 Steel Inorganic materials 0.000 description 1
- 241000194017 Streptococcus Species 0.000 description 1
- 241000193996 Streptococcus pyogenes Species 0.000 description 1
- PPBRXRYQALVLMV-UHFFFAOYSA-N Styrene Natural products C=CC1=CC=CC=C1 PPBRXRYQALVLMV-UHFFFAOYSA-N 0.000 description 1
- 241000718007 Taenionema palladium Species 0.000 description 1
- 108010006785 Taq Polymerase Proteins 0.000 description 1
- 229910003087 TiOx Inorganic materials 0.000 description 1
- ATJFFYVFTNAWJD-UHFFFAOYSA-N Tin Chemical compound [Sn] ATJFFYVFTNAWJD-UHFFFAOYSA-N 0.000 description 1
- 108090000992 Transferases Proteins 0.000 description 1
- 102000004357 Transferases Human genes 0.000 description 1
- 102000004887 Transforming Growth Factor beta Human genes 0.000 description 1
- 108090001012 Transforming Growth Factor beta Proteins 0.000 description 1
- 102000009618 Transforming Growth Factors Human genes 0.000 description 1
- 108010009583 Transforming Growth Factors Proteins 0.000 description 1
- 102400001320 Transforming growth factor alpha Human genes 0.000 description 1
- 101800004564 Transforming growth factor alpha Proteins 0.000 description 1
- 241000589886 Treponema Species 0.000 description 1
- 108090000631 Trypsin Proteins 0.000 description 1
- 102000004142 Trypsin Human genes 0.000 description 1
- 241000700618 Vaccinia virus Species 0.000 description 1
- 241000700647 Variola virus Species 0.000 description 1
- 108010019530 Vascular Endothelial Growth Factors Proteins 0.000 description 1
- 102000005789 Vascular Endothelial Growth Factors Human genes 0.000 description 1
- 241000607598 Vibrio Species 0.000 description 1
- 241000607626 Vibrio cholerae Species 0.000 description 1
- 229910001093 Zr alloy Inorganic materials 0.000 description 1
- USZYSDMBJDPRIF-SVEJIMAYSA-N aclacinomycin A Chemical compound O([C@H]1[C@@H](O)C[C@@H](O[C@H]1C)O[C@H]1[C@H](C[C@@H](O[C@H]1C)O[C@H]1C[C@]([C@@H](C2=CC=3C(=O)C4=CC=CC(O)=C4C(=O)C=3C(O)=C21)C(=O)OC)(O)CC)N(C)C)[C@H]1CCC(=O)[C@H](C)O1 USZYSDMBJDPRIF-SVEJIMAYSA-N 0.000 description 1
- 229960004176 aclarubicin Drugs 0.000 description 1
- 229920006397 acrylic thermoplastic Polymers 0.000 description 1
- 239000012190 activator Substances 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 229960000643 adenine Drugs 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 239000011543 agarose gel Substances 0.000 description 1
- 108010026331 alpha-Fetoproteins Proteins 0.000 description 1
- 230000004075 alteration Effects 0.000 description 1
- 229940025084 amphetamine Drugs 0.000 description 1
- 235000019418 amylase Nutrition 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 150000001450 anions Chemical class 0.000 description 1
- 238000000137 annealing Methods 0.000 description 1
- 239000000935 antidepressant agent Substances 0.000 description 1
- 229940005513 antidepressants Drugs 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 239000008365 aqueous carrier Substances 0.000 description 1
- 229910052785 arsenic Inorganic materials 0.000 description 1
- RQNWIZPPADIBDY-UHFFFAOYSA-N arsenic atom Chemical compound [As] RQNWIZPPADIBDY-UHFFFAOYSA-N 0.000 description 1
- 229940009098 aspartate Drugs 0.000 description 1
- 244000052616 bacterial pathogen Species 0.000 description 1
- 230000005540 biological transmission Effects 0.000 description 1
- 229960001561 bleomycin Drugs 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 210000001185 bone marrow Anatomy 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 239000010951 brass Substances 0.000 description 1
- 229940124630 bronchodilator Drugs 0.000 description 1
- 239000000168 bronchodilator agent Substances 0.000 description 1
- 229910052793 cadmium Inorganic materials 0.000 description 1
- BDOSMKKIYDKNTQ-UHFFFAOYSA-N cadmium atom Chemical compound [Cd] BDOSMKKIYDKNTQ-UHFFFAOYSA-N 0.000 description 1
- 229960004015 calcitonin Drugs 0.000 description 1
- BBBFJLBPOGFECG-VJVYQDLKSA-N calcitonin Chemical compound N([C@H](C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC=1NC=NC=1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H]([C@@H](C)O)C(=O)N1[C@@H](CCC1)C(N)=O)C(C)C)C(=O)[C@@H]1CSSC[C@H](N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)O)C(=O)N1 BBBFJLBPOGFECG-VJVYQDLKSA-N 0.000 description 1
- 238000004364 calculation method Methods 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 238000010351 charge transfer process Methods 0.000 description 1
- 239000013626 chemical specie Substances 0.000 description 1
- 229960005091 chloramphenicol Drugs 0.000 description 1
- WIIZWVCIJKGZOK-RKDXNWHRSA-N chloramphenicol Chemical compound ClC(Cl)C(=O)N[C@H](CO)[C@H](O)C1=CC=C([N+]([O-])=O)C=C1 WIIZWVCIJKGZOK-RKDXNWHRSA-N 0.000 description 1
- CYDMQBQPVICBEU-UHFFFAOYSA-N chlorotetracycline Natural products C1=CC(Cl)=C2C(O)(C)C3CC4C(N(C)C)C(O)=C(C(N)=O)C(=O)C4(O)C(O)=C3C(=O)C2=C1O CYDMQBQPVICBEU-UHFFFAOYSA-N 0.000 description 1
- 229960004475 chlortetracycline Drugs 0.000 description 1
- CYDMQBQPVICBEU-XRNKAMNCSA-N chlortetracycline Chemical compound C1=CC(Cl)=C2[C@](O)(C)[C@H]3C[C@H]4[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]4(O)C(O)=C3C(=O)C2=C1O CYDMQBQPVICBEU-XRNKAMNCSA-N 0.000 description 1
- 235000019365 chlortetracycline Nutrition 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 229910052804 chromium Inorganic materials 0.000 description 1
- 239000011651 chromium Substances 0.000 description 1
- ZYVSOIYQKUDENJ-WKSBCEQHSA-N chromomycin A3 Chemical compound O([C@@H]1C[C@@H](O[C@H](C)[C@@H]1OC(C)=O)OC=1C=C2C=C3C[C@H]([C@@H](C(=O)C3=C(O)C2=C(O)C=1C)O[C@@H]1O[C@H](C)[C@@H](O)[C@H](O[C@@H]2O[C@H](C)[C@@H](O)[C@H](O[C@@H]3O[C@@H](C)[C@H](OC(C)=O)[C@@](C)(O)C3)C2)C1)[C@H](OC)C(=O)[C@@H](O)[C@@H](C)O)[C@@H]1C[C@@H](O)[C@@H](OC)[C@@H](C)O1 ZYVSOIYQKUDENJ-WKSBCEQHSA-N 0.000 description 1
- 229960002376 chymotrypsin Drugs 0.000 description 1
- 238000010344 co-firing Methods 0.000 description 1
- 229960003920 cocaine Drugs 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 239000002131 composite material Substances 0.000 description 1
- 239000000356 contaminant Substances 0.000 description 1
- PMHQVHHXPFUNSP-UHFFFAOYSA-M copper(1+);methylsulfanylmethane;bromide Chemical compound Br[Cu].CSC PMHQVHHXPFUNSP-UHFFFAOYSA-M 0.000 description 1
- 229960003624 creatine Drugs 0.000 description 1
- 239000006046 creatine Substances 0.000 description 1
- DMSZORWOGDLWGN-UHFFFAOYSA-N ctk1a3526 Chemical compound NP(N)(N)=O DMSZORWOGDLWGN-UHFFFAOYSA-N 0.000 description 1
- 229940104302 cytosine Drugs 0.000 description 1
- STQGQHZAVUOBTE-VGBVRHCVSA-N daunorubicin Chemical compound O([C@H]1C[C@@](O)(CC=2C(O)=C3C(=O)C=4C=CC=C(C=4C(=O)C3=C(O)C=21)OC)C(C)=O)[C@H]1C[C@H](N)[C@H](O)[C@H](C)O1 STQGQHZAVUOBTE-VGBVRHCVSA-N 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 238000005137 deposition process Methods 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- VEVRNHHLCPGNDU-MUGJNUQGSA-O desmosine Chemical compound OC(=O)[C@@H](N)CCCC[N+]1=CC(CC[C@H](N)C(O)=O)=C(CCC[C@H](N)C(O)=O)C(CC[C@H](N)C(O)=O)=C1 VEVRNHHLCPGNDU-MUGJNUQGSA-O 0.000 description 1
- 230000010460 detection of virus Effects 0.000 description 1
- 239000003599 detergent Substances 0.000 description 1
- NIJJYAXOARWZEE-UHFFFAOYSA-N di-n-propyl-acetic acid Natural products CCCC(C(O)=O)CCC NIJJYAXOARWZEE-UHFFFAOYSA-N 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- LTMHDMANZUZIPE-PUGKRICDSA-N digoxin Chemical compound C1[C@H](O)[C@H](O)[C@@H](C)O[C@H]1O[C@@H]1[C@@H](C)O[C@@H](O[C@@H]2[C@H](O[C@@H](O[C@@H]3C[C@@H]4[C@]([C@@H]5[C@H]([C@]6(CC[C@@H]([C@@]6(C)[C@H](O)C5)C=5COC(=O)C=5)O)CC4)(C)CC3)C[C@@H]2O)C)C[C@@H]1O LTMHDMANZUZIPE-PUGKRICDSA-N 0.000 description 1
- 229960005156 digoxin Drugs 0.000 description 1
- LTMHDMANZUZIPE-UHFFFAOYSA-N digoxine Natural products C1C(O)C(O)C(C)OC1OC1C(C)OC(OC2C(OC(OC3CC4C(C5C(C6(CCC(C6(C)C(O)C5)C=5COC(=O)C=5)O)CC4)(C)CC3)CC2O)C)CC1O LTMHDMANZUZIPE-UHFFFAOYSA-N 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 229910001873 dinitrogen Inorganic materials 0.000 description 1
- NAGJZTKCGNOGPW-UHFFFAOYSA-K dioxido-sulfanylidene-sulfido-$l^{5}-phosphane Chemical compound [O-]P([O-])([S-])=S NAGJZTKCGNOGPW-UHFFFAOYSA-K 0.000 description 1
- UVTNFZQICZKOEM-UHFFFAOYSA-N disopyramide Chemical compound C=1C=CC=NC=1C(C(N)=O)(CCN(C(C)C)C(C)C)C1=CC=CC=C1 UVTNFZQICZKOEM-UHFFFAOYSA-N 0.000 description 1
- 229960001066 disopyramide Drugs 0.000 description 1
- 239000002270 dispersing agent Substances 0.000 description 1
- 229960004679 doxorubicin Drugs 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 238000004070 electrodeposition Methods 0.000 description 1
- 238000001962 electrophoresis Methods 0.000 description 1
- 238000004049 embossing Methods 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- 230000000688 enterotoxigenic effect Effects 0.000 description 1
- 239000002532 enzyme inhibitor Substances 0.000 description 1
- 229940125532 enzyme inhibitor Drugs 0.000 description 1
- 229960005309 estradiol Drugs 0.000 description 1
- 229930182833 estradiol Natural products 0.000 description 1
- 150000002170 ethers Chemical group 0.000 description 1
- HAPOVYFOVVWLRS-UHFFFAOYSA-N ethosuximide Chemical compound CCC1(C)CC(=O)NC1=O HAPOVYFOVVWLRS-UHFFFAOYSA-N 0.000 description 1
- 229960002767 ethosuximide Drugs 0.000 description 1
- 210000003527 eukaryotic cell Anatomy 0.000 description 1
- 230000007717 exclusion Effects 0.000 description 1
- 210000003608 fece Anatomy 0.000 description 1
- 239000007888 film coating Substances 0.000 description 1
- 238000009501 film coating Methods 0.000 description 1
- 230000004907 flux Effects 0.000 description 1
- 239000005350 fused silica glass Substances 0.000 description 1
- 230000002068 genetic effect Effects 0.000 description 1
- 230000009477 glass transition Effects 0.000 description 1
- 239000003102 growth factor Substances 0.000 description 1
- 208000019622 heart disease Diseases 0.000 description 1
- 208000006454 hepatitis Diseases 0.000 description 1
- 231100000283 hepatitis Toxicity 0.000 description 1
- 230000003054 hormonal effect Effects 0.000 description 1
- 150000002430 hydrocarbons Chemical group 0.000 description 1
- 229960000890 hydrocortisone Drugs 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- AMGQUBHHOARCQH-UHFFFAOYSA-N indium;oxotin Chemical compound [In].[Sn]=O AMGQUBHHOARCQH-UHFFFAOYSA-N 0.000 description 1
- 239000012678 infectious agent Substances 0.000 description 1
- 229910010272 inorganic material Inorganic materials 0.000 description 1
- 239000011147 inorganic material Substances 0.000 description 1
- 229960003786 inosine Drugs 0.000 description 1
- 239000002917 insecticide Substances 0.000 description 1
- 238000009413 insulation Methods 0.000 description 1
- 229940125396 insulin Drugs 0.000 description 1
- 229940047122 interleukins Drugs 0.000 description 1
- 238000005304 joining Methods 0.000 description 1
- 239000004761 kevlar Substances 0.000 description 1
- 229910000833 kovar Inorganic materials 0.000 description 1
- 239000011133 lead Substances 0.000 description 1
- 229940039781 leptin Drugs 0.000 description 1
- NRYBAZVQPHGZNS-ZSOCWYAHSA-N leptin Chemical compound O=C([C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC=1C2=CC=CC=C2NC=1)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)CNC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](N)CC(C)C)CCSC)N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](CS)C(O)=O NRYBAZVQPHGZNS-ZSOCWYAHSA-N 0.000 description 1
- 229960004194 lidocaine Drugs 0.000 description 1
- 238000004502 linear sweep voltammetry Methods 0.000 description 1
- 229910052744 lithium Inorganic materials 0.000 description 1
- 229940006487 lithium cation Drugs 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 230000003908 liver function Effects 0.000 description 1
- 238000011068 loading method Methods 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 210000002751 lymph Anatomy 0.000 description 1
- 230000001404 mediated effect Effects 0.000 description 1
- 102000006240 membrane receptors Human genes 0.000 description 1
- 229960001252 methamphetamine Drugs 0.000 description 1
- MYWUZJCMWCOHBA-VIFPVBQESA-N methamphetamine Chemical compound CN[C@@H](C)CC1=CC=CC=C1 MYWUZJCMWCOHBA-VIFPVBQESA-N 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 239000004005 microsphere Substances 0.000 description 1
- 229960004023 minocycline Drugs 0.000 description 1
- DYKFCLLONBREIL-KVUCHLLUSA-N minocycline Chemical compound C([C@H]1C2)C3=C(N(C)C)C=CC(O)=C3C(=O)C1=C(O)[C@@]1(O)[C@@H]2[C@H](N(C)C)C(O)=C(C(N)=O)C1=O DYKFCLLONBREIL-KVUCHLLUSA-N 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 230000001537 neural effect Effects 0.000 description 1
- 230000003472 neutralizing effect Effects 0.000 description 1
- 229910052759 nickel Inorganic materials 0.000 description 1
- 229920001220 nitrocellulos Polymers 0.000 description 1
- 230000009871 nonspecific binding Effects 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 229920001778 nylon Polymers 0.000 description 1
- 229940127240 opiate Drugs 0.000 description 1
- 239000012074 organic phase Substances 0.000 description 1
- 229920000620 organic polymer Polymers 0.000 description 1
- RVTZCBVAJQQJTK-UHFFFAOYSA-N oxygen(2-);zirconium(4+) Chemical compound [O-2].[O-2].[Zr+4] RVTZCBVAJQQJTK-UHFFFAOYSA-N 0.000 description 1
- 229910052763 palladium Inorganic materials 0.000 description 1
- 230000000149 penetrating effect Effects 0.000 description 1
- 239000000816 peptidomimetic Substances 0.000 description 1
- 239000000575 pesticide Substances 0.000 description 1
- DDBREPKUVSBGFI-UHFFFAOYSA-N phenobarbital Chemical compound C=1C=CC=CC=1C1(CC)C(=O)NC(=O)NC1=O DDBREPKUVSBGFI-UHFFFAOYSA-N 0.000 description 1
- 125000002467 phosphate group Chemical group [H]OP(=O)(O[H])O[*] 0.000 description 1
- 229960001221 pirarubicin Drugs 0.000 description 1
- 239000013612 plasmid Substances 0.000 description 1
- 239000004014 plasticizer Substances 0.000 description 1
- 229920003223 poly(pyromellitimide-1,4-diphenyl ether) Polymers 0.000 description 1
- 229920000515 polycarbonate Polymers 0.000 description 1
- 239000004417 polycarbonate Substances 0.000 description 1
- 229920000573 polyethylene Polymers 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 229920000139 polyethylene terephthalate Polymers 0.000 description 1
- 229920001721 polyimide Polymers 0.000 description 1
- 229920005596 polymer binder Polymers 0.000 description 1
- 239000002491 polymer binding agent Substances 0.000 description 1
- 239000004926 polymethyl methacrylate Substances 0.000 description 1
- 229920001155 polypropylene Polymers 0.000 description 1
- 229920002223 polystyrene Polymers 0.000 description 1
- 229920001343 polytetrafluoroethylene Polymers 0.000 description 1
- 239000004810 polytetrafluoroethylene Substances 0.000 description 1
- 229920000123 polythiophene Polymers 0.000 description 1
- REQCZEXYDRLIBE-UHFFFAOYSA-N procainamide Chemical compound CCN(CC)CCNC(=O)C1=CC=C(N)C=C1 REQCZEXYDRLIBE-UHFFFAOYSA-N 0.000 description 1
- 229960000244 procainamide Drugs 0.000 description 1
- 229940097325 prolactin Drugs 0.000 description 1
- 108010043671 prostatic acid phosphatase Proteins 0.000 description 1
- 125000006239 protecting group Chemical group 0.000 description 1
- 238000004080 punching Methods 0.000 description 1
- 238000010926 purge Methods 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 239000010453 quartz Substances 0.000 description 1
- 238000006479 redox reaction Methods 0.000 description 1
- 230000000241 respiratory effect Effects 0.000 description 1
- 238000012552 review Methods 0.000 description 1
- FZYOVNIOYYPUPY-ZTWDQPHTSA-N rifampicin Chemical compound O([C@](C1=O)(C)O/C=C/[C@@H]([C@H]([C@@H](OC(C)=O)[C@H](C)[C@H](O)[C@H](C)[C@@H](O)[C@@H](C)\C=C\C=C(C)/C(=O)NC2=C(O)C=3C(O)=C4C)C)OC)C4=C1C=3C(=O)\C2=C\NN1CCN(C)CC1 FZYOVNIOYYPUPY-ZTWDQPHTSA-N 0.000 description 1
- 229960001225 rifampicin Drugs 0.000 description 1
- 210000003296 saliva Anatomy 0.000 description 1
- 239000010980 sapphire Substances 0.000 description 1
- 229910052594 sapphire Inorganic materials 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 229910052711 selenium Inorganic materials 0.000 description 1
- 239000011669 selenium Substances 0.000 description 1
- 238000005389 semiconductor device fabrication Methods 0.000 description 1
- HBMJWWWQQXIZIP-UHFFFAOYSA-N silicon carbide Chemical compound [Si+]#[C-] HBMJWWWQQXIZIP-UHFFFAOYSA-N 0.000 description 1
- 229910010271 silicon carbide Inorganic materials 0.000 description 1
- 239000008279 sol Substances 0.000 description 1
- 230000009870 specific binding Effects 0.000 description 1
- 210000000952 spleen Anatomy 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 239000010959 steel Substances 0.000 description 1
- 150000008163 sugars Chemical class 0.000 description 1
- 229940124530 sulfonamide Drugs 0.000 description 1
- 150000003456 sulfonamides Chemical class 0.000 description 1
- 229910000601 superalloy Inorganic materials 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 229910052715 tantalum Inorganic materials 0.000 description 1
- GUVRBAGPIYLISA-UHFFFAOYSA-N tantalum atom Chemical compound [Ta] GUVRBAGPIYLISA-UHFFFAOYSA-N 0.000 description 1
- 238000010345 tape casting Methods 0.000 description 1
- 238000001447 template-directed synthesis Methods 0.000 description 1
- ISXSCDLOGDJUNJ-UHFFFAOYSA-N tert-butyl prop-2-enoate Chemical compound CC(C)(C)OC(=O)C=C ISXSCDLOGDJUNJ-UHFFFAOYSA-N 0.000 description 1
- 229960003604 testosterone Drugs 0.000 description 1
- ZRKFYGHZFMAOKI-QMGMOQQFSA-N tgfbeta Chemical compound C([C@H](NC(=O)[C@H](C(C)C)NC(=O)CNC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCSC)C(C)C)[C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](C)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N1[C@@H](CCC1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(O)=O)C1=CC=C(O)C=C1 ZRKFYGHZFMAOKI-QMGMOQQFSA-N 0.000 description 1
- 150000007970 thio esters Chemical class 0.000 description 1
- RYYWUUFWQRZTIU-UHFFFAOYSA-K thiophosphate Chemical compound [O-]P([O-])([O-])=S RYYWUUFWQRZTIU-UHFFFAOYSA-K 0.000 description 1
- 229910052718 tin Inorganic materials 0.000 description 1
- 239000011135 tin Substances 0.000 description 1
- HLLICFJUWSZHRJ-UHFFFAOYSA-N tioxidazole Chemical compound CCCOC1=CC=C2N=C(NC(=O)OC)SC2=C1 HLLICFJUWSZHRJ-UHFFFAOYSA-N 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 108700012359 toxins Proteins 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- QVWDCTQRORVHHT-UHFFFAOYSA-N tropone Chemical compound O=C1C=CC=CC=C1 QVWDCTQRORVHHT-UHFFFAOYSA-N 0.000 description 1
- 239000012588 trypsin Substances 0.000 description 1
- 201000008827 tuberculosis Diseases 0.000 description 1
- 210000004881 tumor cell Anatomy 0.000 description 1
- 241000712461 unidentified influenza virus Species 0.000 description 1
- 238000011144 upstream manufacturing Methods 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- MSRILKIQRXUYCT-UHFFFAOYSA-M valproate semisodium Chemical compound [Na+].CCCC(C(O)=O)CCC.CCCC(C([O-])=O)CCC MSRILKIQRXUYCT-UHFFFAOYSA-M 0.000 description 1
- 229960000604 valproic acid Drugs 0.000 description 1
- 108700026220 vif Genes Proteins 0.000 description 1
- 229920002554 vinyl polymer Chemical group 0.000 description 1
- 230000003612 virological effect Effects 0.000 description 1
- 235000012431 wafers Nutrition 0.000 description 1
- 229910001928 zirconium oxide Inorganic materials 0.000 description 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
- G01N33/54366—Apparatus specially adapted for solid-phase testing
- G01N33/54373—Apparatus specially adapted for solid-phase testing involving physiochemical end-point determination, e.g. wave-guides, FETS, gratings
- G01N33/5438—Electrodes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6813—Hybridisation assays
- C12Q1/6816—Hybridisation assays characterised by the detection means
- C12Q1/6825—Nucleic acid detection involving sensors
Definitions
- This invention relates to the detection of molecular interactions between biological molecules. Specifically, the invention relates to electrical detection of interactions such as hybridization between nucleic acids or peptide antigen-antibody interactions using arrays of peptides or ohgonucleotides. In particular, the invention relates to an apparatus and methods for detecting nucleic acid hybridization or peptide binding using electronic methods including AC impedance. In some embodiments, no electrochemical or other label moieties are used. In others, electrochemicaily active labels are used to detect reactions on hydrogel arrays, including genotyping reactions such as the single base extension reaction.
- a number of commonly-utilized biological applications including for example, diagnoses of genetic disease, analyses of sequence polymorphisms, and studies of receptor-ligand interactions, rely on the ability of analytical technologies to readily detect events related to the interaction between probe and target molecules. While these molecular detection technologies have traditionally utilized radioactive isotopes or fluorescent compounds to monitor probe-target interactions, methods for the electrical detection of molecular interactions have provided an attractive alternative to detection techniques relying on radioactive or fluorescent labels
- Electrical and electrochemical detection techniques are based on the detection of alterations in the electrical properties of an electrode arising from interactions between probe molecules on the surface of the electrode and target molecules in the reaction mixture. Electrical or electrochemical detection eliminates many of the disadvantages inherent in use of radioactive or fluorescent labels to discern molecular interactions. This process offers, for example, a detection technique that is safe, inexpensive, and sensitive, and is not burdened with complex and onerous regulatory requirements.
- electrical or electrochemical detection techniques for analyzing molecular interactions.
- One such obstacle is the requirement, in some methods, of incorporating an electrochemical label into the target molecule.
- labeled target molecules have been used to increase the signal produced upon the formation of nucleic acid duplexes during hybridization assays.
- Heller ef al. (in U.S. Patent Nos. 5,605,662 and 5,632,957) provide methods for controlling molecular biological reactions in microscopic formats that utilize a self-addressable, self- assembling microelectronic apparatus.
- Heller et al. further provide an apparatus in which target molecules labeled with fluorescent dyes are transported by free field electrophoresis to specific test sites where the target molecules are concentrated thereby, and reacted with specific probes bound to that test site. Unbound or non-specifically interacting target molecules are thereafter removed by reversing the electric polarity at the test site. Interactions between probe and target molecules are subsequently assayed using optical means
- Hollis ef al. in U S. Patent Nos. 5,653,939 and 5,846,708, provide a meth ⁇ "d and apparatus for identifying molecular structures within a sample substance using a monolithic array of test sites formed on a substrate upon which the sample substance is applied
- changes in the electromagnetic or acoustic properties - for example, the change in resonant frequency - of the test sites following the addition of the sample substance are detected in order to determine which probes have interacted with target molecules in the sample substance.
- Eggers et al. (in U S. Patent Nos. 5,532,128, 5,670,322, and 5,891 ,630) provide a method and apparatus for identifying molecular structures within a sample substance
- a plurality of test sites to which probes have been bound is exposed to a sample substance and then an electrical signal is applied to the test sites The dielect ⁇ cal properties of the test sites are subsequently detected to determine which probes have interacted with target molecules in the sample substance
- Guschin et al 1997, Anal Biochem 250 203-11 describe a technique for detecting molecular interactions between target molecules in a biological sample solution and polyacrylamide gel- immobilized probes on a glass substrate
- molecular interactions between probes and target molecules are detected using optical reporters
- the Guschin et al reference neither teaches nor suggests using electrical or electrochemical detection techniques to detect hybridization between target molecules and immobilized probes
- Guschin et al 1997, Appl Environ Mtcrobiol 63 2397-402 also describe the fabrication of microarrays through the immobilization of oligonucleotide probes on a polyacrylamide gel pad placed in contact with a glass substrate
- parallel hybridization between target nucleic acids and immobilized probes is detected using optical reporter moieties
- This Guschin et al reference also does not teach or suggest using electrical or electrochemical detection techniques in combination with the immobilization of probes on polyacrylamide gel pads
- nucleic acid-based assays also play an important role in identifying infectious microorganisms such as bacteria and viruses, in assessing levels of both normal and defective gene expression, and in detecting and identifying mutant genes associated with disease such as oncogenes Improvements in the speed, efficiency, economy and specificity of such assays are thus significant needs in the medical arts
- nucleic acid assays should be sensitive, specific and easily amenable to automation
- Efforts to improve sensitivity in nucleic acid assays are known in the prior art
- the polymerase chain reaction (Mullis, U S Patent No 4,683,195, issued July 28, 1987) provides the capacity to produce useful amounts (about 1 ⁇ g) of a specific nucleic acid in a sample in which the original amount of the specific nucleic acid is substantially smaller (about 1 pg)
- the prior art has been much less successful in improving specificity of nucleic acid hybridization assays
- nucleic acid assays The specificity of nucleic acid assays is determined by the extent of molecular complementarity of hybridization between probe and target sequences Although it is theoretically possible to distinguish complementary targets from one or two mismatched targets under rigorously-defined conditions, the dependence of hybridization on target/probe concentration and hybridization conditions limits the extent to which hybridization mismatch can be used to reliably detect, inter alia mutations and genetic polymorphisms
- U S Patent No 5,925,520 disclosed a method for detecting genetic polymorphisms using single base extension and capture groups on oligonucleotide probes using at least two types of dideoxy, chain-terminating nucleotide t ⁇ phosphates, each labeled with a detectable and distinguishable fluorescent labeling group
- U S Patent No 5,710,028 disclosed a method of determining the identity of nucleotide bases at specific positions in nucleic acids of interest, using detectably-labeled chain-terminating nucleotides, each detectably and distinguishably labeled with a fluorescent labeling group
- U S Patent No 5,547,839 disclosed a method for determining the identity of nucleotide bases at specific positions in a nucleic acid of interest, using chain-terminating nucleotides comprising a photoremovable protecting group
- U S Patent No 5,534,424 disclosed a method for determining the identity of nucleotide bases at specific positions in a nucleic acid of interest, using each of four aliquots of a target nucleic acid annealed to an extension primer and extended with one of four chain-terminating species, and then further extended with all four chain-extending nucleotides, whereby the identity of the nucleotide at the position of interest is identified by failure of the primer to be extended more that a single base
- U S Patent No 4,988,617 disclosed a method for determining the identity of nucleotide bases at specific positions in a nucleic acid of interest, by annealing two adjacent nucleotide primers to a target nucleic acid and providing a linking agent such as a ligase that covalentiy links the two ohgonucleotides to produce a third, combined oligonucleotide only under circumstances wherein the two ohgonucleotides are perfectly matched to the target nu
- U S Patent No 4,656,127 disclosed a method for determining the identity of nucleotide bases at specific positions in a nucleic acid of interest, using primer extension with a chain-terminating or other nucleotide comprising an exonuclease-resistant linkage, followed by exonuclease treatment of the plurality of extension products to detect the resistant species therein
- a significant drawback of single base extension methods based on fluorescent label detection is the need for expensive and technically-complex optical components for detecting the fluorescent label
- fluorescent probes used in such methods impart an adequate level of discrimination between extended and unextended positions in an oligonucleotide array
- these methods typically require detection of up to four different fluorescent labels, each having a unique excitation and fluorescence emission frequency
- assay systems must be capable of producing and distinguishing light at all of these different excitation and emission frequencies, significantly increasing the cost and complexity of producing and operating apparatus used in the practice thereof
- An alternative method for detecting a target nucleic acid molecule is to use an electrochemical tag (or label) such as a redox moiety in combination with an electrochemical detection means such as cyclic voltammetry, some of which are discussed above
- the present invention provides an apparatus and methods, using cations in an electrolyte solution, for detecting the nature and extent of molecular interactions between probe and target molecules
- the most preferred embodiments of the methods of the invention utilize AC impedance for said detection
- the apparatus and methods of the present invention have the advantage of providing electrical detection without any additional requirement that the target molecule be labeled with a reporter molecule
- the apparatus and methods are useful for detecting molecular interactions such as nucleic acid hybridization between oligonucleotide probe molecules bound to defined regions of an ordered array and nucleic acid target molecules which are permitted to interact with the probe molecules
- the apparatus and methods are useful for detecting interactions between peptides (e g , receptor- ligand binding or antibody recognition of antigens)
- the apparatus of the present invention comprises a supporting substrate, an array of microelectrodes in contact with the supporting substrate to which probes are immobilized, at least one counter-electrode in electrochemical contact with the supporting substrate, a means for producing electrical impedance at each microelectrode, a means for detecting changes in impedance at each microelectrode in the presence or absence of a target molecule, and an electrolyte solution in contact with the plurality of microelectrodes
- the apparatus of the present invention comprises a supporting substrate, an array of microelectrodes in contact with the supporting substrate, a plurality of polyacrylamide gel pads in contact with microelectrodes and to which probes are immobilized, at least one counter-electrode in electrochemical contact with the supporting substrate, a means for producing electrical impedance at each microelectrode, a means for detecting changes in impedance at each microelectrode in the presence or absence of a target molecule, and an electrolyte solution in contact with the plurality of microelectrodes
- multiple electrodes can be defined on a substrate and covered with a continuous, unpattemed layer of polyacrylamide or other polymer
- microelectrodes are prepared from, but not limited to, metals such as dense or porous films of gold, platinum, titanium, or copper, metal oxides, metal nitrides, metal carbides, or carbon
- the electrolyte solution comprises metal cations or polymerized cations that are ion conductive and capable of reacting with probes or probe-target complexes
- the electrolyte solution comprises a salt of a lithium cation, most preferably L ⁇ CI0 4
- the apparatus of the present invention may further comprise at least one reference electrode
- the apparatus further comprises a plurality of wells each of which encompasses at least one microelectrode and at least one counter-electrode that is sufficient to interrogate the entire array
- an electrolyte solution as described above is placed in contact with a plurality of microelectrodes to which nucleic acid probes have been immobilized, preferably having a neutral polypyrrole layer there between AC impedance of the microelectrodes is first measured in the absence of added target nucleic acid Thereafter, the microelectrodes are contacted with a biological sample substance containing target nucleic acid molecules, most preferably by adding the sample to the electrolyte solution or replacing the electrolyte solution with the sample contained in or diluted in the electrolyte solution The probes and target molecules are allowed to interact, preferably by hybridization, and the AC impedance measured thereafter
- an electrolyte solution as described above is placed in contact with a plurality of microelectrodes and polyacrylamide gel pads to which nucleic acid probes have been immobilized AC impedance of the microelectrodes is first measured in the absence of added target nucleic acid Thereafter, the microelectrodes are contacted with a biological sample substance containing target nucleic acid molecules, most preferably by adding the sample to the electrolyte solution or replacing the electrolyte solution with the sample contained in or diluted in the electrolyte solution The probes and target molecules are allowed to interact, preferably by hybridization, and the AC impedance measured thereafter
- the AC impedance is measured at different frequencies in order to increase the sensitivity of the method
- Probe-target interactions are detected by differences in the AC impedance signals at individual microelectrodes before and after such interactions
- the method is used to discern the difference between hybridization between an immobilized oligonucleotide probe on a microelectrode and a complimentary target nucleic acid ("complete” hybridization), and hybridization between the immobilized oligonucleotide and a mismatched target nucleic acid (“mismatch” hybridization)
- Information about the nucleotide sequence of the ohgonucleotides immobilized at each microelectrode is then used in conjunction with "complete” or "mismatch” hybridization as detected by the method of the invention to determine the presence or absence of a particular target nucleic acid in the sample
- the present invention provides an apparatus and methods for the electric or electrochemical detection of the nature and extent of molecular interactions between probe molecules and electrochemically active reporter-labeled target molecules
- the apparatus and methods are useful for detecting molecular interactions such as nucleic acid hybridization between oligonucleotide probe molecules bound to defined regions of an ordered array and electrochemically active reporter-labeled nucleic acid target molecules which are permitted to interact with the probe molecules
- the apparatus and methods are useful for detecting interactions between peptides (e g , receptor-ligand binding or antibody recognition of antigens)
- the apparatus of the present invention comprises a supporting substrate, an array of microelectrodes in contact with the supporting substrate, a plurality of polymeric hydrogel pads in contact with the microelectrodes and to which probes are immobilized, at least one counter-electrode in electrochemical contact with the supporting substrate, a means for producing an electrical signal at each microelectrode, a means for detecting changes in the electrical signal at each microelectrode in the presence or absence of an electrochemically active reporter-labeled target molecule, and a electrolyte solution in contact with the plurality of hydrogel porous microelectrodes and counter-electrode
- multiple electrodes can be defined on a substrate and covered with a continuous, unpattemed layer of polymeric hydrogel
- microelectrodes are prepared from metals such as dense or porous films of gold, platinum, titanium, or copper, metal oxides, metal nitrides, metal carbides, or graphite carbon
- the probes are oligonucleotide probes having a sequence comprising from about 10 to about 100 nucleotide residues, and said probes are attached to the polyacrylamide gel pads using techniques known to those with skill in the art
- the probes are peptides, such as receptors, gands, antibodies, antigens, or synthetic peptides, and said probes are attached to the polymeric hydrogel pads using techniques known to those with skill in the art
- the apparatus of the present invention may further comprise at least one reference electrode
- the apparatus further comprises a plurality of wells each of which encompasses at least one hydrogel porous microelectrode and at least one counter-electrode that is sufficient to interrogate the entire array
- molecular interactions between probe molecules and electrochemically active reporter-labeled target molecules are detected by applying conventional electric or electrochemical detection methods, such as, for example, AC impedance
- AC impedance of a plurality of hydrogel porous microelectrodes to which nucleic acid probes have been immobilized is first measured in the absence of an electrochemically- labeled target nucleic acid Thereafter, the hydrogel porous microelectrodes are contacted with a biological sample substance containing electrochemically active reporter-labeled target molecules
- the probes and target molecules are allowed to interact, preferably by hybridization, and AC impedance measured thereafter
- the AC impedance is measured at different frequencies in order to increase the sensitivity of the method
- Interactions between probe molecules and electrochemically-labeled target molecules are detected by differences in the AC impedance signals at individual hydrogel porous microelectrodes before and prior to such interactions
- the method is used to discern the difference between hybridization between an immobilized oligonucleotide probe on a hydrogel porous microelectrode and a complimentary target nucleic acid ("complete” hybridization), and hybridization between the immobilized oligonucleotide and a mismatched target nucleic acid (“mismatch" hybridization)
- other electric and/or electrochemical methods can be used to detect molecular interactions between probe molecules and electrochemically-labeled target molecules, including, but not limited to, cyclic voltammetry, stripping voltammetry, pulse voltammetry, square wave voltammetry, AC voltammetry, hydrodynamic modulation voltammetry, potential step method, potentiomet ⁇ c measurements, amperomet ⁇ c measurements, current step method, and combinations thereof
- the invention further comprises methods and apparatus for detecting mutations and genetic polymorphisms in a biological sample containing a nucleic acid of interest Detection of single base extension using the methods and apparatus of the invention is achieved by sequence- specific incorporation of chain-terminating nucleotide species chemically labeled with an electrochemical species
- single base extension is performed using hybridization to an oligonucleotide array, most preferably an addressable array wherein the sequence of each oligonucleotide in the array is known and associated with a particular address
- the invention provides an array of oligonucleotide probes immobilized to a surface that defines a first electrode
- the sequence of each oligonucleotide at each particular identified position (or “address") in the array is known and at least one of said ohgonucleotides is complementary to a sequence in a nucleic acid contained in the biological sample to be assayed (termed the "target” or “target nucleic acid")
- the sequence of at least one oligonucleotide is selected to hybridize to a position immediately adjacent to the nucleotide position in the sample nucleic acid that is to be interrogated, / e , for mutation or genetic polymorphism
- the term "adjacent" in this context is intended to encompass positions that are one nucleotide base upstream of base to be interrogated, / e in the 3' direction with respect to the template strand of the target DNA Hybridization of the
- the sequence of at least one oligonucleotide is selected to hybridize to the target nucleic acid at a position whereby the 3' residue of the oligonucleotide hybridizes to the nucleotide position in the sample nucleic acid that is to be interrogated for mutation or genetic polymorphism
- ohgonucleotides having sequence identity to the oligonucleotide that hybridizes to the target nucleic acid at it's 3' residue will also hybridize to the target, but the 3' residue of such ohgonucleotides will produce a "mismatch" with the target and will not hybridize at the 3' residue
- Single base extension is performed with a polymerase that will not recognize the mismatch, so that only the oligonucleotide that hybridizes to the target including at its 3' residue will be extended
- only a single chain-terminating species labeled with an electrochemical species can be employed, or the same electrochemical
- electric current is recorded as a function of sweeping voltage to the first electrode specific for each particular chain-terminating nucleotide species labeled with an electrochemically- active reporter
- current flow at each specific potential is detected at each address in the array where single base extension has occurred with the corresponding chain-terminating nucleotide species labeled with a particular electrochemical reporter group
- the detection of the electrical signal at a particular position in the array wherein the nucleotide sequence of the oligonucleotide occupying that position is known enables the identity of the extended nucleotide, and therefore the mutation or genetic polymorphism, to be determined
- Figures 1 A and 1 B illustrate a schematic representation of the structure of a hydrogel porous microelectrode ( Figure 1 A) and a schematic representation of the structure of the tip of a hydrogel porous microelectrode ( Figure 1 B),
- Figures 2A and 2B illustrate the electrochemical oxidation of pyrrole (Figure 2A) and the neutralization of polypyrrole (Figure 2B),
- Figures 3A and 3B illustrate the Frequency Complex curves obtained from polypyrrole microelectrodes before and after the hybridization of a 15-mer oligonucleotide probe and complementary nucleic acid target molecule ( Figure 3A) and the Frequency Complex curve obtained in the high frequency zone from polypyrrole microelectrodes before and after the hybridization of a 15-mer oligonucleotide probe and complementary target molecule ( Figure 3B),
- Figures 4A and 4B illustrate a plot of low frequency resistance versus w 1 2 ( Figure 4A) and the plot of high frequency resistance versus w ( Figure 4B),
- Figures 5A and 5B illustrate the Frequency Complex curve obtained for the hybridization of an oligonucleotide probe and a fully complementary nucleic acid target molecule ( Figure 5A) and the Frequency Complex curve obtained for the hybridization of an oligonucleotide probe and a nucleic acid target molecule possessing three mismatches ( Figure 5B, curve 1 was obtained before hybridization of the target molecule to the probe, curve 2 was obtained following hybridization of probe and target molecules for 48 hours, curve 3 was obtained following washing of hybridized molecules for 30 mm at 37°C, and curve 4 was obtained following washing of hybridized molecules for 30 mm at 38°C),
- Figure 6 illustrates a plot of low frequency resistance versus w " 2 obtained for the hybridization of an oligonucleotide probe and a nucleic acid target molecule possessing three mismatches (curve 1 was obtained before hybridization of the target molecule to the probe, curve 2 was obtained following hybridization of probe and target molecules for 48 hours, curve 3 was obtained following washing of hybridized molecules for 30 mm at 37°C, and curve 4 was obtained following washing of hybridized molecules for 30 m at 38°C)
- Figure 7 illustrates the Frequency Complex curve obtained from polypyrrole microelectrodes before and after the hybridization of a 15-mer oligonucleotide probe and complementary nucleic acid target molecule in an electrolyte containing 0 1 M L ⁇ CI0 4 ,
- Figures 8A through 8C illustrate a schematic representation of the circuit ( Figure 8A), the AC impedance response for a polypyrrole microelectrode with an attached single-strand nucleic acid probe before hybridization to a target molecule ( Figure 8B), and a schematic representation of the circuit for a polypyrrole microelectrode with an attached single-strand nucleic acid probe after hybridization to a target molecule ( Figure 8C),
- Figure 9 illustrates a plot of capacitance versus frequency for a polypyrrole microelectrode with an attacKed single-strand nucleic acid probe after hybridization to a target molecule
- Figure 10 illustrates a plot of resistance versus frequency for a polypyrrole microelectrode with an attached single-strand nucleic acid probe after hybridization to a target molecule
- Figure 1 1 illustrates a hydrogel porous microelectrode
- Figure 12 illustrates the Frequency Complex curves obtained from a hydrogel porous microelectrode with attached 15-mer oligonucleotide probe in the absence of a complementary target molecule (curve 1 ), following incubation with 2 pM of a complementary target molecule (curve 2), and following incubation with 300 nM of a mismatched target molecule (curve 3),
- Figure 13 illustrates a plot of capacitance versus frequency for a hydrogel porous microelectrode with an attached single-strand nucleic acid probe after hybridization to a target molecule
- Figure 14 illustrates a plot of resistance versus frequency for a hydrogel porous microelectrode with an attached single-strand nucleic acid probe after hybridization to a target molecule
- FIG 15 illustrates single base extension using chain-terminating nucleotdie species labeled with an electrochemical reporter group (ECA label)
- the present invention is directed to a variety of electronic and electrochemical techniques that may be used to detect the presence of target analytes, particularly nucleic acids, in samples
- the methods generally rely on the molecular interactions such as nucleic acid hybridization or protein- protein binding reactions done on solid supports with arrays of capture binding ligands As a result of these interactions, some electronic property of the system changes, and detection is achieved
- the methods of the invention utilize AC impedance for the detection
- the apparatus and methods of the present invention have the advantage of providing electrical detection without any additional requirement that the target molecule be labeled with a reporter molecule That is, the electrical impedance of the system changes as a result of the specific binding of a target analyte to its corresponding capture binding gand (frequently referred to herein as "capture probes" when the analyte is a nucleic acid)
- electrochemically active labels allows the detection of specific interactions, in a manner similar to known fluorescent systems
- the target can be labeled with an electrochemically active (ECA) label, for example during an amplification reaction such as PCR when the target is a nucleic acid, or through the use of secondary labeling systems
- ECA electrochemically active
- these ECA labels are exploited to allow the identification of specific bases within a target sequence, as is generally outlined below
- target analyte or “analyte” or grammatical equivalents herein is meant any molecule, compound or particle to be detected
- target analytes preferably bind to binding ligands, as is more fully described above
- a large number of analytes may be detected using the present methods, basically, any target analyte for which a binding hgand, described herein, may be made may be detected using the methods of the invention.
- Suitable analytes include organic and inorganic molecules, including biomolecules.
- the analyte may be an environmental pollutant (including pesticides, insecticides, toxins, etc.); a chemical (including solvents, polymers, organic materials, etc.); therapeutic molecules (including therapeutic and abused drugs, antibiotics, etc.); biomolecules (including hormones, cytokines, proteins, pids, carbohydrates, cellular membrane antigens and receptors (neural, hormonal, nutrient, and cell surface receptors) or their ligands, etc); whole cells (including procaryotic (such as pathogenic bacteria) and eukaryotic cells, including mammalian tumor cells); viruses (including retroviruses, herpesviruses, adenoviruses, lentiviruses, etc.); and spores; etc.
- an environmental pollutant including pesticides, insecticides, toxins, etc.
- a chemical including solvents, polymers, organic materials, etc.
- therapeutic molecules including
- Particularly preferred analytes are environmental pollutants; nucleic acids; proteins (including enzymes, antibodies, antigens, growth factors, cytokines, etc); therapeutic and abused drugs, cells; and viruses.
- the target analyte is a nucleic acid.
- nucleic acid or “oligonucleotide” or grammatical equivalents herein means at least two nucleotides covalentiy linked together.
- a nucleic acid of the present invention will generally contain phosphodiester bonds, although in some cases, as outlined below, nucleic acid analogs are included that may have alternate backbones, comprising, for example, phosphoramide (Beaucage et al., Tetrahedron 49(10):1925 (1993) and references therein; Letsmger, J. Org. Chem. 35:3800 (1970); Sp ⁇ nzl et al., Eur. J. Biochem. 81 :579 (1977); Letsmger et al., Nucl. Acids Res. 14:3487 (1986),
- nucleic acids containing one or more carbocychc sugars are also included within the definition of nucleic acids (see Jenkins et al , Chem.
- nucleic acid analogs may find use in the present invention
- mixtures of naturally occurring nucleic acids and analogs can be made, for example, at the site of conductive o gomer or electron transfer moiety attachment, an analog structure may be used
- mixtures of different nucleic acid analogs, and mixtures of naturally occurring nucleic acids and analogs may be made
- the nucleic acids may be single stranded or double stranded, as specified, or contain portions of both double stranded or single stranded sequence
- the nucleic acid may be DNA, both genomic and cDNA, RNA or a hybrid, where the nucleic acid contains any combination of deoxy ⁇ bo- and ⁇ bo-nucleotides, and any combination of bases, including uracil, adenme, thymme, cytosine, guanine, inosine, xathanme hypoxathanme, isocytosme, isoguanine, etc
- the term "nucleoside” includes nucleotides and nucleoside and nucleotide analogs, and modified nucleosides such as am o modified nucleosides
- "nucleoside” includes non- ⁇ aturally occu ⁇ ng analog structures
- target nucleic acid or “target sequence” or grammatical equivalents herein means a nucleic acid sequence on a single strand of nucleic acid
- the target sequence may be a portion of a gene, a regulatory sequence, genomic DNA, cDNA, RNA including mRNA and rRNA, or others It may be any length, with the understanding that longer sequences are more specific
- the complementary target sequence may take many forms For example, it may be contained within a larger nucleic acid sequence, i e all or part of a gene or mRNA, a restriction fragment of a plasmid or genomic DNA, among others
- probes are made to hybridize to target sequences to determine the presence or absence of the target sequence in a sample Generally speaking, this term will be understood by those skilled in the art
- the target sequence may also be comprised of different target domains, which may be adjacent ( ⁇ e contiguous) or separated
- a first primer may hybridize to a first target domain and a second primer may hybridize to a second target domain; either the domains are adjacent, or they may be separated by one or more nucleotides, coupled with the use of a polymerase and dNTPs, as is more fully outlined below.
- the terms "first” and “second” are not meant to confer an orientation of the sequences with respect to the 5'-3' orientation of the target sequence. For example, assuming a 5'-3' orientation of the complementary target sequence, the first target domain may be located either 5' to the second domain, or 3' to the second domain.
- the target analyte is a protein.
- proteins or grammatical equivalents herein is meant proteins, oligopeptides and peptides, derivatives and analogs, including proteins containing non-naturally occurring ammo acids and ammo acid analogs, and peptidomimetic structures.
- the side chains may be in either the (R) or the (S) configuration.
- the ammo acids are in the (S) or L-configuration.
- Suitable protein target analytes include, but are not limited to, (1 ) immunoglobu ns, particularly IgEs, IgGs and IgMs, and particularly therapeutically or diagnostically relevant antibodies, including but not limited to, for example, antibodies to human albumin, apo poproteins (including apohpoprotein E), human chononic gonadotropm, cortisol, ⁇ -fetoprotein, thyroxin, thyroid stimulating hormone (TSH), antithrombm, antibodies to pharmaceuticals (including antieptileptic drugs (phenyto , p ⁇ midone, carbariezepin, ethosuximide, valproic acid, and phenobarbitol), cardioactive drugs (digoxin, lidocaine, procainamide, and disopyramide), bronchodilators ( theophyllme), antibiotics (chloramphenicol, sulfonamides), antidepressants, immunosuppresants, abused drugs (amphetamine, methamphetamine,
- influenza virus influenza virus
- paramyxoviruses e.g respiratory syncytiai virus, mumps virus, measles virus
- adenoviruses e.g. respiratory syncytiai virus
- mumps virus e.g. mumps virus
- measles virus e.g. adenoviruses
- rhmoviruses coronaviruses
- reoviruses e.g. rubella virus
- parvoviruses poxviruses (e.g. " variola virus, vaccinia virus), enteroviruses (e.g pohovirus, coxsackievirus), hepatitis viruses (including A, B and C), herpesviruses (e.g.
- Vibrio e.g. V. cholerae
- Esche ⁇ chia e.g. Enterotoxigenic E.
- TSH leutinzmg hormone
- LH leutinzmg hormone
- progeterone and testosterone
- other proteins including ⁇ -fetoprotem, carcmoembryonic antigen CEA, cancer markers, etc.
- any of the biomolecules for which antibodies may be detected may be detected directly as well; that is, detection of virus or bacterial cells, therapeutic and abused drugs, etc., may be done directly
- Suitable target analytes include carbohydrates, including but not limited to, markers for breast cancer (CA15-3, CA 549, CA 27 29), mucin-hke carcinoma associated antigen (MCA), ovarian cancer (CA125), pancreatic cancer (DE-PAN-2), prostate cancer (PSA), CEA, and colorectal and pancreatic cancer (CA 19, CA 50, CA242)
- Suitable target analytes include metal ions, particularly heavy and/or toxic metals, including but not limited to, aluminum, arsenic, cadmium, selenium, cobalt, copper, chromium, lead, silver and nickeT
- target analytes may be present in any number of different sample types, including, but not limited to, bodily fluids including blood, lymph, saliva, vaginal and anal secretions, urine, feces, perspiration and tears, and solid tissues, including liver, spleen, bone marrow, lung, muscle, brain, etc.
- bodily fluids including blood, lymph, saliva, vaginal and anal secretions, urine, feces, perspiration and tears, and solid tissues, including liver, spleen, bone marrow, lung, muscle, brain, etc.
- the present invention provides devices for the detection of target analytes comprising a solid substrate
- the solid substrate can be made of a wide variety of materials and can be configured in a large number of ways, as is discussed herein and will be apparent to one of skill in the art
- a single device may be comprises of more than one substrate; for example, there may be a "sample treatment" cassette that interfaces with a separate “detection” cassette, a raw sample is added to the sample treatment cassette and is manipulated to prepare the sample for detection, which is removed from the sample treatment cassette and added to the detection cassette
- There may be an additional functional cassette into which the device fits for example, a heating element which is placed in contact with the sample cassette to effect reactions such as PCR
- a portion of the substrate may be removable, for example, the sample cassette may have a detachable detection cassette, such that the entire sample cassette is not contacted with the detection apparatus See for example U S Patent No 5,603,351 and PCT US96/17116, hereby incorporated by reference
- composition of the solid substrate will depend on a variety of factors, including the techniques used to create the device, the use of the device, the composition of the sample, the analyte to be detected, the size of the wells and microchannels, the presence or absence of electronic components, etc Generally, the devices of the invention should be easily ste ⁇ lizable as well
- the solid substrate can be made from a wide variety of materials Preferred embodiments utilize ceramic components as the solid substrate, as is more generally outlined below, although as will be appreciated by those in the art, the devices of the invention may include other materials These include, but are not limited to, silicon such as silicon wafers, silcon dioxide, silicon nitride, glass and fused silica, gallium arsenide, indium phosphide, aluminum, ceramics, polyimide, quartz, plastics, resins and polymers including polymethylmethacrylate, acrylics, polyethylene, polyethylene terepthalate, polycarbonate, polystyrene and other styrene copolymers, polypropylene, polytetrafluoroethylene, superalloys, zircaloy, steel, gold, silver, copper, tungsten, molybdeumn, tantalum, KOVAR, KEVLAR, KAPTON, MYLAR, brass, sapphire, etc High quality glasses such as high melting
- the solid support comprises ceramic materials, such as are outlined in U S S N s 09/235,081 , 09/337,086, 09/464,490, 09/492,013, 09/466,325, 09/460,281 , 09/460,283, 09/387,691 , 09/438,600, 09/506,178, and 09/458,534, all of which are expressly incorporated by reference in their entirety
- the devices are made from layers of green-sheet that have been laminated and sintered together to form a substantially monolithic structure
- Green-sheet is a composite material that includes inorganic particles of glass, glass-ceramic ceramic, or mixtures thereof, dispersed in a polymer binder, and may also include additives such as plasticizers and dispersants
- the green-sheet is preferably in the form of sheets that are 50 to
- the ceramic particles are typically metal oxides, such as aluminum oxide or zirconium oxide
- metal oxides such as aluminum oxide or zirconium oxide
- An example of such a green-sheet that includes glass-ceramic particles is "AX951” that is sold by E I Du Pont de Nemours and Company
- An example of a green-sheet that includes aluminum oxide particles is "Ferro Alumina” that is sold by Ferro Corp
- the composition of the green-sheet may also be custom formulated to meet particular applications
- the green-sheet layers are laminated together and then fired to form a substantially monolithic multilayered structure
- the manufacturing, processing, and applications of ceramic green-sheets are described generally in Richard E Mistier, "Tape Casting The Basic Process for Meeting the Needs of the Electronics Industry," Ceramic Bulletin, vol 69, no 6, pp 1022-26 (1990), and in U S Patent No 3,991 ,029, which are incorporated herein by reference
- the method for fabricating devices begins with providing sheets of green-sheet that are preferably 50 to 250 microns thick
- the sheets of green-sheet are cut to the desired size, typically 6 inches by 6 inches for conventional processing, although smaller or larger devices may be used as needed
- Each green-sheet layer may then be textured using various techniques to form desired structures, such as vias, channels, or cavities, in the finished multilayered structure
- Various techniques may be used to texture a green-sheet layer
- portions of a green- sheet layer may be punched out to form vias or channels This operation may be accomplished using conventional multilayer ceramic punches, such as the Pacific T ⁇ netics Corp Model APS- 8718 Automated Punch System
- features, such as channels and wells may be embossed into the surface of the green-sheet by pressing the green- sheet against an embossing plate that has a negative image of the desired structure Texturing may also be accomplished by laser tooling with a laser via system, such as the Pacific T ⁇ netics LVS-3012
- Thick-film pastes typically include the desired material, which may be either a metal or a dielectric, in the form of a powder dispersed in an organic vehicle, and the pastes are designed to have the viscosity appropriate for the desired deposition technique, such as screen-printing
- the organic vehicle may include resins, solvents, surfactants, and flow-control agents
- the thick-film paste may also include a small amount of a flux, such as a glass frit, to facilitate sintering Thick-film technology is further described in J D Provance, "Performance Review of Thick Film Materials," Insulation/Circuits (April, 1977) and in Morton L Topfer, Thick Film Microelectronics, Fabrication Design, and Applications (1977), pp 41-59, which are incorporated here
- the porosity of the resulting thick-film can be adjusted by adjusting the amount of organic vehicle present in the thick-film paste Specifically, the porosity of the thick-film can be increased by increased the percentage of organic vehicle in the thick-film paste Similarly, the porosity of a green-sheet layer can be increased by increasing the proportion of organic binder Another way of increasing porosity in thick-films and green-sheet layers is to disperse within the organic vehicle, or the organic binder, another organic phase that is not soluble in the organic vehicle Polymer microspheres can be used advantageously for this purpose
- the thick film pastes typically include metal particles, such as silver, platinum, palladium, gold, copper, tungsten, nickel, tin, or alloys thereof Silver pastes are preferred Examples of suitable silver pastes are silver conductor composition numbers 7025 and 7713 sold by E I Du Pont de Nemours and Company
- the thick-film pastes are preferably applied to a green-sheet layer by screen-printing
- the thick-film paste is forced through a patterned silk screen so as to be deposited onto the green-sheet layer in a corresponding pattern
- the silk screen pattern is created photographically by exposure to a mask
- conductive traces may be applied to a surface of a green-sheet layer Vias present in the green-sheet layer may also be filled with thick-film pastes If filled with thick-filled pastes containing electrically conductive materials, the vias can serve to provide electrical connections between layers
- the adhesive is a room-temperature adhesive
- room-temperature adhesives have glass transition temperatures below room temperature, / e , below about 20° C, so that they can bind substrates together at room temperature Moreover, rather than undergoing a chemical change or chemically reacting with or dissolving components of the substrates, such room-temperature adhesives bind substrates together by penetrating into the surfaces of the substrates
- pressure-sensitive adhesives Suitable room-temperature adhesives are typically supplied as water-based emulsions and are available from Rohm and Haas, Inc and from Air Products, Inc For example, a material sold by Air Products, Inc as
- the room-temperature adhesive may be applied to the green-sheet by conventional coating techniques To facilitate coating, it is often desirable to dilute the supplied pressure-sensitive adhesive in water, depending on the coating technique used and on the viscosity and solids loading of the starting material After coating, the room-temperature adhesive is allowed to dry
- the dried thickness of the film of room-temperature adhesive is preferably in the range of 1 to 10 microns, and the thickness should be uniform over the entire surface of the green-sheet Film thicknesses that exceed 15 microns are undesirable With such thick films of adhesive voiding or delamination can occur during firing, due to the large quantity of organic material that must be removed Films that are less than about 0 5 microns thick when dried are too thin because they provide insufficient adhesion between the layers From among conventional coating techniques, spin-coating and spraying are the preferred methods If spin-coating is used, it is preferable to add 1 gram of deionized water for every 10 grams of "Flexcryl 1653 " If spraying is used, a higher dilution level is preferred to facilitate ease of spraying Additionally, when room-temperature adhesive is sprayed on, it is preferable to hold the green-sheet at an elevated temperature, e g , about 60 to 70° C, so that the material dries nearly instantaneously as it is deposited onto the green-sheet The
- the layers are stacked together to form a multilayered green-sheet structure
- the layers are stacked in an alignment die, so as to maintain the desired registration between the structures of each layer
- alignment holes must be added to each green-sheet layer
- the stacking process alone is sufficient to bind the green-sheet layers together when a room-temperature adhesive is used In other words, little or no pressure is required to bind the layers together
- the layers are preferably laminated together after they are stacked
- the lamination process involves the application of pressure to the stacked layers
- a uniaxial pressure of about 1000 to 1500 psi is applied to the stacked green-sheet layers that is then followed by an application of an isostatic pressure of about 3000 to 5000 psi for about 10 to 15 minutes at an elevated temperature, such as 70° C
- Adhesives do not need to be applied to bind the green-sheet layers together when the conventional lamination process is used
- pressures less than 2500 psi are preferable in order to achieve good control over the dimensions of such structures as internal or external cavities and channels Even lower pressures are more desirable to allow the formation of larger structures, such as cavities and channels
- pressures less than T000 psi are more preferred, as such pressures generally enable structures having sizes greater than about 100 microns to be formed with some measure of dimensional control Pressures of less than 300 psi are even more preferred, as such pressures typically allow structures with sizes greater than 250 microns to be formed with some degree of dimensional control Pressures less than 100 psi, which are referred to herein as "near-zero pressures," are most preferred, because at such pressures few limits exist on the size of internal and external cavities and channels that can be formed in the multilayered structure
- the pressure is preferably applied in the lamination process by means of a uniaxial press
- pressures less than about 100 psi may be applied by hand
- many devices may be present on each sheet
- the multilayered structure may be diced using conventional green- sheet dicing or sawing apparatus to separate the individual devices
- the high level of peel and shear resistance provided by the room-temperature adhesive results in the occurrence of very little edge delamination during the dicing process If some layers become separated around the edges after dicing, the layers may be easily re-laminated by applying pressure to the affected edges by hand, without adversely affecting the rest of the device
- the final processing step is firing to convert the laminated multilayered green-sheet structure from its "green” state to form the finished, substantially monolithic, multilayered structure
- the firing process occurs in two important stages as the temperature is raised
- the first important stage is the binder burnout stage that occurs in the temperature range of about 250 to 500° C, during which the other organic materials, such as the binder in the green-sheet layers and the organic components in any applied thick-film pastes, are removed from the structure
- the sintering stage which occurs at a higher temperature, the inorganic particles sinter together so that the multilayered structure is densified and becomes substantially monolithic
- the sintering temperature used depends on the nature of the inorganic particles present in the green-sheet
- appropriate sintering temperatures range from about 950 to about 1600° C, depending on the material
- sintering temperatures between 1400 and 1600° C are typical
- Other ceramic materials, such as silicon nitride, aluminum nitride, and silicon carbide require higher sintering temperatures, namely 1700 to 2200° C
- a sintering temperature in the range of 750 to 950° C is typical Glass particles generally require sintering temperatures in the range of only about 350 to 700° C
- metal particles may require sintering temperatures anywhere from 550 to 1700° C, depending on the metal
- the devices are fired for a period of about 4 hours to about 12 hours or more, depending on the material used Generally, the firing should be of a sufficient duration so as to remove the organic materials from the structure and to completely sinter the inorganic particles
- polymers are present as a binder in the green-sheet and in the room-temperature adhesive The firing should be of sufficient temperature and duration to decompose these polymers and to allow for their removal from the multilayered structure
- the multilayered structure undergoes a reduction in volume during the firing process During the binder burnout phase, a small volume reduction of about 0 5 to 1 5% is normally observed At higher temperatures, during the sintering stage, a further volume reduction of about 14 to 17% is typically observed
- the volume change due to firing can be controlled In particular, to match volume changes in two materials, such as green-sheet and thick-film paste, one should match (1 ) the particle sizes, and (2) the percentage of organic components, such as binders, which are removed during the firing process Additionally, volume changes need not be matched exactly, but any mismatch will typically result in internal stresses in the device But symmetrical processing, placing the identical material or structure on opposite sides of the device can, to some extent, compensate for shrinkage mismatched materials Too great a mismatch in either sintering temperatures or volume changes may result in defects in or failure of some or all of the device For example, the device may separate into its individual layers, or it may become warped or distorted
- any dissimilar materials added to the green-sheet layers are co-fired with them Such dissimilar materials could be added as thick-film pastes or as other green-sheet layers, or added later in the fabrication process, after sintering
- the benefit of co-firing is that the added materials are sintered to the green-sheet layers and become integral to the substantially monolithic microfluidic device
- the added materials should have sintering temperatures and volume changes due to firing that are matched with those of the green- sheet layers Sintering temperatures are largely material-dependent, so that matching sintering temperatures simply requires proper selection of materials
- silver is the preferred metal for providing electrically conductive pathways
- some other metal, such as platinum must be used due to the relatively low melting point of silver (961 ° C)
- the addition of other substrates or joining of two post-sintered pieces can be done using any variety of adhesive techniques, including those outlined herein
- two "halves" of a device can be glued or fused together
- reagent mixture such as a hydrogel or biological components that are not stable at high temperature
- ceramic devices comprising open channels or wells can be made, additional substrates or materials placed into the devices, and then they may be sealed with other materials
- the substrates comprise arrays of capture binding ligands
- any number of different capture binding ligands, or capture probes can be used, and in a wide variety of formats Preferred embodiments utilize arrays of microelectrodes or hydrogel arrays as are known in the art and disclosed, for example, in U S S N s 09/458,553, 09/458,501 , 09/572,187, 09/495,992, 09/344,217, WO00/31148, 09/439,889, 09/438,209, 09/344,620, PCTUS00/17422, 09/478,727, all of which are expressly incorporated by reference in their entirety
- the probes are oligonucleotide probes having a sequence comprising from about 10 to about 30 nucleotide residues wherein said probes are attached to a conjugated polymer or copolymer that is
- the oligonucleotide probes are attached to the microelectrodes through a neutral polypyrrole matrix
- the probes are oligonucleotide probes having a sequence comprising from about 10 to about 30 nucleotide residues and said probes are attached to polyacrylamide gel pads that are in contact with the microelectrodes
- nucleic acid duplex possesses a high negative charge density Following electrical perturbation of the nucleic acid, strong interactions, such as the intercalation or binding of metal ions to the nucleic acid, occur
- nucleic acid molecules such as a probe
- the result of this molecular interaction is a change in AC impedance This change is used in the methods and apparatus of the invention to distinguish between "complete” hybridization and incomplete or “mismatch” hybridization between the immobilized oligonucleotide probe and target nucleic acid
- the apparatus of the present invention comprises a supporting substrate, a plurality of microelectrodes in contact with the supporting substrate to which probes are immobilized, at least one counter-electrode in contact with the supporting substrate, a means for producing electrical impedance at each microelectrode, a means for detecting changes in impedance at each microelectrode in the presence or absence of a target molecule, and an electrolyte solution in contact with the plurality of microelectrodes
- the apparatus of the present invention comprises a supporting substrate, a plurality of microelectrodes in contact with the supporting substrate, a plurality of polyacrylamide gel pads in contact with the microelectrodes and to which probes are immobilized, at least one counter-electrode in contact with the supporting substrate, a means for producing electrical impedance at each microelectrode, a means for detecting changes in impedance at each microelectrode in the presence or absence of a target molecule, and an electrolyte solution in contact with the plurality of microelectrodes.
- the apparatus is a microarray containing at least 5 microelectrodes on a single substrate to which oligonucleotide probes have been attached.
- arrayed ohgonucleotides are attached to polyacrylamide gel pads that are in contact with the microelectrodes of the apparatus of the present invention.
- ohgonucleotides having a particular nucleotide sequence, or groups of such ohgonucleotides having related (e.g., overlapping) nucleotide sequences are immobilized at each of the plurality of microelectrodes.
- nucleotide sequence(s) of the immobilized ohgonucleotides at each microelectrode and the identity and correspondence between a particular microelectrode and the nucleotide sequence of the oligonucleotide immobilized thereto, are known.
- the probes are ohgonucleotides comprising from about 10 to about 100, more preferably from about 10 to about 50, and most preferably from about 15 to about 30, nucleotide residues.
- the probes are nucleic acids comprising from about 10 to about 5000 basepairs, more preferably from about 100 to about 1000 basepairs, and most preferably from about 200 to about 500 basepairs
- the immobilized probes are peptides comprising from about 5 to about 500 ammo acid residues
- the substrate is composed of silicon
- the substrate is prepared from substances including, but not limited to, glass, plastic, rubber, fabric, or ceramics
- the microelectrodes are embedded within or placed in contact with the substrate
- microelectrodes are prepared from substances including, but not limited to, metals such as gold, silver, platinum, titanium or copper, in solid or porous form and preferably as foils or films, metal oxides, metal nitrides, metal carbides, or carbon
- probes are attached to conjugated polymers or copolymers including, but not limited to, polypyrrole, polythiphene, polyanihne, polyfuran, polypy ⁇ dine, polycarbazole, polyphenylene, poly(phenylenv ⁇ nylene), polyfluorene, polyindole, their derivatives, their copolymers, and combinations thereof.
- probes are attached to polyacrylamide gel pads that are in contact with the microelectrodes
- the substrate of the present invention has a surface area of between 0 01 mm 2 and 5 cm 2 containing between 1 and 1 x 10 8 microelectrodes
- the substrate has a surface area of 100 mm 2 and contains 10 4 microelectrodes, each microelectrode having an oligonucleotide having a particular sequence immobilized thereto
- the substrate has a surface area of 100 mm 2 and contains 10 4 microelectrodes, each microelectrode in contact with a polyacrylamide gel pad to which an oligonucleotide having a particular sequence has been immobilized thereto.
- the microelectrodes are arranged on the substrate so as to be separated by a distance of between 0.05 mm to 0.5 mm. Most preferably, the microelectrodes are regularly spaced on the solid substrate with a uniform spacing there between
- the microelectrodes project from the surface of the substrate, with such projections extending between 5 x 10 '8 and 1 x 10 "5 cm from the surface of the substrate.
- the microelectrodes comprise a flat disk of conductive material that is embedded in the substrate and exposed at the substrate surface, with the substrate acting as an insulator in the spaces between the microelectrodes.
- the microelectrodes comprise a gold conductor and glass insulator.
- the microelectrodes comprise conductor substances such as solid or porous films of silver, platinum, titanium, copper, or metal oxides, metal nitrides, metal carbides, or carbon (graphite).
- the microelectrodes comprise substrate and/or insulator substances such as glass, silicon, plastic, rubber, fabric, or ceramics.
- the microelectrodes of the present invention have an exposed conductive surface of between 0.01 mm 2 to 0.5 cm 2 In the preferred embodiment, the exposed conductive material is between 100 to 10,000 mm 2 .
- the microelectrode comprises a glass capillary tube 1 , containing an ultra fine platinum wire 2, to which a transition wire 3 has been soldered 6.
- the transition wire 3, is soldered 6 in turn to a hookup wire 4, which protrudes from an epoxy plug 5 that seals the capillary tube
- polyacrylamide gel material 7 is packed into a recess etched into the exposed surface of the platinum wire 2
- oligonucleotide probes are immobilized on the microelectrodes of the apparatus of the present invention using a neutral layer between the ohgonucleotides and the micro lectrodes.
- this layer comprises neutral polypyrrole.
- this layer comprises such substances as polythiphene, polyanihne, polyfuran, polypy ⁇ dine, polycarbazole, polyphenylene, poly(phenylenv ⁇ nylene), polyfluorene, polyindole, their derivatives, their copolymers, and combinations thereof.
- the layer is preferably at least about 0.001 to 50 mm thick, more preferably at least about 0 01 to 10 mm thick and most preferably at least about 0 5 mm thick.
- oligonucleotide probes are immobilized on polyacrylamide gel pads in contact with the microelectrodes of the apparatus of the present invention
- the polyacrylamide gel pad is embedded into a recess etched into the surface of the microelectrode.
- the polyacrylamide gel pad is preferably at least about 0.1 to 30 mm thick, more preferably at least about 0 5 to 10 mm thick, and most preferably about 0 5 mm thick
- the apparatus of the present invention comprises at least one counter-electrode
- the counter-electrode comprises a conductive material, with an exposed surface that is significantly larger than that of the individual microelectrodes
- the counter electrode comprises platinum
- the counter electrode comprises solid or porous films of silver, gold, platinum, titanium, copper, or metal oxides, metal nitrides, metal carbides, or carbon
- the apparatus comprises at least one reference electrode
- the reference electrode is used in assays where the further quantification of target molecules is desired
- the reference electrode comprises a silver/ silver chloride electrode
- the reference electrode comprises solid or porous films of gold, platinum, titanium, or copper, metal oxides, metal nitrides, metal carbides, or carbon
- the electrolyte solution comprising the apparatus of the present invention is any electrolyte solution comprising at least one salt containing metal or polymerized cations that are IO ⁇ - conductive and can react with biological molecules, most preferably nucleic acids or peptides
- the salt further comprises anions that exhibit a reduced specific adsorption for the surface of the microelectrode, thereby reducing the noise during the detection of molecular interactions between probe and target molecules
- the electrolyte solution used for the detection of nucleic acid hybridization contains 0 1 M L ⁇ CI0 4 This electrolyte is preferred since CI0 4 is not specifically adsorbed on the electrode surface and thus generates a low background noise
- ⁇ * is preferred since its small size facilitates intercalation of the Lf cations into the nucleic acid duplex and has less diffusion resistance
- the AC impedance is measured in hybridization buffers such as 1X SSC following molecular interactions between probe and target molecules
- the means for producing electrical impedance at each microelectrode can be accomplished using a model 1260 Impedance/Gain-Phase Analyser with model 1287 Electrochemical Interface (Solartron Inc , Houston, TX)
- Other electrical impedance measurement means include, but are not limited to, transient methods with AC signal perturbation superimposed upon a DC potential applied to an electrochemical cell such as AC bridge and AC voltammetry
- the measurements can be conducted at certain frequency determined by scanning frequencies to ascertain the frequency producing the highest signal
- the means for detecting changes in impedance at each microelectrode in the presence or absence of a target molecule can be accomplished by using one of the above-described instruments
- the apparatus further comprises a plurality of wells each of which encompasses at least one microelectrode and at least one counter- electrode
- wells is used herein in its conventional sense, to describe a portion of the substrate in which the microelectrode and at least one counter-electrode are contained in a defined volume
- the present invention provides an apparatus and methods for detecting molecular interactions by detecting cation interactions associated with nucleic acid hybridization
- the detection method used is most preferably AC impedance, but encompasses any detection methods that do not employ or require a reporter-labeled moiety to obtain measurable signals
- the impedance is measured at different frequencies in order to obtain a "signature" of the hybridization reaction that is sensitive enough to permit mismatch hybridization between the oligonucleotide probe and target molecules to be detected
- the inventive methods disclosed herein are useful for electrical detection of molecular interactions between probe molecules bound to defined regions of an ordered array (conventionally termed "a biochip array") and target molecules in a sample which are permitted to interact with the probe molecules By arraying microelectrodes to which individual probe molecules have been attached on a biochip, parallel measurements of many probes can be performed in a single assay
- the present invention further provides an apparatus and methods for detecting cation interactions associated with peptide binding using AC impedance, but without the use of reporter-labeled target to obtain measurable signals
- the methods are used for electrical detection of molecular interactions between probe molecules bound to defined regions of an ordered peptide array and target molecules in a sample which are permitted to interact with the probe molecules
- the apparatus and methods of the present invention can be adapted further to be used with arrays of any substance that can participate in a molecular interaction that can be interrogated with cations, most preferably lithium cations
- Such interactions include gand-receptor interactions, enzyme-inhibitor interactions, and antigen-antibody interactions
- the apparatus and methods of the present invention are not dependent on labeling the target molecule By removing the labeling step, the cost of the assay is reduced as well as simplified, thereby making electrical detection easier and more cost-effective to use Furthermore, by not requiring target molecules to be labeled, the range of assays for which a method of the present invention may be employed is extended For example, the present invention enables one to perform high sensitivity, high resolution measurements of RNA concentrations in gene expression studies without having to label the chemically-labile RNA or to convert the RNA into cDNA The methods of the present invention may also enable new types of assays to be developed In an additional embodiment, the invention relies on the use of ECA labels and detection on hydrogel arrays The apparatus and methods of the present invention are illustrated herein using hybridization between oligonucleotide probes immobilized to a polymeric hydrogel pad that is placed in contact with a microelectrode (a hydrogel porous microelectrode) and electrochemically- labeled target nu
- the apparatus of the present invention comprises a supporting substrate, a plurality of microelectrodes in contact with the supporting substrate, a plurality of polyacrylamide gel pads in contact with the microelectrodes and to which probes are immobilized, at least one counter-electrode in contact with the supporting substrate, a means for producing an electrical signal at each microelectrode, a means for detecting changes in the electrical signal at each microelectrode in the presence or absence of an electrochemically active reporter-labeled target molecule, and an electrolyte solution in contact with the plurality of microelectrodes and polymeric hydrogel pads and the counter-electrode
- the polymeric hydrogel is constructed from hydrophihc polymeric materials including but not limited to polyacrylamide, agarose gel, polyethylene glycol, cellular, and sol gels
- the apparatus is a microarray containing at least 10 3 hydrogel porous microelectrodes to which oligonucleotide probes have been attached.
- ohgonucleotides having a particular nucleotide sequence, or groups of such ohgonucleotides having related (e g , overlapping) nucleotide sequences are immobilized at each of the plurality of hydrogel porous microelectrodes.
- the nucleotide sequence(s) of the immobilized ohgonucleotides at each hydrogel porous microelectrode, and the identity and correspondence between a particular hydrogel porous microelectrode and the nucleotide sequence of the oligonucleotide immobilized thereto are known
- the probes are ohgonucleotides comprising from about 10 to about 100, more preferably from about 10 to about 50, and most preferably from about 15 to about 30, nucleotide residues
- the probes are nucleic acids comprising from about 10 to about 5000T)asepa ⁇ rs, more preferably from about 100 to about 1000 basepairs, and most preferably from about 200 to about 500 basepairs
- the immobilized probes are peptides comprising from about 5 to about 500 ammo acid residues
- the substrate is composed of silicon
- the substrate is prepared from substances including, but not limited to, glass, plastic, rubber, fabric, or ceramics
- the hydrogel porous microelectrodes are embedded within or placed in contact with the substrate
- microelectrodes are prepared from substances including, but not limited to, metals such as gold, silver, platinum, titanium or copper, in solid or porous form and preferably as foils or films, metal oxides, metal nitrides, metal carbides, or carbon.
- the probes are attached to polyacrylamide gel pads that are placed in contact with the microelectrodes.
- the substrate of the present invention has a surface area of between 0 01 mm 2 and 5 cm 2 containing between 1 and 1 x 10 8 hydrogel porous microelectrodes.
- the substrate has a surface area of 10,000 mm 2 and contains 10 4 hydrogel porous microelectrodes, each of which has an oligonucleotide having a particular sequence immobilized thereto
- the hydrogel porous microelectrodes are arranged on the substrate so as to be separated by a distance of between 0.05 mm to 0.5 mm.
- the hydrogel porous microelectrodes are regularly spaced on the solid substrate with a uniform spacing there between
- the hydrogel porous microelectrodes project from the surface of the substrate, with such projections extending between 5 x 10 '8 and 1 x 10 "5 cm from the surface of the substrate
- the hydrogel porous microelectrodes comprise a flat disk of conductive material that is embedded in the substrate and exposed at the substrate surface, with the substrate acting as an insulator in the spaces between the hydrogel porous microelectrodes
- the microelectrodes comprise a gold conductor and glass insulator.
- the microelectrodes comprise conductor substances such as solid or porous films of silver, platinum, titanium, or copper, metal oxides, metal nitrides, metal carbides, or carbon.
- the microelectrodes comprise substrate and/or insulator substances such as glass, silicon, plastic, rubber, fabric, or ceramics.
- the microelectrodes of the present invention have an exposed conductive surface of between 0 01 mm 2 to 0.5 cm 2 In the preferred embodiment, the exposed conductive material is between 100 to 160,000 mm 2
- the microelectrode comprises a glass capillary tube 1, containing an ultra fine platinum wire 2, to which a transition wire 3 has been soldered 6.
- the transition wire 3, is soldered 6 in turn to a hookup wire 4, which protrudes from an epoxy plug 5 that seals the capillary tube
- polyacrylamide gel material 7 is packed into a recess etched into the exposed surface of the platinum wire 2.
- the polyacrylamide gel pad is embedded into a recess etched into the surface of the microelectrode.
- the polyme ⁇ x hydrogel pad is preferably at least about 0 1 to 30 mm thick, more preferably at least about 0.5 to 10 mm thick, and most preferably about 0 5 mm thick
- oligonucleotide probes are immobilized on the polyacrylamide gel.
- the apparatus of the present invention comprises at least one counter-electrode.
- the counter-electrode comprises a conductive material, with an exposed surface that is significantly larger than that of the individual microelectrodes.
- the counter electrode comprises platinum.
- the counter electrode comprises solid or porous films of silver, gold, platinum, titanium, or copper, metal oxides, metal nitrides, metal carbides, or carbon
- the apparatus comprises at least one reference electrode
- the reference electrode is used in assays where the further quantification of target molecules is desired
- the reference electrode comprises a silver/ silver chloride electrode
- the reference electrode comprises solid or porous films of gold, platinum, titanium, or copper, metal oxides, metal nitrides, metal carbides, or carbon
- the apparatus further comprises a plurality of wells each of which encompasses at least one hydrogel porous microelectrode and at least one counter-electrode
- wells is used herein in its conventional sense, to describe a portion of the substrate in which the hydrogel porous microelectrode and at least one counter-electrode are contained in a defined volume
- Electrochemically-labeled target molecules useful in the methods of the present invention may be prepared by labeling suitable target molecules with any electrochemically-distinctive redox reporter which does not interfere with the molecular interaction to be detected
- target molecules are labeled with electrochemical reporter groups comprising a transition metal complex, most preferably containing a transition metal ion that is ruthenium, cobalt, iron, or osmium
- target molecules may be labeled with the following non-limiting examples of electrochemically-active moieties
- Redox moieties useful against an aqueous saturated calomel reference electrode include, but are not limited to, transition metal complexes, 1 ,4-benzoqu ⁇ none, ferrocene, tetracyanoqumodimethane, N,N,N',N'-tetramethyl-p-phenylened ⁇ am ⁇ ne, or tetrathiafulvalene
- Redox moieities useful against an Ag/AgCI reference electrode include 9-am ⁇ noac ⁇ d ⁇ ne, ac ⁇ dine orange, aclarubicm, daunomycm, doxorubicm, pirarubicin, ethidium bromide, ethidium monoazide, chlortetracycline, tetracyclme, minocycline, Hoechst 33258, Hoechst 33342, 7-am ⁇ noact ⁇ nomyc ⁇ n D, Chromomycm A 3 , mithramycin A, Vinblastme, Rifampicin, Os(b ⁇ py ⁇ d ⁇ ne) 2 (d ⁇ py ⁇ dophenaz ⁇ ne) 2 * , Co(b ⁇ py ⁇ d ⁇ ne) 3 3+ , or Fe-bleomycin
- the electrochemically-active moiety comprising the electrochemically active reporter-labeled target molecule of the method of the present invention is optionally linked to the target molecule through a linker, preferably having a length of from about 10 to about 20 Angstroms
- the linker can be an organic moiety such as a hydrocrabon chain (CH 2 ) n , or can comprise an ether, ester, carboxyamide, or thioether moiety, or a combination thereof
- the linker can also be an inorganic moiety such as siloxane (O-S ⁇ -0) The length of the linker is selected so that the electrochemically-active moiety does not interfere with the molecular interaction to be detected
- Electrochemical contact is advantageously provided using an electrolyte solution in contact with each of the hydrogel porous microelectrodes of the invention
- Electrolyte solutions useful in the apparatus and methods of the invention include any electrolyte solution at physiologically-relevant ionic strength (equivalent to about 0 15 M NaCI) and neutral pH
- Examples of electrolyte solutions useful with the apparatus and methods of the invention include but are not limited to phosphate buffered saline, HEPES buffered solutions, and sodium bicarbonate buffered solutions
- the present invention provides an apparatus and methods for detecting molecular interactions by detecting changes in AC impedance
- the impedance is measured at different frequencies in order to obtain a "signature" of the hybridization reaction that is sensitive enough to permit mismatch hybridization between the oligonucleotide probe and target molecules to be detected
- inventive methods disclosed herein are useful for electrochemical detection of molecular interactions between probe molecules bound to defined regions of an ordered array
- a biochip array (conventionally termed “a biochip array”) and electrochemically-labeled target molecules in a sample which are permitted to interact with the probe molecules
- a biochip array By arraying microelectrodes to which individual probe molecules have been attached on a biochip, parallel measurements of many probes can be performed in a single assay
- the means for producing electrical impedance at each microelectrode is accomplished using a model 1260 Impedance/Gain-Phase Analyser with model 1287 Electrochemical Interface (Solartron Inc , Houston, TX)
- Other electrical impedance measurement means include, but are not limited to, transient methods with AC signal perturbation superimposed upon a DC potential applied to an electrochemical cell such as AC bridge and AC voltammetry The measurements can be conducted at certain frequency determined by scanning frequencies to ascertain the frequency producing the highest signal
- the means for detecTmg changes in impedance at each microelectrode in the presence or absence of a electrochemically-labeled target molecule can be accomplished by using one of the above-described instruments
- other electric and/or electrochemical methods can be used to detect molecular interactions between probe molecules and electrochemically-labeled target molecules, including, but not limited to, cyclic voltammetry, stripping voltammetry, pulse voltammetry, square wave voltammetry, AC voltammetry, hydrodynamic modulation voltammetry, potential step method, potentiomet ⁇ c measurements, amperomet ⁇ c measurements, current step method, and combinations thereof
- the electrical signal is current flow in response to an applied voltage at the redox potential of the electrochemical label
- the present invention also provides an apparatus and methods for detecting single nucleotide polymorphisms (SNP) in a nucleic acid sample comprising a specific target nucleic acid
- the devices of the invention are particularly useful for analyzing target nucleic acid for the diagnosis of infectious and genetic disease
- the target nucleic acid is generally a portion of a gene having a known nucleotide sequence that is associated with an infectious agent or genetic disease, more specifically, the disease is caused by a single nucleotide (or point) mutation
- the device incorporates a nucleic acid oligonucleotide array specific for the target gene, and means for detecting and determining the identity of a specific single base in the target sequence adjacent to the hybridization site of at least one probe in the oligonucleotide array (termed the "3' offset method") or encompassing the 3' residue of at least one oligonucleotide probe in the array (termed the "3' inclusive method”)
- the present invention provides an array of oligonucleotide primers or probes immobilized to a surface that defines a first electrode
- the sequence of each oligonucleotide at each address in the array is known and at least one oligonucleotide in said oligonucleotide array is complementary to part of a sequence in a nucleic acid in the sample to be assayed
- the sequence of at least one oligonucleotide is most preferably selected to extend to a position immediately adjacent to the nucleotide position in the sample nucleic acid that is to be interrogated, / e , for mutation or genetic polymorphism
- the oligonucleotide is selected to encompass the site of mutation or genetic polymorphism, in these latter embodiments, it is generally preferred to provide a multiplicity of ohgonucleotides having one of each possible nucleotide at the polymorphic position to ensure hybridization of at least one of the ohgonucleot
- Hybridization and extension reactions are performed in a reaction chamber and in a hybridization buffer for a time and at temperature that permits hybridization to occur between nucleic acid in the sample and the ohgonucleotides in the array complementary thereto
- the apparatus of the present invention comprises a supporting substrate, a plurality of a first electrode (or an array of microelectrodes) in contact with the supporting substrate to which probes are immobilized, at least one counter-electrode and optionally a reference electrode, and an electrolyte solution in contact with the plurality of microelectrodes, counter electrode and reference electrode
- the apparatus of the present invention comprises a supporting substrate, a plurality of first electrodes (or an array of microelectrodes) in contact with the supporting substrate, a plurality of polyacrylamide gel pads in contact with the microelectrodes and to which probes are immobilized, at least one counter-electrode and optionally a reference electrode, and an electrolyte solution in contact with the plurality of microelectrodes, counter electrode and reference electrode
- the substrate is composed of silicon
- the substrate is prepared from substances including, but not limited to, glass, plastic, rubber, fabric, or ceramics
- the electrode comprising the first surface to which the oligonucleotide or array thereof is attached is made of at least one of the following materials: metals such as gold, silver, platinum, copper, and electrically-conductive alloys thereof; conductive metal oxides such as indium oxide, indium-tin oxide, zinc oxide; and other conductive materials such carbon black, conductive epoxy
- microelectrodes are prepared from substances including, but not limited to, metals such as gold, silver, platinum, titanium or copper, in solid or porous form and preferably as foils or films, metal oxides, metal nitrides, metal carbides, or carbon.
- probes are attached to conjugated polymers or copolymers including, but not limited to, polypyrrole, polythiophene, polyanihne, polyfuran, polypy ⁇ dine, polycarbazole, polyphenylene, poly(phenylenv ⁇ nylene), polyfluorene, polyindole, their derivatives, their copolymers, and combinations thereof.
- probes are attached to polyacrylamide gel pads that are in contact with the microelectrodes
- the substrate of the present invention has a surface area of between 0.01 mm 2 and 5 cm 2 containing between 1 and 1 x 10 8 microelectrodes
- the substrate has a surface area of 100 mm 2 and contains 10" microelectrodes, each microelectrode having an oligonucleotide having a particular sequence immobilized thereto.
- the substrate has a surface area of 100 mm 2 and contains 10 4 microelectrodes, each microelectrode in contact with a polyacrylamide gel pad to which an oligonucleotide having a particular sequence has been immobilized thereto.
- the microelectrodes are arranged on the substrate so as to be separated by a distance of between 0 05 mm 2 to 0.5 mm Most preferably, the microelectrodes are regularly spaced on the solid substrate with a uniform spacing there between.
- the apparatus comprises a microarray containing at least 10 3 microelectrodes on a single substrate to which oligonucleotide probes have been attached
- arrayed ohgonucleotides are attached to polyacrylamide gel pads that are in contact with the microelectrodes of the * apparatus of the present invention
- ohgonucleotides having a particular nucleotide sequence, or groups of such ohgonucleotides having related (e.g., overlapping) nucleotide sequences are immobilized at each of the plurality of microelectrodes
- the nucleotide sequence(s) of the immobilized ohgonucleotides at each microelectrode, and the identity and correspondence between a particular microelectrode and the nucleotide sequence of the oligonucleotide immobilized thereto are known
- the primer or probe used in the present invention is preferred to be an oligonucleotide having a length, both the upper and lower limits of which are empirically determined
- the lower limit on probe length is stable hybridization it is known in the art that probes that are too short do not form thermodynamically-stable duplexes sufficient for single base extension under the hybridization conditions of the assay
- the upper limit on probe length are probes that produce a duplex in a region other than that of the predetermined interrogation target, leading to artifactual incorporation of primer extension un ⁇ t(s) labeled with electrochemically active moieties
- Preferred oligonucleotide primer or probes used in the present invention have a length of from about 8 to about 50, more preferably from about 10 to about 40, even more preferably from about 12 to about 30, and most preferably from about 15-25 nucleotides
- longer probes, / e. longer than 40 nucleotides may also be used
- the primer or probe is preferably immobilized directly on the first electrode surface through an anchoring group
- advantageous anchoring groups include, for example, moieties comprising thiols, carboxylates, hydroxyls, amines, hydrazines, esters, amides, ha des, vinyl groups, vinyl carboxylates, phosphates, silicon-containing organic compounds, and their derivatives
- an oligonucleotide which is complementary to a target DNA is covalentiy linked to a metallic gold electrode through a thiol-containmg anchoring group
- the length of these anchoring groups is chosen such that the conductivity of these molecules do not hinder electron transfer from the electrochemical reporter groups, to the electrode, via the hybridized probe and target DNA, and these anchoring groups in series
- these anchoring groups are preferred to have higher conductivities than double-stranded nucleic acid A conductivity, S, of from between about 10 "6 to about
- the primer or probe can be covalentiy bound onto an intermediate support that is placed on top of the first electrode
- the support is preferred to be either a thin layer of porous inorganic material such as TiOx, S ⁇ 0 2 , NO x or a porous organic polymer such as polyacrylamide, agarose, nitrocellulose membranes, nylon, and dextran supports
- Primers are covalentiy bound to the support through a linker Preferred linker moieties include, but are not limited to, thioethers, ethers, esters, amides, amines, hydrazines, carboxylates, hahdes, hydroxyls, vinyls, vinyl carboxylates, thiols, phosphates, silicon containing organic compounds, and their derivatives and other carboxylate moieties More preferably, biotm-streptavidin pairs are advantageous arranged to provide probe bindif g onto the intermediate support
- the apparatus of the invention also includes a second electrode and a reference electrode to permit current flow
- the second electrode is most preferably comprised of any conducting material, including, for example, metals such as gold, silver, platinum, copper, and alloys, conductive metal oxides such as indium oxide, ⁇ d ⁇ um-t ⁇ n oxide, zinc oxide, or other conductive materials such as carbon black, conductive epoxy, most preferred is a platinum (Pt)-w ⁇ re auxiliary electrode
- the reference electrode is preferably a silver wire electrode, a silver/silver chloride (Ag/AgCI) reference electrode, or a saturated calomel electrode
- the apparatus also comprises one or a multiplicity of reaction chambers, each reaction chamber being in electrochemical contact with at least one of each of the aforementioned electrodes, wherein each of the electrodes are connected to a power source and a means for controlling said power source
- the term "in electrochemical contact” is intended to mean, inter alia, that the components are connected such that current can flow through the electrodes when a voltage potential is created between the two electrodes
- Electrochemical contact is advantageously provided using an electrolyte solution in contact with each of the electrodes or microelectrode arrays of the invention
- Electrolyte solutions useful in the apparatus and methods of the invention include any electrolyte solution at physiologically-relevant ionic strength (equivalent to about 0 15M NaCI) and neutral pH
- Nonlimiting examples of electrolyte solutions useful with the apparatus and methods of the invention include but are not limited to phosphate buffered saline, HEPES buffered solutions, and sodium bicarbonate buffered solutions
- Preferred polymerases for performing single base extensions using the methods and apparatus of the invention are polymerases having little or no exonuclease activity More preferred are polymerases that tolerate and are biosynthetically-active at temperatures greater than physiological temperatures, for example, at 50°C or 60°C or 70°C or are tolerant of temperatures of at least 90°C to about 95°C
- Preferred polymerases include Taq polymerase from T aquaticus (commercially available from Perkin-Elmer Cetus, Foster City, CA), Sequenase® and ThermoSequenase® (commercially available from U S Biochemical, Cleveland, OH), and Exo(-)Pfu polymerase (commercially available from New England Biolabs, Beverley, MA)
- the inventive methods for SNP detection generally comprise (1 ) preparing a sample containing the target nucleic ac ⁇ d(s) of interest to obtain single-stranded nucleic acid that spans the specific position (typically by denaturing the sample), (2) contacting the single- stranded target nucleic acid with an oligonucleotide primer of known sequence that hybridizes with a portion of the nucleotide sequence in the target nucleic acid immediately adjacent the nucleotide base to be interrogated (thereby forming a duplex between the primer and the target such that the nucleotide base to be interrogated is the first unpaired base in the target immediately 5' of the nucleotide base annealed with the 3'-end of the primer in the duplex, this oligonucleotide is preferably a specific oligonucleotide occupying a particular address in an addressable array), (3) contacting the duplex with a reagent which includes an aqueous carrier,
- the extension moiety in the primer extension unit is preferably a chain-terminating moiety, most preferably dideoxy ⁇ ucleoside t ⁇ phosphates (ddNTPs), such as ddATP, ddCTP, ddGTP, and ddTTP, however other terminators known to those skilled in the art, such as nucleotide analogs or arabmoside t ⁇ phosphates, are also within the scope of the present invention
- ddNTPs differ from conventional deoxynucleoside t ⁇ phosphates (dNTPs) in that they lack a hydroxyl group at the 3' position of the sugar component This prevents chain extension of incorporated ddNTPs, and thus terminates the chain
- the present invention provides primer extension units labeled with an electrochemical reporter group that are detected electrochemically, most preferably by redox reactions Any electrochemically-distinctive redox label which does not interfere with the incorporation of the d
- the target DNA in the sample to be investigated can be amplified by means of in vitro amplification reactions, such as the polymerase chain reaction (PCR) technique well known to those skilled in the art
- in vitro amplification reactions such as the polymerase chain reaction (PCR) technique well known to those skilled in the art
- PCR polymerase chain reaction
- Enriching the target DNA in a biological sample to be used in the methods of the invention provides more rapid and more accurate template-directed synthesis by the polymerase
- in vitro amplification methods such as PCR
- PCR is optional in the methods of the invention, which feature advantageously distinguishes the instantly-disclosed methods from prior art detection techniques, which typically required such amplification in order to generate sufficient signal to be detected Because of the increased sensitivity of the instantly-claimed methods, the extensive purification steps required after PCR and other in vitro amplification methods are unnecessary, this simplifies performance of the inventive methods
- a general formula of a preferred embodiment of the primer extension unit is ddNTP-L-R where ddNTP represents a dideoxy ⁇ bonucleotide t ⁇ phosphate including ddATP, ddGTP, ddCTP, ddTTP, L represents an optional linker moiety, and R represents an electrochemical reporter group, preferably an electrochemically-active moiety and most preferably a redox moiety
- each chain-terminating nucleotide species (for example, d ⁇ deoxy(dd)ATP, ddGTP, ddCTP and ddTTP) is labeled with a different electrochemical reporter group, most preferably wherein each different reporter group has a different and electrochemically-distmguishable reduction/oxidation (redox) potential
- redox reduction/oxidation
- nucleotides comprising a DNA molecule are themselves electrically active, for example, guanine and adenine can be electrochemically oxidized around 0 75 V and 1 05 V, respectively
- the redox potential of the electrochemical reporter group comprising the primer extension units of the invention it is generally preferable for the redox potential of the electrochemical reporter group comprising the primer extension units of the invention to be distinguishable from the intrinsic redox potential of the incorporated nucleotides themselves
- the following electrochemical species are non-limiting examples of electrochemically- active moieties provided as electrochemical reporter groups of the present invention, the
- Redox moieties useful against an aqueous saturated calomel reference electrode include 1 ,4- benzoqumone (-0 54V), ferrocene (+0 307), tetracyanoqumodimethane (+0 127, -0 291 ), N,N,N',N'-tetramethyl-p-phenylened ⁇ am ⁇ ne (+0 21 ), tetrathiafulvalene (+0 30) - Redox moieties useful against a Ag/AgCI reference electrode include 9-am ⁇ noac ⁇ d ⁇ ne
- electrochemically-active moiety comprising the electrochemical reporter groups of the invention is optimized for detection of the moiety to the exclusion of other redox moieties present in the solution, as well as to prevent interference of the label with hybridization between an oligonucleotide contained in an array and a nucleic acid comprising a biological sample
- the electrochemically-active moiety comprising the chain-terminating nucleotides of the invention is optionally linked to the extension nucleotide through a linker (L), preferably having a length of from about 10 to about 20 Angstroms
- the linker can be an organic moiety such as a hydrocarbon chain
- linker can comprise an ether, ester, carboxyamide, or thioether moiety, or a combination thereof
- the linker can also be an inorganic moiety such as siloxane (O-Si-O)
- the length of the linker is selected so that R, the electrochemically-active moiety, does not interfere with either nucleic acid hybridization between the bound oligonucleotide primer and target nucleic acid, or with polymerase- mediated chain extension
- single base extension is detected by standard electrochemical means such as cyclic voltammetry (CV) or stripping voltammetry
- CV cyclic voltammetry
- stripping voltammetry electric current is recorded as a function of sweeping voltage to the first electrode specific for each particular labeled primer extension unit
- the incorporation and extension of a specific base is identified by the unique oxidation or reduction peak of the primer extension unit detected as current flow in the electrode at the appropriate redox potential
- other electric or/and electrochemical methods useful in the practice of the methods and apparatus of the invention include, but are not limited to, AC impedance, pulse voltammetry, square wave voltammetry, AC voltammetry (ACV), hydrodynamic modulation voltammetry, potential step method, potentiomet ⁇ c measurements, amperomet ⁇ c measurements, current step method, and combinations thereof
- electric current is recorded as a function of sweeping voltage to the first electrode specific for each particular labeled primer extension unit The difference is the type of input/probe signal and/or shape of input/probe signal used to sweep the voltage range
- a DC voltage sweep is done In ACV, an AC signal is superimposed on to the voltage sweep
- square wave voltammetry a square wave is superimposed on to the voltage sweep
- the signal is recorded from each position ("address") in the oligonucleotide array, so that the identity of the extended species can be determined
- a reaction mixture is prepared containing at least one chain-terminating nucleotide labeled with an electrochemical label (such as a redox-labeled ddNTP), a hybridization buffer compatible with the polymerase and having a salt concentration sufficient to permit hybridization between the target nucleic acid and primer ohgonucleotides under the conditions of the assay, and a DNA polymerase such as Tag DNA polymerase or ThermoSequenase Single stranded target nucleic acid, for example, having been denatured by incubation at a temperature >90°C, is diluted to a concentration appropriate for hybridization in deionized water and added to the reaction mixture
- the resulting hybridization mixture is sealed in a reaction chamber of the apparatus of the invention containing a first electrode, wherein the electrode comprises a multiplicity of primers having known sequence linked thereto At least one of the primers has a nucleotide sequence capable of
- a duplex between the primer and the target is formed wherein the nucleotide base to be interrogated is the first unpaired base in the target immediately 5' of the nucleotide base that is annealed with the 3'-end of the primer in the duplex
- Single base extension of the 3' end of the annealed primer is achieved by incorporation of the chain-terminating nucleotide, labeled with an electrochemically active moiety, into the primer
- the primer sequence and labeled chain-terminating nucleotide are chosen so that incorporation of the nucleotide is informative of the identity (/ e , mutant, wildtype or polymorphism) of the interrogated nucleotide in the target
- the probe comprises a 3' terminal residue that corresponds to and hybridizes with the interrogated base
- ohgonucleotides having a "mismatch" at the 3' terminal residue will hybridize but will not be extended by the polymerase Detection of incorporation of the primer extension unit by interrogating the redox label is then informative of the identity of the interrogated nucleotide base, provided that the sequence of the oligonucleotide probe is known at each position in the array
- the electrode is washed at high stringency (i e , in a low-salt and low dielectric constant solution (such as 0 1X SSC 0 015M NaCI, 15mM sodium citrate, pH 7 0), optionally including a detergent such as sodium dodecyl sulfate at temperature of between aboutl 0- 65°C) for a time and at a temperature wherein the target nucleic acid is removed Wash conditions vary depending on factors such as probe length and probe complexity Electrochemical detection is carried out in an electrolyte solution by conventional cyclic voltammetry
- a neutral polypyrrole matrix was used for attachment of nucleic acid probes to the exposed platinum disk ⁇ jf the microelectrodes
- Electrochemical deposition was performed using a model 660A potentiostat (CH Instruments, Inc ), using platinum wire as a counter-electrode, silver/silver chloride (Ag/AgCI) as a reference electrode, and cyclic voltammetry (CV)
- a solution containing 0 05 M pyrrole, 2 5 mM 3-acetate-N-hydrodysucc ⁇ n ⁇ m ⁇ do pyrrole, and 0 1 M LiCIOJ 95% acetonit ⁇ le was prepared as the electrolyte
- the potential range for the CV was 0 2 to 1 3 V versus Ag/AgCI for the first cycle and -0 1 to 1 0 versus Ag/AgCI for 10 additional cycles
- the scan rate was 10 mV/sec
- the electrolyte was purged by nitrogen gas during the entire deposition
- the microelectrodes were incubated at room temperature for 4 hours in a solution consisting of 80 mL dimethylformamide and 20 mL of 15 nM 5'-am ⁇ no labeled 15-mer oligonucleotide (5'-C-C-C-T-C-A-A-G-C-A-G-A-G-G-A-3 ⁇ SEQ ID NO 1 ) Following attachment of the probe molecules, the microelectrodes were washed with
- TBE buffer (0 89 M T ⁇ s-borate, 0 025 M EDTA), rinsed thoroughly in deionized water, and allowed to dry at room temperature
- the AC impedance baseline of the microelectrodes prepared according to Example 2 was first determined in the absence of a complementary target molecule Microelectrodes were then exposed in a sealed conical tube to 35 mL of the complementary target molecule (5'-T-C-C-T-C-T-G-C-T-T-G- A-G-G-G-3', SEQ ID NO 2) present at concentrations in the micromolar (10 6 M, mM) to attomolar (10 18 JVI, aM) range Hybridization of probe and target molecules was performed in 1X SSC buffer
- Figure 3B illustrates the frequency complex curves, as seen in Figure 3A, for the high frequency zone (where Z' ⁇ 5 x 10 4 ) Frequency dependent semicircle impedance curves were observed at high frequencies before and after hybridization Generally, such curves at high frequencies indicate the existence of a Faraday resistance (/ e , electrochemical reaction resistance) in parallel with a capacitance Semicircular curves such as those shown in Figure 3B can be used to obtain the electrochemical reaction resistance and the double layer capacitance by equivalent circuit simulation The simulation results obtained using the data shown in Figure 3B is shown in Table I These results indicate that following hybridization of the probe and target molecules, the high frequency electrochemical resistance decreases and the capacitance increases, which is as expected This demonstrates that the hybridized DNA has a strong electrochemical interactions with L ⁇ +
- the limit of detection in the experiments described above was reached at approximately 0 1 attomol of target molecule With increased target molecule concentrations, higher hybridization signals were obtained, demonstrating that methods of the present invention can be also used to quantify the amount of target hybridized onto the electrode-immobilized probe.
- this method can be used in conjunction with appropriate reference electrodes to measure the absolute quantities of nucleic acid in a test sample.
- the methods of the present invention enable one to perform high sensitivity, high resolution measurements of RNA concentrations in gene expression studies. Comparative gene expression studies performed using such a method permits the direct measurement of the quantity of expressed RNA, rather than relying on a determination of the ratio between the RNA of interest and a control RNA.
- Microelectrodes with attached oligonucleotide probes were prepared as described in Examples 1 and 2 Four microelectrodes were incubated in a solution containing 2 pM of a 15-mer target molecule that was fully complementary to the attached probe (5'-T-C-C-T-C-T-G-C-T-T-G-A-G-G- G-3', SEQ ID NO: 2) and four other microelectrodes were incubated in a solution containing 2 /M of a 15-mer target molecule containing three mismatched bases relative to the attached probe (5'- C-C-C-T-C-A-A-G-C-A-G-A-G-G-G-A-3'; SEQ ID NO: 1 ) using the conditions described in Example
- Microelectrodes were prepared as described in Examples 1 and 2 and were hybridized to suitable target molecules as described in Example 3
- the AC impedance before and after nucleic acid hybridization is shown in Figure 7
- the microelectrode with attached oligonucleotide probe exhibits the characteristics of an ideal polarization electrode prior to hybridization with a target molecule
- the equivalent circuit for this state is shown in Figure 8A and the AC impedance response is shown in Figure 8B
- the behavior of the microelectrode is treated as an "ideal" polarization electrode under conditions of an electrolyte solution comprising 0 1 M L ⁇ Cl0 4 with purging N 2 and before hybridization to a suitable target molecule is reasonable since there is no electrochemically active species and no specific adsorption
- a large deviation from the ideal curve was observed in the same electrolyte, indicating that the impedance was significantly increased
- the AC impedance measured for the microelectrode following hybridization suggests that the electrochemical process and equivalent circuit under such conditions is as shown in Figure 8C (where R, is the Faraday resistance, / e , electrochemical reaction resistance and R ⁇ is Warburg resistance) Resistance from both electrochemical reactions and the diffusion process causes the electrode behavior following hybridization to deviate from the ideal polarization curve
- Microelectrodes were prepared as described in Example 1 ( Figure 1 A) The exposed flat disk of platinum was then etched in hot aqua regia to form a recess (/ e , micropore dent) of a specified depth. The depth of the recess was controlled by the length of time that the platinum disk was exposed to the etching material. The recess thus formed was then packed with polyacrylamide gel material (Figure 1 B) to form a hydrogel porous microelectrode ( Figure 11 ). A hydrogel porous microelectrode having a diameter of 258 mm was used in the following Examples.
- hydrogel porous microelectrodes Prior to attachment of probe molecules, hydrogel porous microelectrodes were activated by incubation for 10 mm. in 2% t ⁇ fluoroacetic acid, and rinsed for 2 mm. in deionized water. Microelectrodes were then incubated for 15 mm. in 0.1 M sodium pe ⁇ odate, and rinsed for 2 mm. in deionized water. Following this treatment, microelectrodes were thoroughly washed by incubation in deionized water for 15 mm., and then air-dried. Microelectrodes were subsequently incubated for 10 mm. in 2% dimethyl dichlorosilane solution and 2% octamethylcyclotetrasiloxane, washed in ethanol, rinsed in deionized water, and air-dried.
- the microelectrodes were incubated at room temperature for 4 hours in a solution consisting of 80 mL dimethylformamide and 20 mL of 2 pM 5'-am ⁇ no-3'fluoresce ⁇ n labeled 15-mer oligonucleotide (5'- C-C-C-T-C-A-A-G-C-A-G-A-G-G-A-3'; SEQ ID NO: 1 ). Following attachment of the probe molecules, the microelectrodes were washed with TBE buffer, rinsed thoroughly in deionized water, and allowed to dry at room temperature.
- the baseline AC impedance of hydrogel porous microelectrodes prepared according to Example 7 was first determined in the absence of target molecules. Microelectrodes were then exposed in a sealed conical tube to either 35 mL of a complementary target molecule (5'-T-C-C-T-C-T-G-C-T-T-)
- Hybridization of the probe with either target molecule was performed in 1X SSC buffer at room temperature for 1 hour. Following hybridization, microelectrodes were thoroughly rinsed for 20 mm at room temperature in an excess volume of 1X SSC and then AC impedance was measured
- AC impedance was measured using a model 1260 Impedance/Gain-Phase Analyser with model 1287 Electrochemical Interface.
- the counter and reference electrodes were platinum and Ag/AgCI, respectively, and the impedance measurements were made under open circuit voltage (OCV) conditions in 1X SSC hybridization solution Samples were excited at an amplitude of 50 mV
- OCV open circuit voltage
- Microelectrodes were prepared as follows Ultra-fine platinum wire having a diameter of 50 mm was inserted into glass capillary tubing having a diameter of 2 mm and sealed by heating to form a solid microelectrode structure The tip of the structure was then polished with gamma alumina powder (CH Instruments, Inc , Austin, TX) to expose a flat disk of the platinum wire Microelectrodes were initially polished with 0 3 mm gamma alumina powder, rinsed with deionized water, and then polished with 0 005 mm powder Following polishing, the microelectrodes were ultrasonically cleaned for 2 mm in deionized water, soaked in 1 N HN0 3 for 20 mm , vigorously washed in deionized water, immersed in acetone for 10 mm , and again washed vigorously in deionized water Through the use of micromanufactu ⁇ ng techniques employed in the fabrication of semiconductors, modifications of this procedure can be applied to the preparation of microelect
- Hydrogel porous microelectrodes were prepared from the above-described microelectrodes as follows.
- the exposed flat disk of platinum of each microelectrode was etched in hot aqua regia to form a recess (i.e., micropore dent) of a specified depth.
- the depth of the recess was controlled by the length of time that the platinum disk was exposed to the etching material.
- the recess thus formed was then packed with polyacrylamide gel material (Figure 1 B) to form a hydrogel porous microelectrode ( Figure 2)
- Figure 2 A hydrogel porous microelectrode having a diameter of 258 mm was used in the Example 2.
- hydrogel porous microelectrodes Prior to attachment of probe molecules, hydrogel porous microelectrodes were activated by incubation for 10 mm. in 2% t ⁇ fluoroacetic acid, and rinsed for 2 mm. in deionized water. Microelectrodes were then incubated for 15 mm. in 0.1 M sodium pe ⁇ odate, and rinsed for 2 mm. in deionized water. Following this treatment, microelectrodes were thoroughly washed by incubation in deionized water for 15 mm , and then air-dried. Microelectrodes were subsequently incubated for 10 mm. in 2% dimethyl dichlorosilane solution and 2% octamethylcyclotetrasiloxane, washed in ethanol, rinsed in deionized water, and air-dried.
- the microelectrodes were incubated at room temperature for 4 hours in a solution consisting of 80 mL dimethylformamide and 20 mL of 2 pM 5'-am ⁇ no-3'fluoresce ⁇ n labeled 15-mer oligonucleotide (5'-C-C- C-T-C-A-A-G-C-A-G-A-G-G-A-3', SEQ ID NO: 1 ) Following attachment of the probe molecules, the microelectrodes were washed with TBE buffer, rinsed thoroughly in deionized water, and allowed to dry at room temperature.
- Nucleic acid hybridization between a probe bound to a hydrogel porous microelectrode and an electrochemically-labeled target molecule is detected as follows.
- the baseline AC impedance of hydrogel porous microelectrodes prepared according to Example 2 is first determined in the absence of the electrochemically-labeled target molecules.
- Microelectrodes are then exposed in a sealed conical tube to either 35 mL of a complementary target molecule (S'-T-C-C-T-C-T-G-C-T-T-G-A-G-G- G-3'; SEQ ID NO.
- AC impedance is measured using a model 1260 Impedance/Gain-Phase Analyser with model 1287 Electrochemical Interface
- the counter and reference electrodes are platinum and Ag/AgCI, respectively, and the impedance measurements are made under open circuit voltage (OCV) conditions in 1X SSC hybridization solution. Samples are excited at an amplitude of 50 mV.
- OCV open circuit voltage
- a glass substrate layer is prepared comprising an ordered array of a plurality of gold microelectrodes connected to a voltage source
- the substrate has a surface area of 100 mm 2 and contains 10 4 microelectrodes, each microelectrode in contact with a polyacrylamide gel pad that is about 0.5 ⁇ m thick to which an oligonucleotide having a particular sequence has been immobilized thereto.
- the microelectrodes are arranged on the substrate so as to be separated by a distance of about 0.1 mm, and are regularly spaced on the solid substrate with a uniform spacing there between
- oligonucleotide probe having a length of 25 nucleotides.
- the resulting ordered array of probes are arranged in groups of four, whereby the probes are identical except for the last (most 3') residue.
- Each group contains an oligonucleotide ending in an adenosme (A), guanme (G), cytosme (C) or thymid e (T) or uracil (U) residue.
- the ohgonucleotides are attached to each of the gold electrodes through the polyacrylamide gel pad using a modification of the oligonucleotide at the 5' residue. This residue comprises a thioester linkage that covalentiy attaches the oligonucleotide to the polyacrylamide polymer.
- This ordered microelectrode array is placed in a reaction chamber, having dimensions sufficient to contain the array and a volume of from about 10 to 100mL of hybridization/extension buffer
- the reaction chamber also comprises a second counter electrode comprising platinum wire and a third, reference electrode that is a silver/ silver chloride electrode, each electrode being elect ⁇ cally connected to a voltage source
- a volume of from about 10 to 100mL of hybridization buffer is added to the reaction chamber
- This solution also contains a target molecule, typically at concentrations in the micromolar (10 "6 M; ⁇ M ) to attomolar (10 "18 M, aM) range.
- Hybridization of probe and target molecules is performed in 1X SSC buffer (0 15 M NaCI, 0.015 M sodium citrate, pH 7.0) at 37°C for 24 to 48 hours Following hybridization, microelectrodes were thoroughly rinsed in an excess volume of 1X SSC at room temperature
- a volume of from about 10 to 100mL of extension buffer containing a polymerase and a plurality of each of 4 chain-terminating nucleotide species is then added to the reaction chamber.
- Each of the four chain-terminating nucleotide species is labeled with a chemical species capable of participating in a reduction/oxidation (redox) reaction at the surface of the microelectrode
- a chemical species capable of participating in a reduction/oxidation (redox) reaction at the surface of the microelectrode An example of such a collection of species is ddATP labeled with cobalt (b ⁇ py ⁇ d ⁇ ne) 3 3t , ddGTP labeled with minocychne, ddCTP labeled with ac ⁇ di ⁇ e orange, and ddTTP labeled with ethidium monoazide
- the redox labels are covalentiy linked to the chain-terminating nucleotides by a hydrocarbon linker (CH 2 ) 2
- each microelectrode is interrogated by conventional cyclic voltammetry to detect a redox signal
- identity of ohgonucleotides containing single base extended species is determined by the redox potential of the signal obtained thereby
- hybridization and single base extension can be performed in the same buffer solution, provided the polymerase is compatible with the hybridization buffer conditions
Landscapes
- Health & Medical Sciences (AREA)
- Immunology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Chemical & Material Sciences (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Food Science & Technology (AREA)
- Biochemistry (AREA)
- Cell Biology (AREA)
- Biotechnology (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Microbiology (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Apparatus Associated With Microorganisms And Enzymes (AREA)
- Investigating Or Analyzing Materials By The Use Of Electric Means (AREA)
- Investigating Or Analyzing Non-Biological Materials By The Use Of Chemical Means (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Abstract
This invention relates to the detection of molecular interactions between biological molecules. Specifically, the invention relates to electrical detection of interactions such as hybridization between nucleic acids or peptide antigen-antibody interactions using arrays of peptides or oligonucleotides. In particular, the invention relates to an apparatus and methods for detecting nucleic acid hybridization or peptide binding using electronic methods including AC impedance. In some embodiments, no electrochemical or other label moieties are used. In others, electrochemically active labels are used to detect reactions on hydrogel arrays, including genotyping reactions such as the single base extension reaction.
Description
METHODS AND COMPOSITIONS RELATING TO ELECTRICAL DETECTION OF NUCLEIC ACID REACTIONS
This is a continuing application of U.S S.N s 09/458,501 , filed December 9, 1999; 09/459,685, filed December 13, 1999 and 09/458,533, filed December 9, 1999, all of which are expressly incorporated by reference herein
FIELD OF THE INVENTION
This invention relates to the detection of molecular interactions between biological molecules. Specifically, the invention relates to electrical detection of interactions such as hybridization between nucleic acids or peptide antigen-antibody interactions using arrays of peptides or ohgonucleotides. In particular, the invention relates to an apparatus and methods for detecting nucleic acid hybridization or peptide binding using electronic methods including AC impedance. In some embodiments, no electrochemical or other label moieties are used. In others, electrochemicaily active labels are used to detect reactions on hydrogel arrays, including genotyping reactions such as the single base extension reaction.
BACKGROUND OF THE INVENTION
A number of commonly-utilized biological applications, including for example, diagnoses of genetic disease, analyses of sequence polymorphisms, and studies of receptor-ligand interactions, rely on the ability of analytical technologies to readily detect events related to the interaction between probe and target molecules. While these molecular detection technologies have traditionally utilized radioactive isotopes or fluorescent compounds to monitor probe-target interactions, methods for the electrical detection of molecular interactions have provided an attractive alternative to detection techniques relying on radioactive or fluorescent labels
Electrical and electrochemical detection techniques are based on the detection of alterations in the electrical properties of an electrode arising from interactions between probe molecules on the surface of the electrode and target molecules in the reaction mixture. Electrical or electrochemical
detection eliminates many of the disadvantages inherent in use of radioactive or fluorescent labels to discern molecular interactions. This process offers, for example, a detection technique that is safe, inexpensive, and sensitive, and is not burdened with complex and onerous regulatory requirements. However, despite these advantages, there are a number of obstacles in using electrical or electrochemical detection techniques for analyzing molecular interactions. One such obstacle is the requirement, in some methods, of incorporating an electrochemical label into the target molecule. For example, labeled target molecules have been used to increase the signal produced upon the formation of nucleic acid duplexes during hybridization assays.
For example, Meade et al. (in U.S. Patent Nos. 5,591 ,578, 5,705,348, 5,770,369, 5,780,234 and
5,824,473) provide methods for the selective covalent modification of nucleic acids with redox- active moieties such as transition metal complexes. Meade et al further disclose nucleic acid hybridization assays employing such covalently-modified nucleic acid molecules. Similar work is further disclosed in U S. Patent No 6,090,933 and WO 98/20162, WO 98/12430, WO 00/16089, WO 99/57317, WO 99/67425, WO 99/37819, WO 00/38836, PCT US 00/19889 and WO
99/57319
Heller ef al. (in U.S. Patent Nos. 5,605,662 and 5,632,957) provide methods for controlling molecular biological reactions in microscopic formats that utilize a self-addressable, self- assembling microelectronic apparatus. Heller et al. further provide an apparatus in which target molecules labeled with fluorescent dyes are transported by free field electrophoresis to specific test sites where the target molecules are concentrated thereby, and reacted with specific probes bound to that test site. Unbound or non-specifically interacting target molecules are thereafter removed by reversing the electric polarity at the test site. Interactions between probe and target molecules are subsequently assayed using optical means
Certain alternative methods that do not employ labeled target nucleic acids have been described in the prior art For example, Hollis ef al. (in U S. Patent Nos. 5,653,939 and 5,846,708) provide a methδ"d and apparatus for identifying molecular structures within a sample substance using a monolithic array of test sites formed on a substrate upon which the sample substance is applied In the method of Hollis et al., changes in the electromagnetic or acoustic properties - for example, the change in resonant frequency - of the test sites following the addition of the sample substance are detected in order to determine which probes have interacted with target molecules in the sample substance.
In addition, Eggers et al. (in U S. Patent Nos. 5,532,128, 5,670,322, and 5,891 ,630) provide a method and apparatus for identifying molecular structures within a sample substance In the method of Eggers et al., a plurality of test sites to which probes have been bound is exposed to a sample substance and then an electrical signal is applied to the test sites The dielectπcal
properties of the test sites are subsequently detected to determine which probes have interacted with target molecules in the sample substance
Another obstacle in the development of a simple and cost-effective electrical and electrochemical detection apparatus for detecting molecular interactions involves the attachment of probe molecules to the microelectrodes or substrate of a microarray For example, although the prior art provides microarrays using polyacrylamide pads for attachment of oligonucleotide probes to a solid support, the art has not provided such pads in conjunction with an electrical or electrochemical detection apparatus
Guschin et al , 1997, Anal Biochem 250 203-11 describe a technique for detecting molecular interactions between target molecules in a biological sample solution and polyacrylamide gel- immobilized probes on a glass substrate In the technique disclosed by Guschin et al , molecular interactions between probes and target molecules are detected using optical reporters The Guschin et al reference neither teaches nor suggests using electrical or electrochemical detection techniques to detect hybridization between target molecules and immobilized probes
Guschin et al , 1997, Appl Environ Mtcrobiol 63 2397-402 also describe the fabrication of microarrays through the immobilization of oligonucleotide probes on a polyacrylamide gel pad placed in contact with a glass substrate In this technique disclosed by Guschin et al , parallel hybridization between target nucleic acids and immobilized probes is detected using optical reporter moieties This Guschin et al reference also does not teach or suggest using electrical or electrochemical detection techniques in combination with the immobilization of probes on polyacrylamide gel pads
In addition Yang et al , 1997, Anal Chim Ada 346 259-75 describe the fabrication of microarrays through the immobilization of nucleic acid probes on polyacrylamide gel pads and subsequent detection of molecular interactions between probe and target molecules using optical reporter moieties Yang et al further describe an alternative technique in which molecular interactions between labeled target molecules and nucleic acid probes that have been directly attached to solid electrodes are detected using electrical or electrochemical means Yang et al , however does not suggest using electrical or electrochemical detection techniques in combination with the immobilization of probes on polyacrylamide gel pads
The detection of single base mutations and genetic polymorphisms in nucleic acids is an important tool in modern diagnostic medicine and biological research In addition, nucleic acid-based assays also play an important role in identifying infectious microorganisms such as bacteria and viruses, in assessing levels of both normal and defective gene expression, and in detecting and identifying mutant genes associated with disease such as oncogenes Improvements in the
speed, efficiency, economy and specificity of such assays are thus significant needs in the medical arts
Ideally, such assays should be sensitive, specific and easily amenable to automation Efforts to improve sensitivity in nucleic acid assays are known in the prior art For example, the polymerase chain reaction (Mullis, U S Patent No 4,683,195, issued July 28, 1987) provides the capacity to produce useful amounts (about 1 μg) of a specific nucleic acid in a sample in which the original amount of the specific nucleic acid is substantially smaller (about 1 pg) However, the prior art has been much less successful in improving specificity of nucleic acid hybridization assays
The specificity of nucleic acid assays is determined by the extent of molecular complementarity of hybridization between probe and target sequences Although it is theoretically possible to distinguish complementary targets from one or two mismatched targets under rigorously-defined conditions, the dependence of hybridization on target/probe concentration and hybridization conditions limits the extent to which hybridization mismatch can be used to reliably detect, inter alia mutations and genetic polymorphisms
Detection of single base extension has been used for mutation and genetic polymorphism detection in the prior art
U S Patent No 5,925,520 disclosed a method for detecting genetic polymorphisms using single base extension and capture groups on oligonucleotide probes using at least two types of dideoxy, chain-terminating nucleotide tπphosphates, each labeled with a detectable and distinguishable fluorescent labeling group
U S Patent No 5,710,028 disclosed a method of determining the identity of nucleotide bases at specific positions in nucleic acids of interest, using detectably-labeled chain-terminating nucleotides, each detectably and distinguishably labeled with a fluorescent labeling group
U S Patent No 5,547,839 disclosed a method for determining the identity of nucleotide bases at specific positions in a nucleic acid of interest, using chain-terminating nucleotides comprising a photoremovable protecting group
U S Patent No 5,534,424 disclosed a method for determining the identity of nucleotide bases at specific positions in a nucleic acid of interest, using each of four aliquots of a target nucleic acid annealed to an extension primer and extended with one of four chain-terminating species, and then further extended with all four chain-extending nucleotides, whereby the identity of the nucleotide at the position of interest is identified by failure of the primer to be extended more that a single base
U S Patent No 4,988,617 disclosed a method for determining the identity of nucleotide bases at specific positions in a nucleic acid of interest, by annealing two adjacent nucleotide primers to a target nucleic acid and providing a linking agent such as a ligase that covalentiy links the two ohgonucleotides to produce a third, combined oligonucleotide only under circumstances wherein the two ohgonucleotides are perfectly matched to the target nucleic acid at the 3' extent of the first oligonucleotide and at the 5' extent of the second oligonucleotide
U S Patent No 4,656,127 disclosed a method for determining the identity of nucleotide bases at specific positions in a nucleic acid of interest, using primer extension with a chain-terminating or other nucleotide comprising an exonuclease-resistant linkage, followed by exonuclease treatment of the plurality of extension products to detect the resistant species therein
One common feature in this prior art is that single base extension has been detected by incorporation of fluorescent labels into the extended nucleic acid species
A significant drawback of single base extension methods based on fluorescent label detection is the need for expensive and technically-complex optical components for detecting the fluorescent label Although fluorescent probes used in such methods impart an adequate level of discrimination between extended and unextended positions in an oligonucleotide array, these methods typically require detection of up to four different fluorescent labels, each having a unique excitation and fluorescence emission frequency As a consequence of these properties, such assay systems must be capable of producing and distinguishing light at all of these different excitation and emission frequencies, significantly increasing the cost and complexity of producing and operating apparatus used in the practice thereof
An alternative method for detecting a target nucleic acid molecule is to use an electrochemical tag (or label) such as a redox moiety in combination with an electrochemical detection means such as cyclic voltammetry, some of which are discussed above
In addition, disclosure of similar methods for detecting biological molecules such as DNA and proteins can be found in lhara ef al , 1996, Nucleic Acids Res 24 4273-4280, Livache et al , 1995, Synthetic Metals 7 2143-2146, Hashimoto, 1993, Supramolecular Chem 2 265-270, Millan ef a/ , 1993, Anal Chem 65 2317-2323
However, most of the electrochemical tag-dependent methods known in the prior art require hybridization of the probe/target in the presence of a redox intercalator Electrochemical detection based on redox mtercalators are generally not as reproducible as redox tags that are covalentiy bound to an incorporated moiety Redox intercalator methods are exceedingly dependent on washing conditions to remove excess label while not reducing the actual signal As a
consequence, false positives are often obtained using these methods The specificity of redox intercalator methods is often much worse than can be achieved with covalently-bound redox tags
There remains a need in this art for simple, economical, and efficient ways to detect single base extension products of nucleic acid assays for detecting mutation and genetic polymorphisms in biological samples containing a nucleic acid of interest
Similarly, there remains a need in the art to develop alternatives to current detection methods used to detect interactions between biological molecules, particularly nucleic acids and peptides In particular, there is a need in the art to develop electrical or electrochemical methods for detecting interactions between biological molecules that do not require modifying target or probe molecules with reporter labels The development of such methods has wide applications in the medical, genetic, and molecular biological arts There further remains a need in the art to develop alternatives for the attaching such biological molecules to the microelectrodes or substrate of an electrical or electrochemical device
SUMMARY OF THE INVENTION
The present invention provides an apparatus and methods, using cations in an electrolyte solution, for detecting the nature and extent of molecular interactions between probe and target molecules The most preferred embodiments of the methods of the invention utilize AC impedance for said detection The apparatus and methods of the present invention have the advantage of providing electrical detection without any additional requirement that the target molecule be labeled with a reporter molecule
In preferred embodiments of the present invention, the apparatus and methods are useful for detecting molecular interactions such as nucleic acid hybridization between oligonucleotide probe molecules bound to defined regions of an ordered array and nucleic acid target molecules which are permitted to interact with the probe molecules In other embodiments of the present invention, the apparatus and methods are useful for detecting interactions between peptides (e g , receptor- ligand binding or antibody recognition of antigens)
In more preferred embodiments, the apparatus of the present invention comprises a supporting substrate, an array of microelectrodes in contact with the supporting substrate to which probes are immobilized, at least one counter-electrode in electrochemical contact with the supporting substrate, a means for producing electrical impedance at each microelectrode, a means for detecting changes in impedance at each microelectrode in the presence or absence of a target molecule, and an electrolyte solution in contact with the plurality of microelectrodes
In alternative preferred embodiments, the apparatus of the present invention comprises a
supporting substrate, an array of microelectrodes in contact with the supporting substrate, a plurality of polyacrylamide gel pads in contact with microelectrodes and to which probes are immobilized, at least one counter-electrode in electrochemical contact with the supporting substrate, a means for producing electrical impedance at each microelectrode, a means for detecting changes in impedance at each microelectrode in the presence or absence of a target molecule, and an electrolyte solution in contact with the plurality of microelectrodes Alternatively, multiple electrodes can be defined on a substrate and covered with a continuous, unpattemed layer of polyacrylamide or other polymer
In preferred embodiments of the present invention, microelectrodes are prepared from, but not limited to, metals such as dense or porous films of gold, platinum, titanium, or copper, metal oxides, metal nitrides, metal carbides, or carbon
In a preferred embodiment of the invention, the electrolyte solution comprises metal cations or polymerized cations that are ion conductive and capable of reacting with probes or probe-target complexes In a more preferred embodiment, the electrolyte solution comprises a salt of a lithium cation, most preferably LιCI04
The apparatus of the present invention may further comprise at least one reference electrode In an alternative embodiment of the present invention, the apparatus further comprises a plurality of wells each of which encompasses at least one microelectrode and at least one counter-electrode that is sufficient to interrogate the entire array
In a preferred method of the present invention, an electrolyte solution as described above is placed in contact with a plurality of microelectrodes to which nucleic acid probes have been immobilized, preferably having a neutral polypyrrole layer there between AC impedance of the microelectrodes is first measured in the absence of added target nucleic acid Thereafter, the microelectrodes are contacted with a biological sample substance containing target nucleic acid molecules, most preferably by adding the sample to the electrolyte solution or replacing the electrolyte solution with the sample contained in or diluted in the electrolyte solution The probes and target molecules are allowed to interact, preferably by hybridization, and the AC impedance measured thereafter
In another embodiment of the methods of the present invention, an electrolyte solution as described above is placed in contact with a plurality of microelectrodes and polyacrylamide gel pads to which nucleic acid probes have been immobilized AC impedance of the microelectrodes is first measured in the absence of added target nucleic acid Thereafter, the microelectrodes are contacted with a biological sample substance containing target nucleic acid molecules, most preferably by adding the sample to the electrolyte solution or replacing the electrolyte solution with the sample contained in or diluted in the electrolyte solution The probes and target molecules are
allowed to interact, preferably by hybridization, and the AC impedance measured thereafter
In a preferred embodiment of the methods of the present invention, the AC impedance is measured at different frequencies in order to increase the sensitivity of the method Probe-target interactions are detected by differences in the AC impedance signals at individual microelectrodes before and after such interactions Most preferably, the method is used to discern the difference between hybridization between an immobilized oligonucleotide probe on a microelectrode and a complimentary target nucleic acid ("complete" hybridization), and hybridization between the immobilized oligonucleotide and a mismatched target nucleic acid ("mismatch" hybridization) Information about the nucleotide sequence of the ohgonucleotides immobilized at each microelectrode is then used in conjunction with "complete" or "mismatch" hybridization as detected by the method of the invention to determine the presence or absence of a particular target nucleic acid in the sample
In an alternate embodiment, the present invention provides an apparatus and methods for the electric or electrochemical detection of the nature and extent of molecular interactions between probe molecules and electrochemically active reporter-labeled target molecules In preferred embodiments of the present invention, the apparatus and methods are useful for detecting molecular interactions such as nucleic acid hybridization between oligonucleotide probe molecules bound to defined regions of an ordered array and electrochemically active reporter-labeled nucleic acid target molecules which are permitted to interact with the probe molecules In other embodiments of the present invention, the apparatus and methods are useful for detecting interactions between peptides (e g , receptor-ligand binding or antibody recognition of antigens)
In more preferred embodiments, the apparatus of the present invention comprises a supporting substrate, an array of microelectrodes in contact with the supporting substrate, a plurality of polymeric hydrogel pads in contact with the microelectrodes and to which probes are immobilized, at least one counter-electrode in electrochemical contact with the supporting substrate, a means for producing an electrical signal at each microelectrode, a means for detecting changes in the electrical signal at each microelectrode in the presence or absence of an electrochemically active reporter-labeled target molecule, and a electrolyte solution in contact with the plurality of hydrogel porous microelectrodes and counter-electrode Alternatively, multiple electrodes can be defined on a substrate and covered with a continuous, unpattemed layer of polymeric hydrogel
In preferred embodiments of the present invention, microelectrodes are prepared from metals such as dense or porous films of gold, platinum, titanium, or copper, metal oxides, metal nitrides, metal carbides, or graphite carbon
In some embodiments of the present invention, the probes are oligonucleotide probes having a sequence comprising from about 10 to about 100 nucleotide residues, and said probes are
attached to the polyacrylamide gel pads using techniques known to those with skill in the art In other embodiments, the probes are peptides, such as receptors, gands, antibodies, antigens, or synthetic peptides, and said probes are attached to the polymeric hydrogel pads using techniques known to those with skill in the art
The apparatus of the present invention may further comprise at least one reference electrode In an alternative embodiment of the present invention, the apparatus further comprises a plurality of wells each of which encompasses at least one hydrogel porous microelectrode and at least one counter-electrode that is sufficient to interrogate the entire array
In the method of the present invention, molecular interactions between probe molecules and electrochemically active reporter-labeled target molecules are detected by applying conventional electric or electrochemical detection methods, such as, for example, AC impedance In one embodiment, the AC impedance of a plurality of hydrogel porous microelectrodes to which nucleic acid probes have been immobilized is first measured in the absence of an electrochemically- labeled target nucleic acid Thereafter, the hydrogel porous microelectrodes are contacted with a biological sample substance containing electrochemically active reporter-labeled target molecules
The probes and target molecules are allowed to interact, preferably by hybridization, and AC impedance measured thereafter
In a preferred embodiment of the methods of the present invention, the AC impedance is measured at different frequencies in order to increase the sensitivity of the method Interactions between probe molecules and electrochemically-labeled target molecules are detected by differences in the AC impedance signals at individual hydrogel porous microelectrodes before and prior to such interactions Most preferably, the method is used to discern the difference between hybridization between an immobilized oligonucleotide probe on a hydrogel porous microelectrode and a complimentary target nucleic acid ("complete" hybridization), and hybridization between the immobilized oligonucleotide and a mismatched target nucleic acid ("mismatch" hybridization)
Information about the nucleotide sequence of the ohgonucleotides immobilized at each hydrogel porous microelectrode is then used in conjunction with "complete" or "mismatch" hybridization as detected by the method of the invention to determine the presence or absence of a particular target nucleic acid in the sample
In other embodiments of the present invention, other electric and/or electrochemical methods can be used to detect molecular interactions between probe molecules and electrochemically-labeled target molecules, including, but not limited to, cyclic voltammetry, stripping voltammetry, pulse voltammetry, square wave voltammetry, AC voltammetry, hydrodynamic modulation voltammetry, potential step method, potentiometπc measurements, amperometπc measurements, current step method, and combinations thereof
The invention further comprises methods and apparatus for detecting mutations and genetic polymorphisms in a biological sample containing a nucleic acid of interest Detection of single base extension using the methods and apparatus of the invention is achieved by sequence- specific incorporation of chain-terminating nucleotide species chemically labeled with an electrochemical species In preferred embodiments, single base extension is performed using hybridization to an oligonucleotide array, most preferably an addressable array wherein the sequence of each oligonucleotide in the array is known and associated with a particular address in the array In additional preferred embodiments, single base extension is detected using extension products labeled with electrochemical reporter groups, wherein the electrochemical reporter groups comprise a transition metal complex, most preferably containing a transition metal ion that is ruthenium, cobalt, iron or osmium
In the practice of the methods of the invention, the invention provides an array of oligonucleotide probes immobilized to a surface that defines a first electrode Preferably, the sequence of each oligonucleotide at each particular identified position (or "address") in the array is known and at least one of said ohgonucleotides is complementary to a sequence in a nucleic acid contained in the biological sample to be assayed (termed the "target" or "target nucleic acid") In one preferred embodiment, the sequence of at least one oligonucleotide is selected to hybridize to a position immediately adjacent to the nucleotide position in the sample nucleic acid that is to be interrogated, / e , for mutation or genetic polymorphism The term "adjacent" in this context is intended to encompass positions that are one nucleotide base upstream of base to be interrogated, / e in the 3' direction with respect to the template strand of the target DNA Hybridization of the ohgonucleotides in the array to nucleic acid in the sample is performed in a reaction chamber and in a hybridization buffer for a time and at a temperature that permits hybridization to occur between nucleic acid in the sample and the ohgonucleotides in the array complementary thereto Single base extension is performed using a polymerase, most preferably a thermally stable polymerase, in the presence of chain-terminating primer extension units that are covalentiy linked to an electrochemical label In a preferred embodiment, each chain-terminating nucleotide species (for example, dιdeoxy(dd)ATP, ddGTP, ddCTP and ddTTP) is labeled with a different electrochemical label, most preferably having a different, distinct and differentially- detectable reduction/oxidation potential Single base extension is detected by applying conventional electrochemical detection methods, such as cyclic voltammetry or stripping voltammetry Other electric or/and electrochemical methods that may also be used, include, but are not limited to, AC impedance, pulse voltammetry, square wave voltammetry, AC voltammetry (ACV), hydrodynamic modulation voltammetry, potential step method, potentiometπc measurements, amperometπc measurements, current step method, and combinations thereof
In alternative embodiments, the sequence of at least one oligonucleotide is selected to hybridize to the target nucleic acid at a position whereby the 3' residue of the oligonucleotide hybridizes to the nucleotide position in the sample nucleic acid that is to be interrogated for mutation or genetic
polymorphism In the array, ohgonucleotides having sequence identity to the oligonucleotide that hybridizes to the target nucleic acid at it's 3' residue will also hybridize to the target, but the 3' residue of such ohgonucleotides will produce a "mismatch" with the target and will not hybridize at the 3' residue Single base extension is performed with a polymerase that will not recognize the mismatch, so that only the oligonucleotide that hybridizes to the target including at its 3' residue will be extended In these embodiments of the invention, only a single chain-terminating species labeled with an electrochemical species can be employed, or the same electrochemical species can be used for all four chain-terminating species, provided that the nucleotide sequence of each oligonucleotide in the array is known and properly associated with its position in the array The detection of an electrochemical signal from the redox species using conventional electrochemical detection methods, such as cyclic voltammetry, at a particular position in the array thus provides the identity of the 3'resιdue of the probe and hence the identity of the complementary nucleotide at the corresponding position in the target nucleic acid
In the practice of a preferred embodiment of the methods and use of the apparatus of the invention, electric current is recorded as a function of sweeping voltage to the first electrode specific for each particular chain-terminating nucleotide species labeled with an electrochemically- active reporter In preferred embodiments, current flow at each specific potential is detected at each address in the array where single base extension has occurred with the corresponding chain-terminating nucleotide species labeled with a particular electrochemical reporter group The detection of the electrical signal at a particular position in the array wherein the nucleotide sequence of the oligonucleotide occupying that position is known enables the identity of the extended nucleotide, and therefore the mutation or genetic polymorphism, to be determined
BRIEF DESCRIPTION OF THE DRAWINGS
Figures 1 A and 1 B illustrate a schematic representation of the structure of a hydrogel porous microelectrode (Figure 1 A) and a schematic representation of the structure of the tip of a hydrogel porous microelectrode (Figure 1 B),
Figures 2A and 2B illustrate the electrochemical oxidation of pyrrole (Figure 2A) and the neutralization of polypyrrole (Figure 2B),
Figures 3A and 3B illustrate the Frequency Complex curves obtained from polypyrrole microelectrodes before and after the hybridization of a 15-mer oligonucleotide probe and complementary nucleic acid target molecule (Figure 3A) and the Frequency Complex curve obtained in the high frequency zone from polypyrrole microelectrodes before and after the hybridization of a 15-mer oligonucleotide probe and complementary target molecule (Figure 3B),
Figures 4A and 4B illustrate a plot of low frequency resistance versus w 1 2 (Figure 4A) and the plot
of high frequency resistance versus w (Figure 4B),
Figures 5A and 5B illustrate the Frequency Complex curve obtained for the hybridization of an oligonucleotide probe and a fully complementary nucleic acid target molecule (Figure 5A) and the Frequency Complex curve obtained for the hybridization of an oligonucleotide probe and a nucleic acid target molecule possessing three mismatches (Figure 5B, curve 1 was obtained before hybridization of the target molecule to the probe, curve 2 was obtained following hybridization of probe and target molecules for 48 hours, curve 3 was obtained following washing of hybridized molecules for 30 mm at 37°C, and curve 4 was obtained following washing of hybridized molecules for 30 mm at 38°C),
Figure 6 illustrates a plot of low frequency resistance versus w "2 obtained for the hybridization of an oligonucleotide probe and a nucleic acid target molecule possessing three mismatches (curve 1 was obtained before hybridization of the target molecule to the probe, curve 2 was obtained following hybridization of probe and target molecules for 48 hours, curve 3 was obtained following washing of hybridized molecules for 30 mm at 37°C, and curve 4 was obtained following washing of hybridized molecules for 30 m at 38°C)
Figure 7 illustrates the Frequency Complex curve obtained from polypyrrole microelectrodes before and after the hybridization of a 15-mer oligonucleotide probe and complementary nucleic acid target molecule in an electrolyte containing 0 1 M LιCI04,
Figures 8A through 8C illustrate a schematic representation of the circuit (Figure 8A), the AC impedance response for a polypyrrole microelectrode with an attached single-strand nucleic acid probe before hybridization to a target molecule (Figure 8B), and a schematic representation of the circuit for a polypyrrole microelectrode with an attached single-strand nucleic acid probe after hybridization to a target molecule (Figure 8C),
Figure 9 illustrates a plot of capacitance versus frequency for a polypyrrole microelectrode with an attacKed single-strand nucleic acid probe after hybridization to a target molecule,
Figure 10 illustrates a plot of resistance versus frequency for a polypyrrole microelectrode with an attached single-strand nucleic acid probe after hybridization to a target molecule,
Figure 1 1 illustrates a hydrogel porous microelectrode,
Figure 12 illustrates the Frequency Complex curves obtained from a hydrogel porous microelectrode with attached 15-mer oligonucleotide probe in the absence of a complementary target molecule (curve 1 ), following incubation with 2 pM of a complementary target molecule (curve 2), and following incubation with 300 nM of a mismatched target molecule (curve 3),
Figure 13 illustrates a plot of capacitance versus frequency for a hydrogel porous microelectrode with an attached single-strand nucleic acid probe after hybridization to a target molecule,
Figure 14 illustrates a plot of resistance versus frequency for a hydrogel porous microelectrode with an attached single-strand nucleic acid probe after hybridization to a target molecule
Figure 15 illustrates single base extension using chain-terminating nucleotdie species labeled with an electrochemical reporter group (ECA label)
DETAILED DESCRIPTION OF THE INVENTION
The present invention is directed to a variety of electronic and electrochemical techniques that may be used to detect the presence of target analytes, particularly nucleic acids, in samples The methods generally rely on the molecular interactions such as nucleic acid hybridization or protein- protein binding reactions done on solid supports with arrays of capture binding ligands As a result of these interactions, some electronic property of the system changes, and detection is achieved
This may be done in a variety of ways In a preferred embodiment, the methods of the invention utilize AC impedance for the detection In some embodiments, the apparatus and methods of the present invention have the advantage of providing electrical detection without any additional requirement that the target molecule be labeled with a reporter molecule That is, the electrical impedance of the system changes as a result of the specific binding of a target analyte to its corresponding capture binding gand (frequently referred to herein as "capture probes" when the analyte is a nucleic acid)
Alternatively, the use of electrochemically active labels allows the detection of specific interactions, in a manner similar to known fluorescent systems In this embodiment, either the target can be labeled with an electrochemically active (ECA) label, for example during an amplification reaction such as PCR when the target is a nucleic acid, or through the use of secondary labeling systems
In a preferred embodiment, when the target is a nucleic acid, these ECA labels are exploited to allow the identification of specific bases within a target sequence, as is generally outlined below
The methods and compositions of the invention are used to detect target analytes in samples By "target analyte" or "analyte" or grammatical equivalents herein is meant any molecule, compound or particle to be detected As outlined below, target analytes preferably bind to binding ligands, as is more fully described above As will be appreciated by those in the art, a large number of analytes may be detected using the present methods, basically, any target analyte for which a
binding hgand, described herein, may be made may be detected using the methods of the invention.
Suitable analytes include organic and inorganic molecules, including biomolecules. In a preferred embodiment, the analyte may be an environmental pollutant (including pesticides, insecticides, toxins, etc.); a chemical (including solvents, polymers, organic materials, etc.); therapeutic molecules (including therapeutic and abused drugs, antibiotics, etc.); biomolecules (including hormones, cytokines, proteins, pids, carbohydrates, cellular membrane antigens and receptors (neural, hormonal, nutrient, and cell surface receptors) or their ligands, etc); whole cells (including procaryotic (such as pathogenic bacteria) and eukaryotic cells, including mammalian tumor cells); viruses (including retroviruses, herpesviruses, adenoviruses, lentiviruses, etc.); and spores; etc.
Particularly preferred analytes are environmental pollutants; nucleic acids; proteins (including enzymes, antibodies, antigens, growth factors, cytokines, etc); therapeutic and abused drugs, cells; and viruses.
In a preferred embodiment, the target analyte is a nucleic acid. By "nucleic acid" or "oligonucleotide" or grammatical equivalents herein means at least two nucleotides covalentiy linked together. A nucleic acid of the present invention will generally contain phosphodiester bonds, although in some cases, as outlined below, nucleic acid analogs are included that may have alternate backbones, comprising, for example, phosphoramide (Beaucage et al., Tetrahedron 49(10):1925 (1993) and references therein; Letsmger, J. Org. Chem. 35:3800 (1970); Spπnzl et al., Eur. J. Biochem. 81 :579 (1977); Letsmger et al., Nucl. Acids Res. 14:3487 (1986),
Sawai et al, Chem. Lett. 805 (1984), Letsmger et al., J. Am. Chem. Soc. 1 10:4470 (1988); and Pauwels et al., Chemica Scπpta 26*141 91986)), phosphorothioate (Mag et al., Nucleic Acids Res 19:1437 (1991 ); and U.S Patent No. 5,644,048), phosphorodithioate (Bπu et al., J. Am. Chem Soc. 11 1 :2321 (1989), O-methylphophoroamidite linkages (see Eckstein, Ohgonucleotides and Analogues: A Practical Approach, Oxford University Press), and peptide nucleic acid backbones and linkages (see Egholm, J. Am. Chem. Soc. 114:1895 (1992); Meier et al., Chem. Int. Ed. Engl. 31 :1008 (1992); Nielsen, Nature, 365.566 (1993), Carlsson et al., Nature 380:207 (1996), all of whicfTare incorporated by reference). Other analog nucleic acids include those with positive backbones (Denpcy et al., Proc. Natl. Acad. Sci. USA 92:6097 (1995); non-ionic backbones (U.S Patent Nos. 5,386,023, 5,637,684, 5,602,240, 5,216,141 and 4,469,863, Kiedrowshi et al , Angew
Chem. Intl. Ed. English 30:423 (1991 ), Letsmger et al., J. Am Chem Soc. 110:4470 (1988), Letsmger et al., Nucleoside & Nucleotide 13:1597 (1994), Chapters 2 and 3, ASC Symposium Series 580, "Carbohydrate Modifications in Antisense Research", Ed Y S Sanghui and P. Dan Cook; Mesmaeker et al., Bioorganic & Medicinal Chem. Lett. 4.395 (1994); Jeffs et al., J. Biomolecular NMR 34:17 (1994); Tetrahedron Lett. 37:743 (1996)) and non-πbose backbones, including those described in U S Patent Nos. 5,235,033 and 5,034,506, and Chapters 6 and 7, ASC Symposium Series 580, "Carbohydrate Modifications in Antisense Research", Ed. Y S Sanghui and P. Dan Cook. Nucleic acids containing one or more carbocychc sugars are also
included within the definition of nucleic acids (see Jenkins et al , Chem. Soc Rev (1995) pp169- 176) Several nucleic acid analogs are described in Rawls, C & E News June 2, 1997 page 35 Nucleic acid analogs also include "locked nucleic acids" All of these references are hereby expressly incorporated by reference These modifications of the πbose-phosphate backbone may be done to facilitate the addition of electron transfer moieties, or to increase the stability and half- life of such molecules in physiological environments
As will be appreciated by those in the art, all of these nucleic acid analogs may find use in the present invention In addition, mixtures of naturally occurring nucleic acids and analogs can be made, for example, at the site of conductive o gomer or electron transfer moiety attachment, an analog structure may be used Alternatively, mixtures of different nucleic acid analogs, and mixtures of naturally occurring nucleic acids and analogs may be made
As outlined herein, the nucleic acids may be single stranded or double stranded, as specified, or contain portions of both double stranded or single stranded sequence The nucleic acid may be DNA, both genomic and cDNA, RNA or a hybrid, where the nucleic acid contains any combination of deoxyπbo- and πbo-nucleotides, and any combination of bases, including uracil, adenme, thymme, cytosine, guanine, inosine, xathanme hypoxathanme, isocytosme, isoguanine, etc As used herein, the term "nucleoside" includes nucleotides and nucleoside and nucleotide analogs, and modified nucleosides such as am o modified nucleosides In addition, "nucleoside" includes non-πaturally occuπng analog structures Thus for example the individual units of a peptide nucleic acid, each containing a base, are referred to herein as nucleosides
In a preferred embodiment, the present invention provides methods of detecting target nucleic acids By "target nucleic acid" or "target sequence" or grammatical equivalents herein means a nucleic acid sequence on a single strand of nucleic acid The target sequence may be a portion of a gene, a regulatory sequence, genomic DNA, cDNA, RNA including mRNA and rRNA, or others It may be any length, with the understanding that longer sequences are more specific In some embodiments, it may be desirable to fragment or cleave the sample nucleic acid into fragments of 100 to* 10,000 basepairs, with fragments of roughly 500 basepairs being preferred in some embodiments As will be appreciated by those in the art, the complementary target sequence may take many forms For example, it may be contained within a larger nucleic acid sequence, i e all or part of a gene or mRNA, a restriction fragment of a plasmid or genomic DNA, among others
As is outlined more fully below, probes (including primers) are made to hybridize to target sequences to determine the presence or absence of the target sequence in a sample Generally speaking, this term will be understood by those skilled in the art
The target sequence may also be comprised of different target domains, which may be adjacent (ι e contiguous) or separated For example, when gation chain reaction (LCR) techniques are
used, a first primer may hybridize to a first target domain and a second primer may hybridize to a second target domain; either the domains are adjacent, or they may be separated by one or more nucleotides, coupled with the use of a polymerase and dNTPs, as is more fully outlined below. The terms "first" and "second" are not meant to confer an orientation of the sequences with respect to the 5'-3' orientation of the target sequence. For example, assuming a 5'-3' orientation of the complementary target sequence, the first target domain may be located either 5' to the second domain, or 3' to the second domain.
In a preferred embodiment, the target analyte is a protein. As will be appreciated by those in the art, there are a large number of possible proteinaceous target analytes that may be detected using the present invention. By "proteins" or grammatical equivalents herein is meant proteins, oligopeptides and peptides, derivatives and analogs, including proteins containing non-naturally occurring ammo acids and ammo acid analogs, and peptidomimetic structures. The side chains may be in either the (R) or the (S) configuration. In a preferred embodiment, the ammo acids are in the (S) or L-configuration. As discussed below, when the protein is used as a binding hgand, it may be desirable to utilize protein analogs to retard degradation by sample contaminants.
Suitable protein target analytes include, but are not limited to, (1 ) immunoglobu ns, particularly IgEs, IgGs and IgMs, and particularly therapeutically or diagnostically relevant antibodies, including but not limited to, for example, antibodies to human albumin, apo poproteins (including apohpoprotein E), human chononic gonadotropm, cortisol, α-fetoprotein, thyroxin, thyroid stimulating hormone (TSH), antithrombm, antibodies to pharmaceuticals (including antieptileptic drugs (phenyto , pπmidone, carbariezepin, ethosuximide, valproic acid, and phenobarbitol), cardioactive drugs (digoxin, lidocaine, procainamide, and disopyramide), bronchodilators ( theophyllme), antibiotics (chloramphenicol, sulfonamides), antidepressants, immunosuppresants, abused drugs (amphetamine, methamphetamine, cannabmoids, cocaine and opiates) and antibodies to any number of viruses (including orthomyxoviruses, (e.g. influenza virus), paramyxoviruses (e.g respiratory syncytiai virus, mumps virus, measles virus), adenoviruses, rhmoviruses, coronaviruses, reoviruses, togaviruses (e.g. rubella virus), parvoviruses, poxviruses (e.g. "variola virus, vaccinia virus), enteroviruses (e.g pohovirus, coxsackievirus), hepatitis viruses (including A, B and C), herpesviruses (e.g. Herpes simplex virus, varicella-zoster virus, cytomegalovirus, Epstem-Barr virus), rotaviruses, Norwalk viruses, hantavirus, arenavirus, rhabdovirus (e g. rabies virus), retroviruses (including HIV, HTLV-I and -II), papovaviruses (e g. papillomavirus), polyomaviruses, and picornaviruses, and the like), and bacteria (including a wide variety of pathogenic and non-pathogenic prokaryotes of interest including Bacillus; Vibrio, e.g. V. cholerae; Escheπchia, e.g. Enterotoxigenic E. coli, Shigella, e.g. S. dysentenae; Salmonella, e.g S. typhi; Mycobacteπum e.g. M. tuberculosis, M. leprae; Clostπdium, e.g. C. botulmum, C. tetani,
C. difficile, C.perfringens; Cornyebacteπum, e.g. C. diphthenae, Streptococcus, S. pyogenes, S. pneumoniae; Staphylococcus, e.g. S. aureus; Haemophilus, e.g. H influenzae; Neisseπa, e.g. N. meningitidis, N. gonorrhoeae; Yersmia, e.g. G. lambliaY. pestis, Pseudomonas, e.g. P.
aerugmosa, P. puttda; Chlamydia, e.g. C. trachomatis; Bordetella, e.g. B. pertussis; Treponema, e.g. T. palladium: and the like); (2) enzymes (and other proteins), including but not limited to, enzymes used as indicators of or treatment for heart disease, including creatine kmase, lactate dehydrogenase, aspartate am o transferase, tropon T, myoglobin, fibπnogen, cholesterol, triglyceπdes, thrombm, tissue plasmmogen activator (tPA); pancreatic disease indicators including amylase, pase, chymotrypsin and trypsin; liver function enzymes and proteins including cholmesterase, bilirub , and alkaline phosphotase, aldolase, prostatic acid phosphatase, terminal deoxynucleotidyl transferase, and bacterial and viral enzymes such as HIV protease; (3) hormones and cytokines (many of which serve as ligands for cellular receptors) such as erythropoietin (EPO), thrombopoietin (TPO), the interleukins (including IL-1 through IL-17), insulin, insulin-like growth factors (including IGF-1 and -2), epidermal growth factor (EGF), transforming growth factors (including TGF-α and TGF-β), human growth hormone, transferπn, epidermal growth factor (EGF), low density hpoprotein, high density hpoprotein, leptin, VEGF, PDGF, ciliary neurotrophic factor, prolactin, adrenocorticotropic hormone (ACTH), calcitonin, human choπonic gonadotropm, cotπsol, estradiol, follicle stimulating hormone (FSH), thyroid-stimulating hormone
(TSH), leutinzmg hormone (LH), progeterone and testosterone; and (4) other proteins (including α-fetoprotem, carcmoembryonic antigen CEA, cancer markers, etc.)
In addition, any of the biomolecules for which antibodies may be detected may be detected directly as well; that is, detection of virus or bacterial cells, therapeutic and abused drugs, etc., may be done directly
Suitable target analytes include carbohydrates, including but not limited to, markers for breast cancer (CA15-3, CA 549, CA 27 29), mucin-hke carcinoma associated antigen (MCA), ovarian cancer (CA125), pancreatic cancer (DE-PAN-2), prostate cancer (PSA), CEA, and colorectal and pancreatic cancer (CA 19, CA 50, CA242)
Suitable target analytes include metal ions, particularly heavy and/or toxic metals, including but not limited to, aluminum, arsenic, cadmium, selenium, cobalt, copper, chromium, lead, silver and nickeT
These target analytes may be present in any number of different sample types, including, but not limited to, bodily fluids including blood, lymph, saliva, vaginal and anal secretions, urine, feces, perspiration and tears, and solid tissues, including liver, spleen, bone marrow, lung, muscle, brain, etc.
Accordingly, the present invention provides devices for the detection of target analytes comprising a solid substrate The solid substrate can be made of a wide variety of materials and can be configured in a large number of ways, as is discussed herein and will be apparent to one of skill in the art In addition, a single device may be comprises of more than one substrate; for example, there may be a "sample treatment" cassette that interfaces with a separate "detection" cassette, a
raw sample is added to the sample treatment cassette and is manipulated to prepare the sample for detection, which is removed from the sample treatment cassette and added to the detection cassette There may be an additional functional cassette into which the device fits, for example, a heating element which is placed in contact with the sample cassette to effect reactions such as PCR In some cases, a portion of the substrate may be removable, for example, the sample cassette may have a detachable detection cassette, such that the entire sample cassette is not contacted with the detection apparatus See for example U S Patent No 5,603,351 and PCT US96/17116, hereby incorporated by reference
The composition of the solid substrate will depend on a variety of factors, including the techniques used to create the device, the use of the device, the composition of the sample, the analyte to be detected, the size of the wells and microchannels, the presence or absence of electronic components, etc Generally, the devices of the invention should be easily steπlizable as well
In a preferred embodiment, the solid substrate can be made from a wide variety of materials Preferred embodiments utilize ceramic components as the solid substrate, as is more generally outlined below, although as will be appreciated by those in the art, the devices of the invention may include other materials These include, but are not limited to, silicon such as silicon wafers, silcon dioxide, silicon nitride, glass and fused silica, gallium arsenide, indium phosphide, aluminum, ceramics, polyimide, quartz, plastics, resins and polymers including polymethylmethacrylate, acrylics, polyethylene, polyethylene terepthalate, polycarbonate, polystyrene and other styrene copolymers, polypropylene, polytetrafluoroethylene, superalloys, zircaloy, steel, gold, silver, copper, tungsten, molybdeumn, tantalum, KOVAR, KEVLAR, KAPTON, MYLAR, brass, sapphire, etc High quality glasses such as high melting borosihcate or fused silicas may be preferred for their UV transmission properties when any of the sample manipulation steps require light based technologies In addition, as outlined herein, portions of the internal surfaces of the device may be coated with a variety of coatings as needed, to reduce nonspecific binding, to allow the attachment of binding ligands, for biocompatibihty, for flow resistance, etc
In a preferred embodiment, the solid support comprises ceramic materials, such as are outlined in U S S N s 09/235,081 , 09/337,086, 09/464,490, 09/492,013, 09/466,325, 09/460,281 , 09/460,283, 09/387,691 , 09/438,600, 09/506,178, and 09/458,534, all of which are expressly incorporated by reference in their entirety In this embodiment, the devices are made from layers of green-sheet that have been laminated and sintered together to form a substantially monolithic structure Green-sheet is a composite material that includes inorganic particles of glass, glass-ceramic ceramic, or mixtures thereof, dispersed in a polymer binder, and may also include additives such as plasticizers and dispersants The green-sheet is preferably in the form of sheets that are 50 to
250 microns thick The ceramic particles are typically metal oxides, such as aluminum oxide or zirconium oxide An example of such a green-sheet that includes glass-ceramic particles is
"AX951" that is sold by E I Du Pont de Nemours and Company An example of a green-sheet that includes aluminum oxide particles is "Ferro Alumina" that is sold by Ferro Corp The composition of the green-sheet may also be custom formulated to meet particular applications The green-sheet layers are laminated together and then fired to form a substantially monolithic multilayered structure The manufacturing, processing, and applications of ceramic green-sheets are described generally in Richard E Mistier, "Tape Casting The Basic Process for Meeting the Needs of the Electronics Industry," Ceramic Bulletin, vol 69, no 6, pp 1022-26 (1990), and in U S Patent No 3,991 ,029, which are incorporated herein by reference
The method for fabricating devices (such as those depicted in Figures 27-30 as devices 100 and 200) begins with providing sheets of green-sheet that are preferably 50 to 250 microns thick The sheets of green-sheet are cut to the desired size, typically 6 inches by 6 inches for conventional processing, although smaller or larger devices may be used as needed Each green-sheet layer may then be textured using various techniques to form desired structures, such as vias, channels, or cavities, in the finished multilayered structure
Various techniques may be used to texture a green-sheet layer For example, portions of a green- sheet layer may be punched out to form vias or channels This operation may be accomplished using conventional multilayer ceramic punches, such as the Pacific Tπnetics Corp Model APS- 8718 Automated Punch System Instead of punching out part of the material, features, such as channels and wells may be embossed into the surface of the green-sheet by pressing the green- sheet against an embossing plate that has a negative image of the desired structure Texturing may also be accomplished by laser tooling with a laser via system, such as the Pacific Tπnetics LVS-3012
Next, a wide variety of materials may be applied, preferably in the form of thick-film pastes, to each textured green-sheet layer For example, electrically conductive pathways may be provided by depositing metal-containing thick-film pastes onto the green-sheet layers Thick-film pastes typically include the desired material, which may be either a metal or a dielectric, in the form of a powder dispersed in an organic vehicle, and the pastes are designed to have the viscosity appropriate for the desired deposition technique, such as screen-printing The organic vehicle may include resins, solvents, surfactants, and flow-control agents The thick-film paste may also include a small amount of a flux, such as a glass frit, to facilitate sintering Thick-film technology is further described in J D Provance, "Performance Review of Thick Film Materials," Insulation/Circuits (April, 1977) and in Morton L Topfer, Thick Film Microelectronics, Fabrication Design, and Applications (1977), pp 41-59, which are incorporated herein by reference
The porosity of the resulting thick-film can be adjusted by adjusting the amount of organic vehicle present in the thick-film paste Specifically, the porosity of the thick-film can be increased by increased the percentage of organic vehicle in the thick-film paste Similarly, the porosity of a
green-sheet layer can be increased by increasing the proportion of organic binder Another way of increasing porosity in thick-films and green-sheet layers is to disperse within the organic vehicle, or the organic binder, another organic phase that is not soluble in the organic vehicle Polymer microspheres can be used advantageously for this purpose
To add electrically conductive pathways, the thick film pastes typically include metal particles, such as silver, platinum, palladium, gold, copper, tungsten, nickel, tin, or alloys thereof Silver pastes are preferred Examples of suitable silver pastes are silver conductor composition numbers 7025 and 7713 sold by E I Du Pont de Nemours and Company
The thick-film pastes are preferably applied to a green-sheet layer by screen-printing In the screen-printing process, the thick-film paste is forced through a patterned silk screen so as to be deposited onto the green-sheet layer in a corresponding pattern Typically, the silk screen pattern is created photographically by exposure to a mask In this way, conductive traces may be applied to a surface of a green-sheet layer Vias present in the green-sheet layer may also be filled with thick-film pastes If filled with thick-filled pastes containing electrically conductive materials, the vias can serve to provide electrical connections between layers
After the desired structures are formed in each layer of green-sheet, preferably a layer of adhesive is applied to either surface of the green-sheet Preferably, the adhesive is a room-temperature adhesive Such room-temperature adhesives have glass transition temperatures below room temperature, / e , below about 20° C, so that they can bind substrates together at room temperature Moreover, rather than undergoing a chemical change or chemically reacting with or dissolving components of the substrates, such room-temperature adhesives bind substrates together by penetrating into the surfaces of the substrates Sometimes such room-temperature adhesives are referred to as "pressure-sensitive adhesives " Suitable room-temperature adhesives are typically supplied as water-based emulsions and are available from Rohm and Haas, Inc and from Air Products, Inc For example, a material sold by Air Products, Inc as
"Flexcryl 1653" has been found to work well
The room-temperature adhesive may be applied to the green-sheet by conventional coating techniques To facilitate coating, it is often desirable to dilute the supplied pressure-sensitive adhesive in water, depending on the coating technique used and on the viscosity and solids loading of the starting material After coating, the room-temperature adhesive is allowed to dry
The dried thickness of the film of room-temperature adhesive is preferably in the range of 1 to 10 microns, and the thickness should be uniform over the entire surface of the green-sheet Film thicknesses that exceed 15 microns are undesirable With such thick films of adhesive voiding or delamination can occur during firing, due to the large quantity of organic material that must be removed Films that are less than about 0 5 microns thick when dried are too thin because they provide insufficient adhesion between the layers
From among conventional coating techniques, spin-coating and spraying are the preferred methods If spin-coating is used, it is preferable to add 1 gram of deionized water for every 10 grams of "Flexcryl 1653 " If spraying is used, a higher dilution level is preferred to facilitate ease of spraying Additionally, when room-temperature adhesive is sprayed on, it is preferable to hold the green-sheet at an elevated temperature, e g , about 60 to 70° C, so that the material dries nearly instantaneously as it is deposited onto the green-sheet The instantaneous drying results in a more uniform and homogeneous film of adhesive
After the room-temperature adhesive has been applied to the green-sheet layers, the layers are stacked together to form a multilayered green-sheet structure Preferably, the layers are stacked in an alignment die, so as to maintain the desired registration between the structures of each layer When an alignment die is used, alignment holes must be added to each green-sheet layer Typically, the stacking process alone is sufficient to bind the green-sheet layers together when a room-temperature adhesive is used In other words, little or no pressure is required to bind the layers together However, in order to effect a more secure binding of the layers, the layers are preferably laminated together after they are stacked
The lamination process involves the application of pressure to the stacked layers For example, in the conventional lamination process, a uniaxial pressure of about 1000 to 1500 psi is applied to the stacked green-sheet layers that is then followed by an application of an isostatic pressure of about 3000 to 5000 psi for about 10 to 15 minutes at an elevated temperature, such as 70° C Adhesives do not need to be applied to bind the green-sheet layers together when the conventional lamination process is used
However, pressures less than 2500 psi are preferable in order to achieve good control over the dimensions of such structures as internal or external cavities and channels Even lower pressures are more desirable to allow the formation of larger structures, such as cavities and channels For example, if a lamination pressure of 2500 psi is used, the size of well-formed internal cavities and channels is typically limited to no larger than roughly 20 microns Accordingly, pressures less than T000 psi are more preferred, as such pressures generally enable structures having sizes greater than about 100 microns to be formed with some measure of dimensional control Pressures of less than 300 psi are even more preferred, as such pressures typically allow structures with sizes greater than 250 microns to be formed with some degree of dimensional control Pressures less than 100 psi, which are referred to herein as "near-zero pressures," are most preferred, because at such pressures few limits exist on the size of internal and external cavities and channels that can be formed in the multilayered structure
The pressure is preferably applied in the lamination process by means of a uniaxial press
Alternatively, pressures less than about 100 psi may be applied by hand
As with semiconductor device fabrication, many devices may be present on each sheet
Accordingly, after lamination the multilayered structure may be diced using conventional green- sheet dicing or sawing apparatus to separate the individual devices The high level of peel and shear resistance provided by the room-temperature adhesive results in the occurrence of very little edge delamination during the dicing process If some layers become separated around the edges after dicing, the layers may be easily re-laminated by applying pressure to the affected edges by hand, without adversely affecting the rest of the device
The final processing step is firing to convert the laminated multilayered green-sheet structure from its "green" state to form the finished, substantially monolithic, multilayered structure The firing process occurs in two important stages as the temperature is raised The first important stage is the binder burnout stage that occurs in the temperature range of about 250 to 500° C, during which the other organic materials, such as the binder in the green-sheet layers and the organic components in any applied thick-film pastes, are removed from the structure
In the next important stage, the sintering stage, which occurs at a higher temperature, the inorganic particles sinter together so that the multilayered structure is densified and becomes substantially monolithic The sintering temperature used depends on the nature of the inorganic particles present in the green-sheet For many types of ceramics, appropriate sintering temperatures range from about 950 to about 1600° C, depending on the material For example, for green-sheet containing aluminum oxide, sintering temperatures between 1400 and 1600° C are typical Other ceramic materials, such as silicon nitride, aluminum nitride, and silicon carbide, require higher sintering temperatures, namely 1700 to 2200° C For green-sheet with glass- ceramic particles, a sintering temperature in the range of 750 to 950° C is typical Glass particles generally require sintering temperatures in the range of only about 350 to 700° C Finally, metal particles may require sintering temperatures anywhere from 550 to 1700° C, depending on the metal
Typically, the devices are fired for a period of about 4 hours to about 12 hours or more, depending on the material used Generally, the firing should be of a sufficient duration so as to remove the organic materials from the structure and to completely sinter the inorganic particles In particular, polymers are present as a binder in the green-sheet and in the room-temperature adhesive The firing should be of sufficient temperature and duration to decompose these polymers and to allow for their removal from the multilayered structure
Typically, the multilayered structure undergoes a reduction in volume during the firing process During the binder burnout phase, a small volume reduction of about 0 5 to 1 5% is normally observed At higher temperatures, during the sintering stage, a further volume reduction of about 14 to 17% is typically observed
The volume change due to firing, on the other hand, can be controlled In particular, to match volume changes in two materials, such as green-sheet and thick-film paste, one should match (1 ) the particle sizes, and (2) the percentage of organic components, such as binders, which are removed during the firing process Additionally, volume changes need not be matched exactly, but any mismatch will typically result in internal stresses in the device But symmetrical processing, placing the identical material or structure on opposite sides of the device can, to some extent, compensate for shrinkage mismatched materials Too great a mismatch in either sintering temperatures or volume changes may result in defects in or failure of some or all of the device For example, the device may separate into its individual layers, or it may become warped or distorted
As noted above, preferably any dissimilar materials added to the green-sheet layers are co-fired with them Such dissimilar materials could be added as thick-film pastes or as other green-sheet layers, or added later in the fabrication process, after sintering The benefit of co-firing is that the added materials are sintered to the green-sheet layers and become integral to the substantially monolithic microfluidic device However, to be co-fireable, the added materials should have sintering temperatures and volume changes due to firing that are matched with those of the green- sheet layers Sintering temperatures are largely material-dependent, so that matching sintering temperatures simply requires proper selection of materials For example, although silver is the preferred metal for providing electrically conductive pathways, if the green-sheet layers contain alumina particles, which require a sintering temperature in the range of 1400 to 1600° C, some other metal, such as platinum, must be used due to the relatively low melting point of silver (961 ° C)
Alternatively, the addition of other substrates or joining of two post-sintered pieces can be done using any variety of adhesive techniques, including those outlined herein For example, two "halves" of a device can be glued or fused together For example, a particular detection platform, reagent mixture such as a hydrogel or biological components that are not stable at high temperature can be sandwiched in between the two halves Alternatively, ceramic devices comprising open channels or wells can be made, additional substrates or materials placed into the devices, and then they may be sealed with other materials
The substrates comprise arrays of capture binding ligands As will be appreciated by those in the art, any number of different capture binding ligands, or capture probes (when the target analyte is a nucleic acid) can be used, and in a wide variety of formats Preferred embodiments utilize arrays of microelectrodes or hydrogel arrays as are known in the art and disclosed, for example, in U S S N s 09/458,553, 09/458,501 , 09/572,187, 09/495,992, 09/344,217, WO00/31148, 09/439,889, 09/438,209, 09/344,620, PCTUS00/17422, 09/478,727, all of which are expressly incorporated by reference in their entirety
In some embodiments of the present invention, the probes are oligonucleotide probes having a sequence comprising from about 10 to about 30 nucleotide residues wherein said probes are attached to a conjugated polymer or copolymer that is in contact with the microelectrodes The conjugated polymer or copolymer used for probe attachment includes, but is not limited to, polypyrrole, polythiphene, polyanihne, polyfuran, polypyπdine, polycarbazole, polyphenylene, poly
(phenylenvinylene), polyfluorene, polyindole, their derivatives, their copolymers, and combinations thereof In a preferred embodiment, the oligonucleotide probes are attached to the microelectrodes through a neutral polypyrrole matrix
In other embodiments of the present invention, the probes are oligonucleotide probes having a sequence comprising from about 10 to about 30 nucleotide residues and said probes are attached to polyacrylamide gel pads that are in contact with the microelectrodes
As is known in the art, samples are prepared in a variety of ways and applied to a device of the invention Preferred embodiments are directed to the use of systems that do not require the use of ECA labels and are discussed below with reference to Figures 1-14 and Examples 1-6
In this embodiment, the apparatus and methods of the present invention are illustrated herein using hybridization between oligonucleotide probes immobilized on microelectrodes and target nucleic acid molecules contained in a biological sample The phosphate groups of nucleic acids are negatively charged at all biologically relevant pH values Thus, a nucleic acid duplex possesses a high negative charge density Following electrical perturbation of the nucleic acid, strong interactions, such as the intercalation or binding of metal ions to the nucleic acid, occur
These interactions are dependent upon the structure and charge density of the nucleic acid Since the structural and electrical properties of a nucleic acid molecule (such as a probe) are altered when the probe is hybridized to a suitable target molecule, the result of this molecular interaction is a change in AC impedance This change is used in the methods and apparatus of the invention to distinguish between "complete" hybridization and incomplete or "mismatch" hybridization between the immobilized oligonucleotide probe and target nucleic acid
In one embodiment, the apparatus of the present invention comprises a supporting substrate, a plurality of microelectrodes in contact with the supporting substrate to which probes are immobilized, at least one counter-electrode in contact with the supporting substrate, a means for producing electrical impedance at each microelectrode, a means for detecting changes in impedance at each microelectrode in the presence or absence of a target molecule, and an electrolyte solution in contact with the plurality of microelectrodes
In another embodiment, the apparatus of the present invention comprises a supporting substrate, a plurality of microelectrodes in contact with the supporting substrate, a plurality of polyacrylamide gel pads in contact with the microelectrodes and to which probes are immobilized, at least one
counter-electrode in contact with the supporting substrate, a means for producing electrical impedance at each microelectrode, a means for detecting changes in impedance at each microelectrode in the presence or absence of a target molecule, and an electrolyte solution in contact with the plurality of microelectrodes.
In one embodiment, the apparatus is a microarray containing at least 5 microelectrodes on a single substrate to which oligonucleotide probes have been attached. Alternatively, arrayed ohgonucleotides are attached to polyacrylamide gel pads that are in contact with the microelectrodes of the apparatus of the present invention Most preferably, ohgonucleotides having a particular nucleotide sequence, or groups of such ohgonucleotides having related (e.g., overlapping) nucleotide sequences, are immobilized at each of the plurality of microelectrodes. In further preferred embodiments, the nucleotide sequence(s) of the immobilized ohgonucleotides at each microelectrode, and the identity and correspondence between a particular microelectrode and the nucleotide sequence of the oligonucleotide immobilized thereto, are known.
In preferred embodiments, the probes are ohgonucleotides comprising from about 10 to about 100, more preferably from about 10 to about 50, and most preferably from about 15 to about 30, nucleotide residues. In alternative embodiments, the probes are nucleic acids comprising from about 10 to about 5000 basepairs, more preferably from about 100 to about 1000 basepairs, and most preferably from about 200 to about 500 basepairs In further preferred embodiments, the immobilized probes are peptides comprising from about 5 to about 500 ammo acid residues
In the preferred embodiment of the apparatus of the present invention, the substrate is composed of silicon In alternative embodiments, the substrate is prepared from substances including, but not limited to, glass, plastic, rubber, fabric, or ceramics The microelectrodes are embedded within or placed in contact with the substrate
In preferred embodiments, microelectrodes are prepared from substances including, but not limited to, metals such as gold, silver, platinum, titanium or copper, in solid or porous form and preferably as foils or films, metal oxides, metal nitrides, metal carbides, or carbon In certain preferred embodiments, probes are attached to conjugated polymers or copolymers including, but not limited to, polypyrrole, polythiphene, polyanihne, polyfuran, polypyπdine, polycarbazole, polyphenylene, poly(phenylenvιnylene), polyfluorene, polyindole, their derivatives, their copolymers, and combinations thereof. In alternative embodiments, probes are attached to polyacrylamide gel pads that are in contact with the microelectrodes
The substrate of the present invention has a surface area of between 0 01 mm2 and 5 cm2 containing between 1 and 1 x 108 microelectrodes In one embodiment, the substrate has a surface area of 100 mm2 and contains 104 microelectrodes, each microelectrode having an oligonucleotide having a particular sequence immobilized thereto In another embodiment, the
substrate has a surface area of 100 mm2 and contains 104 microelectrodes, each microelectrode in contact with a polyacrylamide gel pad to which an oligonucleotide having a particular sequence has been immobilized thereto. In preferred embodiments, the microelectrodes are arranged on the substrate so as to be separated by a distance of between 0.05 mm to 0.5 mm. Most preferably, the microelectrodes are regularly spaced on the solid substrate with a uniform spacing there between
In some embodiments of the present invention, the microelectrodes project from the surface of the substrate, with such projections extending between 5 x 10'8and 1 x 10"5 cm from the surface of the substrate. In other embodiments, the microelectrodes comprise a flat disk of conductive material that is embedded in the substrate and exposed at the substrate surface, with the substrate acting as an insulator in the spaces between the microelectrodes.
In the preferred embodiment of the present invention the microelectrodes comprise a gold conductor and glass insulator. In alternative embodiments, the microelectrodes comprise conductor substances such as solid or porous films of silver, platinum, titanium, copper, or metal oxides, metal nitrides, metal carbides, or carbon (graphite). In alternative embodiments, the microelectrodes comprise substrate and/or insulator substances such as glass, silicon, plastic, rubber, fabric, or ceramics. The microelectrodes of the present invention have an exposed conductive surface of between 0.01 mm2 to 0.5 cm2 In the preferred embodiment, the exposed conductive material is between 100 to 10,000 mm2. One embodiment of the present invention is shown in Figure 1A, wherein the microelectrode comprises a glass capillary tube 1 , containing an ultra fine platinum wire 2, to which a transition wire 3 has been soldered 6. The transition wire 3, is soldered 6 in turn to a hookup wire 4, which protrudes from an epoxy plug 5 that seals the capillary tube In one embodiment of the present invention, polyacrylamide gel material 7 is packed into a recess etched into the exposed surface of the platinum wire 2
In some embodiments, oligonucleotide probes are immobilized on the microelectrodes of the apparatus of the present invention using a neutral layer between the ohgonucleotides and the micro lectrodes. In a preferred embodiment, this layer comprises neutral polypyrrole. In alternative embodiments, this layer comprises such substances as polythiphene, polyanihne, polyfuran, polypyπdine, polycarbazole, polyphenylene, poly(phenylenvιnylene), polyfluorene, polyindole, their derivatives, their copolymers, and combinations thereof. The layer is preferably at least about 0.001 to 50 mm thick, more preferably at least about 0 01 to 10 mm thick and most preferably at least about 0 5 mm thick.
In other embodiments, oligonucleotide probes are immobilized on polyacrylamide gel pads in contact with the microelectrodes of the apparatus of the present invention In a preferred embodiment, the polyacrylamide gel pad is embedded into a recess etched into the surface of the microelectrode. The polyacrylamide gel pad is preferably at least about 0.1 to 30 mm thick, more
preferably at least about 0 5 to 10 mm thick, and most preferably about 0 5 mm thick
The apparatus of the present invention comprises at least one counter-electrode In the preferred embodiment of the present invention the counter-electrode comprises a conductive material, with an exposed surface that is significantly larger than that of the individual microelectrodes In a preferred embodiment, the counter electrode comprises platinum In alternative embodiments, the counter electrode comprises solid or porous films of silver, gold, platinum, titanium, copper, or metal oxides, metal nitrides, metal carbides, or carbon
In other embodiments of the present invention, the apparatus comprises at least one reference electrode The reference electrode is used in assays where the further quantification of target molecules is desired In preferred embodiments, the reference electrode comprises a silver/ silver chloride electrode In alternative embodiments, the reference electrode comprises solid or porous films of gold, platinum, titanium, or copper, metal oxides, metal nitrides, metal carbides, or carbon The electrolyte solution comprising the apparatus of the present invention is any electrolyte solution comprising at least one salt containing metal or polymerized cations that are IOΠ- conductive and can react with biological molecules, most preferably nucleic acids or peptides
Most preferably, the salt further comprises anions that exhibit a reduced specific adsorption for the surface of the microelectrode, thereby reducing the noise during the detection of molecular interactions between probe and target molecules
In a preferred embodiment of the present invention, the electrolyte solution used for the detection of nucleic acid hybridization contains 0 1 M LιCI04 This electrolyte is preferred since CI04 is not specifically adsorbed on the electrode surface and thus generates a low background noise In addition, \* is preferred since its small size facilitates intercalation of the Lf cations into the nucleic acid duplex and has less diffusion resistance However, in other embodiments, the AC impedance is measured in hybridization buffers such as 1X SSC following molecular interactions between probe and target molecules
In the~apparatus of the present invention the means for producing electrical impedance at each microelectrode can be accomplished using a model 1260 Impedance/Gain-Phase Analyser with model 1287 Electrochemical Interface (Solartron Inc , Houston, TX) Other electrical impedance measurement means include, but are not limited to, transient methods with AC signal perturbation superimposed upon a DC potential applied to an electrochemical cell such as AC bridge and AC voltammetry The measurements can be conducted at certain frequency determined by scanning frequencies to ascertain the frequency producing the highest signal The means for detecting changes in impedance at each microelectrode in the presence or absence of a target molecule can be accomplished by using one of the above-described instruments
In still further alternative embodiments of the present invention, the apparatus further comprises a
plurality of wells each of which encompasses at least one microelectrode and at least one counter- electrode The term "wells" is used herein in its conventional sense, to describe a portion of the substrate in which the microelectrode and at least one counter-electrode are contained in a defined volume
The present invention provides an apparatus and methods for detecting molecular interactions by detecting cation interactions associated with nucleic acid hybridization The detection method used is most preferably AC impedance, but encompasses any detection methods that do not employ or require a reporter-labeled moiety to obtain measurable signals The impedance is measured at different frequencies in order to obtain a "signature" of the hybridization reaction that is sensitive enough to permit mismatch hybridization between the oligonucleotide probe and target molecules to be detected The inventive methods disclosed herein are useful for electrical detection of molecular interactions between probe molecules bound to defined regions of an ordered array (conventionally termed "a biochip array") and target molecules in a sample which are permitted to interact with the probe molecules By arraying microelectrodes to which individual probe molecules have been attached on a biochip, parallel measurements of many probes can be performed in a single assay
The present invention further provides an apparatus and methods for detecting cation interactions associated with peptide binding using AC impedance, but without the use of reporter-labeled target to obtain measurable signals The methods are used for electrical detection of molecular interactions between probe molecules bound to defined regions of an ordered peptide array and target molecules in a sample which are permitted to interact with the probe molecules By arraying microelectrodes to which individual probe molecules have been attached on a biochip, parallel measurements of many probes can be performed in a single assay
The apparatus and methods of the present invention can be adapted further to be used with arrays of any substance that can participate in a molecular interaction that can be interrogated with cations, most preferably lithium cations Such interactions include gand-receptor interactions, enzyme-inhibitor interactions, and antigen-antibody interactions
An important advantage of the apparatus and methods of the present invention is that they are not dependent on labeling the target molecule By removing the labeling step, the cost of the assay is reduced as well as simplified, thereby making electrical detection easier and more cost-effective to use Furthermore, by not requiring target molecules to be labeled, the range of assays for which a method of the present invention may be employed is extended For example, the present invention enables one to perform high sensitivity, high resolution measurements of RNA concentrations in gene expression studies without having to label the chemically-labile RNA or to convert the RNA into cDNA The methods of the present invention may also enable new types of assays to be developed
In an additional embodiment, the invention relies on the use of ECA labels and detection on hydrogel arrays The apparatus and methods of the present invention are illustrated herein using hybridization between oligonucleotide probes immobilized to a polymeric hydrogel pad that is placed in contact with a microelectrode (a hydrogel porous microelectrode) and electrochemically- labeled target nucleic acid molecules contained in a biological sample
In a preferred embodiment, the apparatus of the present invention comprises a supporting substrate, a plurality of microelectrodes in contact with the supporting substrate, a plurality of polyacrylamide gel pads in contact with the microelectrodes and to which probes are immobilized, at least one counter-electrode in contact with the supporting substrate, a means for producing an electrical signal at each microelectrode, a means for detecting changes in the electrical signal at each microelectrode in the presence or absence of an electrochemically active reporter-labeled target molecule, and an electrolyte solution in contact with the plurality of microelectrodes and polymeric hydrogel pads and the counter-electrode The polymeric hydrogel is constructed from hydrophihc polymeric materials including but not limited to polyacrylamide, agarose gel, polyethylene glycol, cellular, and sol gels
In one embodiment, the apparatus is a microarray containing at least 103 hydrogel porous microelectrodes to which oligonucleotide probes have been attached Most preferably, ohgonucleotides having a particular nucleotide sequence, or groups of such ohgonucleotides having related (e g , overlapping) nucleotide sequences, are immobilized at each of the plurality of hydrogel porous microelectrodes In further preferred embodiments, the nucleotide sequence(s) of the immobilized ohgonucleotides at each hydrogel porous microelectrode, and the identity and correspondence between a particular hydrogel porous microelectrode and the nucleotide sequence of the oligonucleotide immobilized thereto, are known
In preferred embodiments, the probes are ohgonucleotides comprising from about 10 to about 100, more preferably from about 10 to about 50, and most preferably from about 15 to about 30, nucleotide residues In alternative embodiments, the probes are nucleic acids comprising from about 10 to about 5000T)asepaιrs, more preferably from about 100 to about 1000 basepairs, and most preferably from about 200 to about 500 basepairs In further preferred embodiments, the immobilized probes are peptides comprising from about 5 to about 500 ammo acid residues
In the preferred embodiment of the apparatus of the present invention, the substrate is composed of silicon In alternative embodiments, the substrate is prepared from substances including, but not limited to, glass, plastic, rubber, fabric, or ceramics The hydrogel porous microelectrodes are embedded within or placed in contact with the substrate
In preferred embodiments, microelectrodes are prepared from substances including, but not limited to, metals such as gold, silver, platinum, titanium or copper, in solid or porous form and preferably as
foils or films, metal oxides, metal nitrides, metal carbides, or carbon. In the apparatus of the present invention, the probes are attached to polyacrylamide gel pads that are placed in contact with the microelectrodes.
The substrate of the present invention has a surface area of between 0 01 mm2 and 5 cm2 containing between 1 and 1 x 108 hydrogel porous microelectrodes. In one embodiment, the substrate has a surface area of 10,000 mm2 and contains 104 hydrogel porous microelectrodes, each of which has an oligonucleotide having a particular sequence immobilized thereto In preferred embodiments, the hydrogel porous microelectrodes are arranged on the substrate so as to be separated by a distance of between 0.05 mm to 0.5 mm. Most preferably, the hydrogel porous microelectrodes are regularly spaced on the solid substrate with a uniform spacing there between
In some embodiments of the present invention, the hydrogel porous microelectrodes project from the surface of the substrate, with such projections extending between 5 x 10'8 and 1 x 10"5 cm from the surface of the substrate In other embodiments, the hydrogel porous microelectrodes comprise a flat disk of conductive material that is embedded in the substrate and exposed at the substrate surface, with the substrate acting as an insulator in the spaces between the hydrogel porous microelectrodes
In a preferred embodiment of the present invention the microelectrodes comprise a gold conductor and glass insulator. In alternative embodiments, the microelectrodes comprise conductor substances such as solid or porous films of silver, platinum, titanium, or copper, metal oxides, metal nitrides, metal carbides, or carbon. In alternative embodiments, the microelectrodes comprise substrate and/or insulator substances such as glass, silicon, plastic, rubber, fabric, or ceramics. The microelectrodes of the present invention have an exposed conductive surface of between 0 01 mm2 to 0.5 cm2 In the preferred embodiment, the exposed conductive material is between 100 to 160,000 mm2
One embodiment of the present invention is shown in Figure 1A, wherein the microelectrode comprises a glass capillary tube 1, containing an ultra fine platinum wire 2, to which a transition wire 3 has been soldered 6. The transition wire 3, is soldered 6 in turn to a hookup wire 4, which protrudes from an epoxy plug 5 that seals the capillary tube In one embodiment of the present invention, polyacrylamide gel material 7 is packed into a recess etched into the exposed surface of the platinum wire 2. In a preferred embodiment, the polyacrylamide gel pad is embedded into a recess etched into the surface of the microelectrode. The polymeπx hydrogel pad is preferably at least about 0 1 to 30 mm thick, more preferably at least about 0.5 to 10 mm thick, and most preferably about 0 5 mm thick
In one embodiment of the hydrogel porous microelectrode of the present invention, oligonucleotide probes are immobilized on the polyacrylamide gel.
The apparatus of the present invention comprises at least one counter-electrode. In the preferred embodiment of the present invention the counter-electrode comprises a conductive material, with an exposed surface that is significantly larger than that of the individual microelectrodes. In a preferred embodiment, the counter electrode comprises platinum. In alternative embodiments, the counter
electrode comprises solid or porous films of silver, gold, platinum, titanium, or copper, metal oxides, metal nitrides, metal carbides, or carbon
In other embodiments of the present invention, the apparatus comprises at least one reference electrode The reference electrode is used in assays where the further quantification of target molecules is desired In preferred embodiments, the reference electrode comprises a silver/ silver chloride electrode In alternative embodiments, the reference electrode comprises solid or porous films of gold, platinum, titanium, or copper, metal oxides, metal nitrides, metal carbides, or carbon
In still further alternative embodiments of the present invention, the apparatus further comprises a plurality of wells each of which encompasses at least one hydrogel porous microelectrode and at least one counter-electrode The term "wells" is used herein in its conventional sense, to describe a portion of the substrate in which the hydrogel porous microelectrode and at least one counter-electrode are contained in a defined volume
In the method of the present invention, molecular interactions between probe molecules bound to hydrogel porous microelectrodes and electrochemically-labeled target molecules are detected Electrochemically-labeled target molecules useful in the methods of the present invention may be prepared by labeling suitable target molecules with any electrochemically-distinctive redox reporter which does not interfere with the molecular interaction to be detected In preferred embodiments of the method of the present invention, target molecules are labeled with electrochemical reporter groups comprising a transition metal complex, most preferably containing a transition metal ion that is ruthenium, cobalt, iron, or osmium
In other embodiments of the present invention, target molecules may be labeled with the following non-limiting examples of electrochemically-active moieties
Redox moieties useful against an aqueous saturated calomel reference electrode include, but are not limited to, transition metal complexes, 1 ,4-benzoquιnone, ferrocene, tetracyanoqumodimethane, N,N,N',N'-tetramethyl-p-phenylenedιamιne, or tetrathiafulvalene
Redox moieities useful against an Ag/AgCI reference electrode include 9-amιnoacπdιne, acπdine orange, aclarubicm, daunomycm, doxorubicm, pirarubicin, ethidium bromide, ethidium monoazide, chlortetracycline, tetracyclme, minocycline, Hoechst 33258, Hoechst 33342, 7-amιnoactιnomycιn D, Chromomycm A3, mithramycin A, Vinblastme, Rifampicin, Os(bιpyπdιne)2(dιpyπdophenazιne)2 *, Co(bιpyπdιne)3 3+, or Fe-bleomycin
The electrochemically-active moiety comprising the electrochemically active reporter-labeled target molecule of the method of the present invention is optionally linked to the target molecule through a linker, preferably having a length of from about 10 to about 20 Angstroms The linker can be an organic moiety such as a hydrocrabon chain (CH2)n, or can comprise an ether, ester, carboxyamide,
or thioether moiety, or a combination thereof The linker can also be an inorganic moiety such as siloxane (O-Sι-0) The length of the linker is selected so that the electrochemically-active moiety does not interfere with the molecular interaction to be detected
Electrochemical contact is advantageously provided using an electrolyte solution in contact with each of the hydrogel porous microelectrodes of the invention Electrolyte solutions useful in the apparatus and methods of the invention include any electrolyte solution at physiologically-relevant ionic strength (equivalent to about 0 15 M NaCI) and neutral pH Examples of electrolyte solutions useful with the apparatus and methods of the invention include but are not limited to phosphate buffered saline, HEPES buffered solutions, and sodium bicarbonate buffered solutions
In preferred embodiments, the present invention provides an apparatus and methods for detecting molecular interactions by detecting changes in AC impedance The impedance is measured at different frequencies in order to obtain a "signature" of the hybridization reaction that is sensitive enough to permit mismatch hybridization between the oligonucleotide probe and target molecules to be detected The inventive methods disclosed herein are useful for electrochemical detection of molecular interactions between probe molecules bound to defined regions of an ordered array
(conventionally termed "a biochip array") and electrochemically-labeled target molecules in a sample which are permitted to interact with the probe molecules By arraying microelectrodes to which individual probe molecules have been attached on a biochip, parallel measurements of many probes can be performed in a single assay
In one embodiment of the apparatus of the present invention, the means for producing electrical impedance at each microelectrode is accomplished using a model 1260 Impedance/Gain-Phase Analyser with model 1287 Electrochemical Interface (Solartron Inc , Houston, TX) Other electrical impedance measurement means include, but are not limited to, transient methods with AC signal perturbation superimposed upon a DC potential applied to an electrochemical cell such as AC bridge and AC voltammetry The measurements can be conducted at certain frequency determined by scanning frequencies to ascertain the frequency producing the highest signal The means for detecTmg changes in impedance at each microelectrode in the presence or absence of a electrochemically-labeled target molecule can be accomplished by using one of the above-described instruments
In other embodiments of the present invention, other electric and/or electrochemical methods can be used to detect molecular interactions between probe molecules and electrochemically-labeled target molecules, including, but not limited to, cyclic voltammetry, stripping voltammetry, pulse voltammetry, square wave voltammetry, AC voltammetry, hydrodynamic modulation voltammetry, potential step method, potentiometπc measurements, amperometπc measurements, current step method, and combinations thereof In these embodiments, the electrical signal is current flow in response to an applied voltage at the redox potential of the electrochemical label
The present invention also provides an apparatus and methods for detecting single nucleotide polymorphisms (SNP) in a nucleic acid sample comprising a specific target nucleic acid
The devices of the invention are particularly useful for analyzing target nucleic acid for the diagnosis of infectious and genetic disease The target nucleic acid is generally a portion of a gene having a known nucleotide sequence that is associated with an infectious agent or genetic disease, more specifically, the disease is caused by a single nucleotide (or point) mutation The device incorporates a nucleic acid oligonucleotide array specific for the target gene, and means for detecting and determining the identity of a specific single base in the target sequence adjacent to the hybridization site of at least one probe in the oligonucleotide array (termed the "3' offset method") or encompassing the 3' residue of at least one oligonucleotide probe in the array (termed the "3' inclusive method")
The present invention provides an array of oligonucleotide primers or probes immobilized to a surface that defines a first electrode Preferably, the sequence of each oligonucleotide at each address in the array is known and at least one oligonucleotide in said oligonucleotide array is complementary to part of a sequence in a nucleic acid in the sample to be assayed The sequence of at least one oligonucleotide is most preferably selected to extend to a position immediately adjacent to the nucleotide position in the sample nucleic acid that is to be interrogated, / e , for mutation or genetic polymorphism Alternatively, the oligonucleotide is selected to encompass the site of mutation or genetic polymorphism, in these latter embodiments, it is generally preferred to provide a multiplicity of ohgonucleotides having one of each possible nucleotide at the polymorphic position to ensure hybridization of at least one of the ohgonucleotides in the array to nucleic acid in the sample
Hybridization and extension reactions are performed in a reaction chamber and in a hybridization buffer for a time and at temperature that permits hybridization to occur between nucleic acid in the sample and the ohgonucleotides in the array complementary thereto
In one embodiment, the apparatus of the present invention comprises a supporting substrate, a plurality of a first electrode (or an array of microelectrodes) in contact with the supporting substrate to which probes are immobilized, at least one counter-electrode and optionally a reference electrode, and an electrolyte solution in contact with the plurality of microelectrodes, counter electrode and reference electrode
In another embodiment, the apparatus of the present invention comprises a supporting substrate, a plurality of first electrodes (or an array of microelectrodes) in contact with the supporting substrate, a plurality of polyacrylamide gel pads in contact with the microelectrodes and to which probes are immobilized, at least one counter-electrode and optionally a reference electrode, and an electrolyte solution in contact with the plurality of microelectrodes, counter electrode and reference electrode In the preferred embodiment of the apparatus of the present invention, the substrate is composed of silicon In alternative embodiments, the substrate is prepared from substances including, but not
limited to, glass, plastic, rubber, fabric, or ceramics
The electrode comprising the first surface to which the oligonucleotide or array thereof is attached is made of at least one of the following materials: metals such as gold, silver, platinum, copper, and electrically-conductive alloys thereof; conductive metal oxides such as indium oxide, indium-tin oxide, zinc oxide; and other conductive materials such carbon black, conductive epoxy
In preferred embodiments, microelectrodes are prepared from substances including, but not limited to, metals such as gold, silver, platinum, titanium or copper, in solid or porous form and preferably as foils or films, metal oxides, metal nitrides, metal carbides, or carbon. In certain preferred embodiments, probes are attached to conjugated polymers or copolymers including, but not limited to, polypyrrole, polythiophene, polyanihne, polyfuran, polypyπdine, polycarbazole, polyphenylene, poly(phenylenvιnylene), polyfluorene, polyindole, their derivatives, their copolymers, and combinations thereof. In alternative embodiments, probes are attached to polyacrylamide gel pads that are in contact with the microelectrodes
The substrate of the present invention has a surface area of between 0.01 mm2 and 5 cm2 containing between 1 and 1 x 108 microelectrodes In one embodiment, the substrate has a surface area of 100 mm2 and contains 10" microelectrodes, each microelectrode having an oligonucleotide having a particular sequence immobilized thereto. In another embodiment, the substrate has a surface area of 100 mm2 and contains 104 microelectrodes, each microelectrode in contact with a polyacrylamide gel pad to which an oligonucleotide having a particular sequence has been immobilized thereto. In preferred embodiments, the microelectrodes are arranged on the substrate so as to be separated by a distance of between 0 05 mm2 to 0.5 mm Most preferably, the microelectrodes are regularly spaced on the solid substrate with a uniform spacing there between.
In one embodiment, the apparatus comprises a microarray containing at least 103 microelectrodes on a single substrate to which oligonucleotide probes have been attached Alternatively, arrayed ohgonucleotides are attached to polyacrylamide gel pads that are in contact with the microelectrodes of the* apparatus of the present invention Most preferably, ohgonucleotides having a particular nucleotide sequence, or groups of such ohgonucleotides having related (e.g., overlapping) nucleotide sequences, are immobilized at each of the plurality of microelectrodes In further preferred embodiments, the nucleotide sequence(s) of the immobilized ohgonucleotides at each microelectrode, and the identity and correspondence between a particular microelectrode and the nucleotide sequence of the oligonucleotide immobilized thereto, are known
The primer or probe used in the present invention is preferred to be an oligonucleotide having a length, both the upper and lower limits of which are empirically determined The lower limit on probe length is stable hybridization it is known in the art that probes that are too short do not form thermodynamically-stable duplexes sufficient for single base extension under the hybridization
conditions of the assay The upper limit on probe length are probes that produce a duplex in a region other than that of the predetermined interrogation target, leading to artifactual incorporation of primer extension unιt(s) labeled with electrochemically active moieties Preferred oligonucleotide primer or probes used in the present invention have a length of from about 8 to about 50, more preferably from about 10 to about 40, even more preferably from about 12 to about 30, and most preferably from about 15-25 nucleotides However, longer probes, / e. longer than 40 nucleotides, may also be used
In the present invention, the primer or probe is preferably immobilized directly on the first electrode surface through an anchoring group As will be appreciated by those in the art, advantageous anchoring groups include, for example, moieties comprising thiols, carboxylates, hydroxyls, amines, hydrazines, esters, amides, ha des, vinyl groups, vinyl carboxylates, phosphates, silicon-containing organic compounds, and their derivatives For example, an oligonucleotide which is complementary to a target DNA is covalentiy linked to a metallic gold electrode through a thiol-containmg anchoring group In a preferred embodiment, the length of these anchoring groups is chosen such that the conductivity of these molecules do not hinder electron transfer from the electrochemical reporter groups, to the electrode, via the hybridized probe and target DNA, and these anchoring groups in series Stated differently, these anchoring groups are preferred to have higher conductivities than double-stranded nucleic acid A conductivity, S, of from between about 10"6 to about 10"4 W * cm 1, more preferably from about 105 to about 103 W * cm ', corresponds to a length for the anchoring groups ranging from about 5 A to about 200 A
Alternatively, the primer or probe can be covalentiy bound onto an intermediate support that is placed on top of the first electrode The support is preferred to be either a thin layer of porous inorganic material such as TiOx, Sι02, NOx or a porous organic polymer such as polyacrylamide, agarose, nitrocellulose membranes, nylon, and dextran supports Primers are covalentiy bound to the support through a linker Preferred linker moieties include, but are not limited to, thioethers, ethers, esters, amides, amines, hydrazines, carboxylates, hahdes, hydroxyls, vinyls, vinyl carboxylates, thiols, phosphates, silicon containing organic compounds, and their derivatives and other carboxylate moieties More preferably, biotm-streptavidin pairs are advantageous arranged to provide probe bindif g onto the intermediate support
The apparatus of the invention also includes a second electrode and a reference electrode to permit current flow The second electrode is most preferably comprised of any conducting material, including, for example, metals such as gold, silver, platinum, copper, and alloys, conductive metal oxides such as indium oxide, ιπdιum-tιn oxide, zinc oxide, or other conductive materials such as carbon black, conductive epoxy, most preferred is a platinum (Pt)-wιre auxiliary electrode The reference electrode is preferably a silver wire electrode, a silver/silver chloride (Ag/AgCI) reference electrode, or a saturated calomel electrode
The apparatus also comprises one or a multiplicity of reaction chambers, each reaction chamber
being in electrochemical contact with at least one of each of the aforementioned electrodes, wherein each of the electrodes are connected to a power source and a means for controlling said power source For the purposes of this invention, the term "in electrochemical contact" is intended to mean, inter alia, that the components are connected such that current can flow through the electrodes when a voltage potential is created between the two electrodes
Electrochemical contact is advantageously provided using an electrolyte solution in contact with each of the electrodes or microelectrode arrays of the invention Electrolyte solutions useful in the apparatus and methods of the invention include any electrolyte solution at physiologically-relevant ionic strength (equivalent to about 0 15M NaCI) and neutral pH Nonlimiting examples of electrolyte solutions useful with the apparatus and methods of the invention include but are not limited to phosphate buffered saline, HEPES buffered solutions, and sodium bicarbonate buffered solutions
Preferred polymerases for performing single base extensions using the methods and apparatus of the invention are polymerases having little or no exonuclease activity More preferred are polymerases that tolerate and are biosynthetically-active at temperatures greater than physiological temperatures, for example, at 50°C or 60°C or 70°C or are tolerant of temperatures of at least 90°C to about 95°C Preferred polymerases include Taq polymerase from T aquaticus (commercially available from Perkin-Elmer Cetus, Foster City, CA), Sequenase® and ThermoSequenase® (commercially available from U S Biochemical, Cleveland, OH), and Exo(-)Pfu polymerase (commercially available from New England Biolabs, Beverley, MA)
The inventive methods for SNP detection provided by the invention generally comprise (1 ) preparing a sample containing the target nucleic acιd(s) of interest to obtain single-stranded nucleic acid that spans the specific position (typically by denaturing the sample), (2) contacting the single- stranded target nucleic acid with an oligonucleotide primer of known sequence that hybridizes with a portion of the nucleotide sequence in the target nucleic acid immediately adjacent the nucleotide base to be interrogated (thereby forming a duplex between the primer and the target such that the nucleotide base to be interrogated is the first unpaired base in the target immediately 5' of the nucleotide base annealed with the 3'-end of the primer in the duplex, this oligonucleotide is preferably a specific oligonucleotide occupying a particular address in an addressable array), (3) contacting the duplex with a reagent which includes an aqueous carrier, a polymerase, and at least one primer extension unit, wherein the primer extension unit comprises an extension moiety, an optional linker, and an electrochemical detection moiety The primer extension reaction catalyzed by the polymerase results in incorporation of the extension moiety of the primer extension unit at the 3'-end of the primer, and the extension of the primer by a single base, (4) removing the unincorporated primer extension unιt(s), and (5) determining the identity of the incorporated primer extension unit in the extended duplex by its unique electrochemical detection moiety
The extension moiety in the primer extension unit is preferably a chain-terminating moiety, most
preferably dideoxyπucleoside tπphosphates (ddNTPs), such as ddATP, ddCTP, ddGTP, and ddTTP, however other terminators known to those skilled in the art, such as nucleotide analogs or arabmoside tπphosphates, are also within the scope of the present invention These ddNTPs differ from conventional deoxynucleoside tπphosphates (dNTPs) in that they lack a hydroxyl group at the 3' position of the sugar component This prevents chain extension of incorporated ddNTPs, and thus terminates the chain Unlike conventional detection moieties that have been either fluorescent dyes or radioactive labels, the present invention provides primer extension units labeled with an electrochemical reporter group that are detected electrochemically, most preferably by redox reactions Any electrochemically-distinctive redox label which does not interfere with the incorporation of the ddNTP into a nucleotide chain is preferred
Optionally, the target DNA in the sample to be investigated can be amplified by means of in vitro amplification reactions, such as the polymerase chain reaction (PCR) technique well known to those skilled in the art Enriching the target DNA in a biological sample to be used in the methods of the invention provides more rapid and more accurate template-directed synthesis by the polymerase The use of such in vitro amplification methods, such as PCR, is optional in the methods of the invention, which feature advantageously distinguishes the instantly-disclosed methods from prior art detection techniques, which typically required such amplification in order to generate sufficient signal to be detected Because of the increased sensitivity of the instantly-claimed methods, the extensive purification steps required after PCR and other in vitro amplification methods are unnecessary, this simplifies performance of the inventive methods
Single base extension is performed using a polymerase in the presence of at least one primer extension unit in a buffer solution appropriate for the biochemical activity of the polymerase A general formula of a preferred embodiment of the primer extension unit is ddNTP-L-R where ddNTP represents a dideoxyπbonucleotide tπphosphate including ddATP, ddGTP, ddCTP, ddTTP, L represents an optional linker moiety, and R represents an electrochemical reporter group, preferably an electrochemically-active moiety and most preferably a redox moiety
In preferred embodiments, each chain-terminating nucleotide species (for example, dιdeoxy(dd)ATP, ddGTP, ddCTP and ddTTP) is labeled with a different electrochemical reporter group, most preferably wherein each different reporter group has a different and electrochemically-distmguishable reduction/oxidation (redox) potential In this regard, it will be appreciated that nucleotides comprising a DNA molecule are themselves electrically active, for example, guanine and adenine can be electrochemically oxidized around 0 75 V and 1 05 V, respectively Thus, it is generally preferable for the redox potential of the electrochemical reporter group comprising the primer extension units of the invention to be distinguishable from the intrinsic redox potential of the incorporated nucleotides themselves The following electrochemical species are non-limiting examples of electrochemically- active moieties provided as electrochemical reporter groups of the present invention, the oxidation
(+) potential or reduction (-) potential being listed in the parenthesis (in volt units)
Redox moieties useful against an aqueous saturated calomel reference electrode include 1 ,4- benzoqumone (-0 54V), ferrocene (+0 307), tetracyanoqumodimethane (+0 127, -0 291 ), N,N,N',N'-tetramethyl-p-phenylenedιamιne (+0 21 ), tetrathiafulvalene (+0 30) - Redox moieties useful against a Ag/AgCI reference electrode include 9-amιnoacπdιne
(+0 85V), acπdine orange (+0 830), aclarubicin (+0 774), daunomycin (+0 446), doxorubicin (+0 440), pirarubicm (+0 446), ethidium bromide (+0 678), ethidium monoazide (+0 563), chlortetracychne (+0 650), tetracychne (+0 674), minocychne (+0 385), Hoechst 33258 (+0 586), Hoechst 33342 (+0 571 ), 7-amιnoactιnomycιn D (+0 651 ), Chromomycin A3 (+0 550), mithramycin A (+0 510), Vinblastme (+0 522), Rifampicm (+0 103),
Os(bιpyπdιne)2(dιpyπdophenazιne)2+ (+0 72), Co(bιpyrιdιne)3 3+(+0 11 ), Fe-bleomycm (-0 08)
(The redox data are from Bard & Faulkner, 1980, ELECTROCHEMICAL METHODS, JohnWiley & Sons,
Inc and Hshimoto et al , 1994, Analytica Chimtca Acta 286 219-224)
The choice of the electrochemically-active moiety comprising the electrochemical reporter groups of the invention is optimized for detection of the moiety to the exclusion of other redox moieties present in the solution, as well as to prevent interference of the label with hybridization between an oligonucleotide contained in an array and a nucleic acid comprising a biological sample
The electrochemically-active moiety comprising the chain-terminating nucleotides of the invention is optionally linked to the extension nucleotide through a linker (L), preferably having a length of from about 10 to about 20 Angstroms The linker can be an organic moiety such as a hydrocarbon chain
(CH2)n, or can comprise an ether, ester, carboxyamide, or thioether moiety, or a combination thereof The linker can also be an inorganic moiety such as siloxane (O-Si-O) The length of the linker is selected so that R, the electrochemically-active moiety, does not interfere with either nucleic acid hybridization between the bound oligonucleotide primer and target nucleic acid, or with polymerase- mediated chain extension
In preferred embodiments, single base extension is detected by standard electrochemical means such as cyclic voltammetry (CV) or stripping voltammetry In a non-hmiting example, electric current is recorded as a function of sweeping voltage to the first electrode specific for each particular labeled primer extension unit The incorporation and extension of a specific base is identified by the unique oxidation or reduction peak of the primer extension unit detected as current flow in the electrode at the appropriate redox potential
In additional embodiments, other electric or/and electrochemical methods useful in the practice of the methods and apparatus of the invention include, but are not limited to, AC impedance, pulse voltammetry, square wave voltammetry, AC voltammetry (ACV), hydrodynamic modulation voltammetry, potential step method, potentiometπc measurements, amperometπc measurements, current step method, and combinations thereof In all these methods, electric current is recorded as
a function of sweeping voltage to the first electrode specific for each particular labeled primer extension unit The difference is the type of input/probe signal and/or shape of input/probe signal used to sweep the voltage range For example, in cyclic voltammetry, a DC voltage sweep is done In ACV, an AC signal is superimposed on to the voltage sweep In square wave voltammetry, a square wave is superimposed on to the voltage sweep Most preferably, the signal is recorded from each position ("address") in the oligonucleotide array, so that the identity of the extended species can be determined The identity of the nucleotide comprising the extension unit is determined from the redox potential at which current flow is detected
In the use of the apparatus of the invention to perform a single base extension reaction, a reaction mixture is prepared containing at least one chain-terminating nucleotide labeled with an electrochemical label (such as a redox-labeled ddNTP), a hybridization buffer compatible with the polymerase and having a salt concentration sufficient to permit hybridization between the target nucleic acid and primer ohgonucleotides under the conditions of the assay, and a DNA polymerase such as Tag DNA polymerase or ThermoSequenase Single stranded target nucleic acid, for example, having been denatured by incubation at a temperature >90°C, is diluted to a concentration appropriate for hybridization in deionized water and added to the reaction mixture The resulting hybridization mixture is sealed in a reaction chamber of the apparatus of the invention containing a first electrode, wherein the electrode comprises a multiplicity of primers having known sequence linked thereto At least one of the primers has a nucleotide sequence capable of hybridizing with a portion of the nucleotide sequence of the target immediately adjacent the nucleotide base to be interrogated under the hybridization conditions employed in the assay
A duplex between the primer and the target is formed wherein the nucleotide base to be interrogated is the first unpaired base in the target immediately 5' of the nucleotide base that is annealed with the 3'-end of the primer in the duplex Single base extension of the 3' end of the annealed primer is achieved by incorporation of the chain-terminating nucleotide, labeled with an electrochemically active moiety, into the primer The primer sequence and labeled chain-terminating nucleotide are chosen so that incorporation of the nucleotide is informative of the identity (/ e , mutant, wildtype or polymorphism) of the interrogated nucleotide in the target
Alternatively, the probe comprises a 3' terminal residue that corresponds to and hybridizes with the interrogated base In these embodiments, ohgonucleotides having a "mismatch" at the 3' terminal residue will hybridize but will not be extended by the polymerase Detection of incorporation of the primer extension unit by interrogating the redox label is then informative of the identity of the interrogated nucleotide base, provided that the sequence of the oligonucleotide probe is known at each position in the array
After the SBE reaction is performed, the electrode is washed at high stringency (i e , in a low-salt and
low dielectric constant solution (such as 0 1X SSC 0 015M NaCI, 15mM sodium citrate, pH 7 0), optionally including a detergent such as sodium dodecyl sulfate at temperature of between aboutl 0- 65°C) for a time and at a temperature wherein the target nucleic acid is removed Wash conditions vary depending on factors such as probe length and probe complexity Electrochemical detection is carried out in an electrolyte solution by conventional cyclic voltammetry
The following examples serve to more fully describe the manner of using the above-described invention, as well as to set forth the best modes contemplated for carrying out various aspects of the invention It is understood that these examples in no way serve to limit the true scope of this invention, but rather are presented for illustrative purposes All references cited herein are incorporated by reference
EXAMPLES EXAMPLE 1 Preparation of Polypyrrole Microelectrodes Polypyrrole microelectrodes were prepared as follows Ultra-fine platinum wire having a diameter of 50 mm was inserted into glass capillary tubing having a diameter of 2 mm and sealed by heating to form a solid microelectrode structure The tip of the structure was then polished with gamma alumina powder (CH Instruments, Inc , Austin, TX) to expose a flat disk of the platinum wire Microelectrodes were initially polished with 0 3 mm gamma alumina powder, rinsed with deionized water, and then polished with 0 005 mm powder Following polishing, the microelectrodes were ultrasonically cleaned for 2 mm in deionized water, soaked in 1 N HN03 for 20 mm , vigorously washed in deionized water, immersed in acetone for 10 mm , and again washed vigorously in deionized water Through the use of micromanufactuπng techniques employed in the fabrication of semiconductors, modifications of this procedure can be applied to the preparation of microelectrodes of a size required for the construction of bioarray chips
A neutral polypyrrole matrix was used for attachment of nucleic acid probes to the exposed platinum disk {jf the microelectrodes Electrochemical deposition was performed using a model 660A potentiostat (CH Instruments, Inc ), using platinum wire as a counter-electrode, silver/silver chloride (Ag/AgCI) as a reference electrode, and cyclic voltammetry (CV) A solution containing 0 05 M pyrrole, 2 5 mM 3-acetate-N-hydrodysuccιnιmιdo pyrrole, and 0 1 M LiCIOJ 95% acetonitπle was prepared as the electrolyte The potential range for the CV was 0 2 to 1 3 V versus Ag/AgCI for the first cycle and -0 1 to 1 0 versus Ag/AgCI for 10 additional cycles The scan rate was 10 mV/sec The electrolyte was purged by nitrogen gas during the entire deposition process Alternatively, polypyrrole film can be formed by oxidation of pyrrole at a constant current of 0 20 to 0 25 mA/cm2 in the same solution described above This method is more convenient to make array-based microelectrodes since the reference electrode is not required An electrochemical oxidation of the pyrrole produced the polypyrrole shown to the right of the arrow in Figure 2A
The polypyrrole electrodes in oxidized form were put into 0 1 M LιCI04 and cycled over a potential range of -0 1 to 0 8 for 20 cycles This procedure stabilizes the polypyrrole film To make a neutralized polypyrrole, the microelectrodes were placed in the electrolyte again and cycled for 10 cycles over a potential range of -0 2 to 0 3 versus Ag/AgCI, which is the reduction zone for this electrochemical system The neutralization is desired in order to reduce the background charge of the probe attachment matrix and thus increase the sensitivity of the hybridization electrical measurements The reaction for neutralizing the polypyrrole film is illustrated in Figure 2B Following neutralization of the polypyrrole film coating the microelectrodes, the microelectrodes were vigorously rinsed with deionized water
EXAMPLE 2
Attachment of Nucleic Acid Probes to Polypyrrole Microelectrodes
To attach nucleic acid probes to the microelectrodes prepared in Example 1 , the microelectrodes were incubated at room temperature for 4 hours in a solution consisting of 80 mL dimethylformamide and 20 mL of 15 nM 5'-amιno labeled 15-mer oligonucleotide (5'-C-C-C-T-C-A-A-G-C-A-G-A-G-G-A-3\ SEQ ID NO 1 ) Following attachment of the probe molecules, the microelectrodes were washed with
TBE buffer (0 89 M Tπs-borate, 0 025 M EDTA), rinsed thoroughly in deionized water, and allowed to dry at room temperature
EXAMPLE 3 Electrical Detection of Nucleic Acid Hybridization Using Polypyrrole Microelectrodes
The AC impedance baseline of the microelectrodes prepared according to Example 2 was first determined in the absence of a complementary target molecule Microelectrodes were then exposed in a sealed conical tube to 35 mL of the complementary target molecule (5'-T-C-C-T-C-T-G-C-T-T-G- A-G-G-G-3', SEQ ID NO 2) present at concentrations in the micromolar (106 M, mM) to attomolar (10 18 JVI, aM) range Hybridization of probe and target molecules was performed in 1X SSC buffer
(0 15 M NaCI, 0 015 M sodium citrate, pH 7 0) at 37°C for 24 to 48 hours Following hybridization, microelectrodes were thoroughly rinsed in an excess volume of 1X SSC at room temperature and then AC impedance was measured
AC impedance was measured using a model 1260 Impedance/Gain-Phase Analyser with model 1287 Electrochemical Interface (Solartron Inc , Houston, TX) The counter and reference electrodes were platinum and Ag/AgCI, respectively, and the impedance measurements were made under open circuit voltage (OCV) conditions in a 1 M LιCI04 solution The measured complex impedance (Z) versus frequency for a polypyrrole microelectrode with attached 15-mer oligonucleotide before and after hybridization with a 2 /M solution of the complementary target molecule is shown in Figure 3A
(Complex impedance is described by the equation Z = Z' + /Z", in which Z' is real part of the impedance, / is 0-1 and Z" is imaginary part of the impedance) A significant difference was observed between the microelectrodes before and after hybridization to the target molecule (Figure 3A) The large signals produced at low target concentration (/ e , 2/M of target is equivalent to 0 1 amol of target molecules) indicates the high sensitivity of the methods of the present invention for detecting hybridization between oligonucleotide probes and target nucleic acid molecules The frequency increases from 0 1 Hz at large values of Z' to 1 MHz at a Z' of -0
Figure 3B illustrates the frequency complex curves, as seen in Figure 3A, for the high frequency zone (where Z' < 5 x 104) Frequency dependent semicircle impedance curves were observed at high frequencies before and after hybridization Generally, such curves at high frequencies indicate the existence of a Faraday resistance (/ e , electrochemical reaction resistance) in parallel with a capacitance Semicircular curves such as those shown in Figure 3B can be used to obtain the electrochemical reaction resistance and the double layer capacitance by equivalent circuit simulation The simulation results obtained using the data shown in Figure 3B is shown in Table I These results indicate that following hybridization of the probe and target molecules, the high frequency electrochemical resistance decreases and the capacitance increases, which is as expected This demonstrates that the hybridized DNA has a strong electrochemical interactions with Lι+
TABLE I
Equivalent Circuit Parameters Obtained from High Frequency Impedance Data Nucleic Acid Status Faraday Resistance, R (W) Capacitance, C (nF)
Single-stranded 2236 0 198
Double-stranded 922 0 597
The real part of the complex impedance data shown in Figure 3A, / e , the resistance (R) versus the square root of the frequency (w 1/2), is plotted in Figures 4A and 4B Linear regions are observed, demonstrating that the Lι+ diffusion process dominates the measurements at lower frequencies Figures 4A and 4B show that a significant change in the resistance occurs after hybridization of the single-stranded probe with the target molecule The decrease in high frequency resistance following hybridization (Figure 4B) can be explained by a decrease in the Faraday resistance of the hybridized nucleic acid At low frequencies, the large ion diffusion resistance dominates the impedance and thus the resistance is higher for the hybridized probe- target duplex (Figure 4A) As the frequency increases, the contribution of the frequency- dependent diffusion resistance decreases and thus the smaller Faraday resistance dominates
The limit of detection in the experiments described above was reached at approximately 0 1 attomol of target molecule With increased target molecule concentrations, higher hybridization signals were obtained, demonstrating that methods of the present invention can be also used to
quantify the amount of target hybridized onto the electrode-immobilized probe. Thus, this method can be used in conjunction with appropriate reference electrodes to measure the absolute quantities of nucleic acid in a test sample. For example, the methods of the present invention enable one to perform high sensitivity, high resolution measurements of RNA concentrations in gene expression studies. Comparative gene expression studies performed using such a method permits the direct measurement of the quantity of expressed RNA, rather than relying on a determination of the ratio between the RNA of interest and a control RNA.
EXAMPLE 4 Specificity of Electrical Detection Using Polypyrrole Microelectrodes
Microelectrodes with attached oligonucleotide probes were prepared as described in Examples 1 and 2 Four microelectrodes were incubated in a solution containing 2 pM of a 15-mer target molecule that was fully complementary to the attached probe (5'-T-C-C-T-C-T-G-C-T-T-G-A-G-G- G-3', SEQ ID NO: 2) and four other microelectrodes were incubated in a solution containing 2 /M of a 15-mer target molecule containing three mismatched bases relative to the attached probe (5'- C-C-C-T-C-A-A-G-C-A-G-A-G-G-A-3'; SEQ ID NO: 1 ) using the conditions described in Example
3.
Following hybridization, individual microelectrodes were washed at successively higher temperatures to electrically measure the melting of the duplexes. Washing was performed by placing the microelectrodes in 1 X SSC for 30 mm. at either 37°C or 38°C. AC impedance curves for the microelectrodes that were not hybridized, hybridized to the target, or washed at 37°C or
38°C are shown in Figures 5A (fully complementary target molecule) and 5B (mismatched target molecule)
AC impedance measurements showed a pronounced difference between the fully complementary (perfect) and mismatched hybridized nucleic acid duplexes. The impedance curves obtained for the fully complementary target molecule remained unchanged following the washes, indicating that the melting temperature of the perfect duplex was not exceeded. The impedance curves obtained for the mismatched target molecule moved toward the baseline (i.e., unhybπdized probe) following washes, indicating that the melting of this duplex was occurring at temperatures near to that duplexes melting temperature. The ability to discriminate between matched and mismatched nucleic acid sequences demonstrates the applicability of the methods of the present invention in the detection of gene polymorphism Figure 6 indicates that the resistance in the mismatched DNA system continuously decreases with increasing wash temperature going back to the baseline of the single-stranded DNA
EXAMPLE 5
Use of Li* Reporter in Polypyrrole Microelectrode Electrical Detection of Molecular Interactions
Microelectrodes were prepared as described in Examples 1 and 2 and were hybridized to suitable target molecules as described in Example 3 The AC impedance before and after nucleic acid hybridization is shown in Figure 7 The microelectrode with attached oligonucleotide probe exhibits the characteristics of an ideal polarization electrode prior to hybridization with a target molecule The equivalent circuit for this state is shown in Figure 8A and the AC impedance response is shown in Figure 8B In this state, the microelectrode can be described by the equation Z = Rs -y(wCdl) 1, where Z is impedance, R5 is solution resistance, j = 0-1 , w is 2, and Caι is double layer capacitance
The behavior of the microelectrode is treated as an "ideal" polarization electrode under conditions of an electrolyte solution comprising 0 1 M LιCl04 with purging N2 and before hybridization to a suitable target molecule is reasonable since there is no electrochemically active species and no specific adsorption However, following hybridization to a suitable target molecule, a large deviation from the ideal curve was observed in the same electrolyte, indicating that the impedance was significantly increased The AC impedance measured for the microelectrode following hybridization suggests that the electrochemical process and equivalent circuit under such conditions is as shown in Figure 8C (where R, is the Faraday resistance, / e , electrochemical reaction resistance and R^ is Warburg resistance) Resistance from both electrochemical reactions and the diffusion process causes the electrode behavior following hybridization to deviate from the ideal polarization curve
While simulation would enable the calculation of all the parameters in the equivalent circuit for this state, the equivalent circuit can also be simplified for R and C The results of such simplification are shown in Figures 9 and 10, indicating that the resistance from both R and C increases as one orderjDf magnitude The results of the experiments described above (particularly those described in Example 4) indicate that Lf in the electrolyte can serve as a reporter, permitting the mismatches between probes and target molecules to be detected Since a method of the present invention relies on the intercalation or binding of cations, more preferably Lf cations, to enable electrical detection, this method does not require that target molecules be labeled
EXAMPLE 6 Preparation of Hydrogel Porous Microelectrodes
Microelectrodes were prepared as described in Example 1 (Figure 1 A) The exposed flat disk of platinum was then etched in hot aqua regia to form a recess (/ e , micropore dent) of a specified
depth. The depth of the recess was controlled by the length of time that the platinum disk was exposed to the etching material. The recess thus formed was then packed with polyacrylamide gel material (Figure 1 B) to form a hydrogel porous microelectrode (Figure 11 ). A hydrogel porous microelectrode having a diameter of 258 mm was used in the following Examples.
Prior to attachment of probe molecules, hydrogel porous microelectrodes were activated by incubation for 10 mm. in 2% tπfluoroacetic acid, and rinsed for 2 mm. in deionized water. Microelectrodes were then incubated for 15 mm. in 0.1 M sodium peπodate, and rinsed for 2 mm. in deionized water. Following this treatment, microelectrodes were thoroughly washed by incubation in deionized water for 15 mm., and then air-dried. Microelectrodes were subsequently incubated for 10 mm. in 2% dimethyl dichlorosilane solution and 2% octamethylcyclotetrasiloxane, washed in ethanol, rinsed in deionized water, and air-dried.
EXAMPLE 7 Attachment of Nucleic Acid Probes to Hydrogel Porous Microelectrodes
To attach nucleic acid probes to the microelectrodes prepared in Example 6, the microelectrodes were incubated at room temperature for 4 hours in a solution consisting of 80 mL dimethylformamide and 20 mL of 2 pM 5'-amιno-3'fluoresceιn labeled 15-mer oligonucleotide (5'- C-C-C-T-C-A-A-G-C-A-G-A-G-G-A-3'; SEQ ID NO: 1 ). Following attachment of the probe molecules, the microelectrodes were washed with TBE buffer, rinsed thoroughly in deionized water, and allowed to dry at room temperature.
EXAMPLE 8
Electrical Detection of Nucleic Acid Hybridization Using Hydrogel Porous Microelectrodes
The baseline AC impedance of hydrogel porous microelectrodes prepared according to Example 7 was first determined in the absence of target molecules. Microelectrodes were then exposed in a sealed conical tube to either 35 mL of a complementary target molecule (5'-T-C-C-T-C-T-G-C-T-T-
G-A-G-G-G-3', SEQ ID NO: 2) present at a concentration of either 2 pM or 35mL of a mismatched target molecule (5'-C-C-C-T-C-A-A-G-C-A-G-A-G-G-A-3\ SEQ ID NO* 1 ) present at a concentration of 300 nM Hybridization of the probe with either target molecule was performed in 1X SSC buffer at room temperature for 1 hour. Following hybridization, microelectrodes were thoroughly rinsed for 20 mm at room temperature in an excess volume of 1X SSC and then AC impedance was measured
AC impedance was measured using a model 1260 Impedance/Gain-Phase Analyser with model 1287 Electrochemical Interface. The counter and reference electrodes were platinum and
Ag/AgCI, respectively, and the impedance measurements were made under open circuit voltage (OCV) conditions in 1X SSC hybridization solution Samples were excited at an amplitude of 50 mV The measured complex impedance (Z) versus frequency for the hydrogel porous microelectrode with attached 15-mer oligonucleotide following hybridization with the complementary target molecule or mismatched target molecule is shown in Figure 12
The signal generated following hybridization of probe molecules with a mismatched target molecule was indistinguishable from the signal generated in the absence of target molecule The results, as shown in Figure 12, indicate that the charge transfer has diffusion control at lower frequencies The diffusion impedance is expressed as the Warburg element, W, and has a linear region in plots of both imaginary and real parts vs w 1/2 From the imaginary and real parts of the complex impedance data shown in Figure 12, plots of resistance (R) vs w 1/2 and of capacitance (C) vs w 1 2 were extracted and plotted as shown in Figures 13 and 14 Linear regions are observed in these plots, proving that a diffusion process dominates the electronic measurements These plots show that both resistance and capacitance exhibit a significant change after the hybridization of the single stranded DNA probe with the target DNA The resistance decreases and the capacitance increases following hybridization These results indicate that the hybridization of target molecules to probe molecules attached to the polyacrylamide gel can improve the charge transfer process by decreasing the resistance The increase in capacitance is due to the increase in the surface charge as a result of nucleic acid hybridization The results obtained with the hydrogel porous microelectrode demonstrate that such microelectrodes can be used to detect 40 frnol of target molecule in solution
EXAMPLE 9 Preparation of Hydrogel Porous Microelectrodes
Microelectrodes were prepared as follows Ultra-fine platinum wire having a diameter of 50 mm was inserted into glass capillary tubing having a diameter of 2 mm and sealed by heating to form a solid microelectrode structure The tip of the structure was then polished with gamma alumina powder (CH Instruments, Inc , Austin, TX) to expose a flat disk of the platinum wire Microelectrodes were initially polished with 0 3 mm gamma alumina powder, rinsed with deionized water, and then polished with 0 005 mm powder Following polishing, the microelectrodes were ultrasonically cleaned for 2 mm in deionized water, soaked in 1 N HN03 for 20 mm , vigorously washed in deionized water, immersed in acetone for 10 mm , and again washed vigorously in deionized water Through the use of micromanufactuπng techniques employed in the fabrication of semiconductors, modifications of this procedure can be applied to the preparation of microelectrodes of a size required for the construction of bioarray chips
Hydrogel porous microelectrodes were prepared from the above-described microelectrodes as
follows. The exposed flat disk of platinum of each microelectrode was etched in hot aqua regia to form a recess (i.e., micropore dent) of a specified depth. The depth of the recess was controlled by the length of time that the platinum disk was exposed to the etching material. The recess thus formed was then packed with polyacrylamide gel material (Figure 1 B) to form a hydrogel porous microelectrode (Figure 2) A hydrogel porous microelectrode having a diameter of 258 mm was used in the Example 2.
Prior to attachment of probe molecules, hydrogel porous microelectrodes were activated by incubation for 10 mm. in 2% tπfluoroacetic acid, and rinsed for 2 mm. in deionized water. Microelectrodes were then incubated for 15 mm. in 0.1 M sodium peπodate, and rinsed for 2 mm. in deionized water. Following this treatment, microelectrodes were thoroughly washed by incubation in deionized water for 15 mm , and then air-dried. Microelectrodes were subsequently incubated for 10 mm. in 2% dimethyl dichlorosilane solution and 2% octamethylcyclotetrasiloxane, washed in ethanol, rinsed in deionized water, and air-dried.
EXAMPLE 10 Attachment of Nucleic Acid Probes to Hydrogel Porous Microelectrodes
To attach nucleic acid probes to the microelectrodes prepared in Example 1 , the microelectrodes were incubated at room temperature for 4 hours in a solution consisting of 80 mL dimethylformamide and 20 mL of 2 pM 5'-amιno-3'fluoresceιn labeled 15-mer oligonucleotide (5'-C-C- C-T-C-A-A-G-C-A-G-A-G-G-A-3', SEQ ID NO: 1 ) Following attachment of the probe molecules, the microelectrodes were washed with TBE buffer, rinsed thoroughly in deionized water, and allowed to dry at room temperature.
EXAMPLE 11 Electrochemical Detection of Nucleic Acid Hybridization
Nucleic acid hybridization between a probe bound to a hydrogel porous microelectrode and an electrochemically-labeled target molecule is detected as follows. The baseline AC impedance of hydrogel porous microelectrodes prepared according to Example 2 is first determined in the absence of the electrochemically-labeled target molecules. Microelectrodes are then exposed in a sealed conical tube to either 35 mL of a complementary target molecule (S'-T-C-C-T-C-T-G-C-T-T-G-A-G-G- G-3'; SEQ ID NO. 2) present at a concentration of either 2 pM or 35mL of a mismatched target molecule (5'-T-C-C-T-C-T-G-C-T-T-G-A-G-G-G-3\ SEQ ID NO. 1 ; present at a concentration of 300 nM. Hybridization of the probe with either target molecule is performed in 1X SSC buffer at room temperature for 1 hour. Following hybridization, microelectrodes are thoroughly rinsed for 20 mm. at room temperature in an excess volume of 1X SSC and then AC impedance is measured
AC impedance is measured using a model 1260 Impedance/Gain-Phase Analyser with model 1287 Electrochemical Interface The counter and reference electrodes are platinum and Ag/AgCI,
respectively, and the impedance measurements are made under open circuit voltage (OCV) conditions in 1X SSC hybridization solution. Samples are excited at an amplitude of 50 mV. The complex impedance (Z) versus frequency for the hydrogel porous microelectrode with attached 15- mer oligonucleotide following hybridization with the complementary target molecule or mismatched target molecule is then determined.
EXAMPLE 12 Single Base Extension
An apparatus of the invention is produced as follows. A glass substrate layer is prepared comprising an ordered array of a plurality of gold microelectrodes connected to a voltage source The substrate has a surface area of 100 mm2 and contains 104 microelectrodes, each microelectrode in contact with a polyacrylamide gel pad that is about 0.5μm thick to which an oligonucleotide having a particular sequence has been immobilized thereto. The microelectrodes are arranged on the substrate so as to be separated by a distance of about 0.1 mm, and are regularly spaced on the solid substrate with a uniform spacing there between
To each of the gold electrodes is affixed an oligonucleotide probe having a length of 25 nucleotides. The resulting ordered array of probes are arranged in groups of four, whereby the probes are identical except for the last (most 3') residue. Each group contains an oligonucleotide ending in an adenosme (A), guanme (G), cytosme (C) or thymid e (T) or uracil (U) residue. The ohgonucleotides are attached to each of the gold electrodes through the polyacrylamide gel pad using a modification of the oligonucleotide at the 5' residue. This residue comprises a thioester linkage that covalentiy attaches the oligonucleotide to the polyacrylamide polymer.
This ordered microelectrode array is placed in a reaction chamber, having dimensions sufficient to contain the array and a volume of from about 10 to 100mL of hybridization/extension buffer The reaction chamber also comprises a second counter electrode comprising platinum wire and a third, reference electrode that is a silver/ silver chloride electrode, each electrode being electπcally connected to a voltage source
In the use of the apparatus of the invention, a volume of from about 10 to 100mL of hybridization buffer is added to the reaction chamber This solution also contains a target molecule, typically at concentrations in the micromolar (10"6 M; μM ) to attomolar (10"18 M, aM) range. Hybridization of probe and target molecules is performed in 1X SSC buffer (0 15 M NaCI, 0.015 M sodium citrate, pH 7.0) at 37°C for 24 to 48 hours Following hybridization, microelectrodes were thoroughly rinsed in an excess volume of 1X SSC at room temperature
A volume of from about 10 to 100mL of extension buffer containing a polymerase and a plurality of each of 4 chain-terminating nucleotide species is then added to the reaction chamber. Each of the
four chain-terminating nucleotide species is labeled with a chemical species capable of participating in a reduction/oxidation (redox) reaction at the surface of the microelectrode An example of such a collection of species is ddATP labeled with cobalt (bιpyπdιne)3 3t, ddGTP labeled with minocychne, ddCTP labeled with acπdiπe orange, and ddTTP labeled with ethidium monoazide The redox labels are covalentiy linked to the chain-terminating nucleotides by a hydrocarbon linker (CH2)2 a The extension buffer is chosen to accommodate the polymerase, such as Thermosequenase (obtained from U S Biochemicals, Cleveland, OH) The extension reaction is performed at a temperature appropriate for the polymerase, such as about 65°C, that does not denature the hybridized duplex between the target and the oligonucleotide probes, and for a time sufficient for the extension reaction to go to completion After the extension reaction is complete, the array is washed at high stringency in 0 1X SSC/ 1 % SDS at a temperature that does not denature the hybridized duplex
After washing, a volume of about 10 to 100mL of an electrolyte solution is added to the reaction chamber, and each microelectrode is interrogated by conventional cyclic voltammetry to detect a redox signal The identity of ohgonucleotides containing single base extended species is determined by the redox potential of the signal obtained thereby
Equivaleπtly, hybridization and single base extension can be performed in the same buffer solution, provided the polymerase is compatible with the hybridization buffer conditions
Claims
CLAIMS We claim
1 An apparatus for electric or electrochemical detection of molecular interactions between an immobilized probe and an electrochemically active reporter-labeled target molecule, comprising (a) a supporting substrate,
(b) a plurality of microelectrodes in contact with the supporting substrate,
(c) a plurality of polymeric hydrogel pads in contact with the microelectrodes and to which probes are immobilized,
(d) at least one counter-electrode in contact with the supporting substrate, (e) a means for producing an electrical signal at each microelectrode,
(f) a means for detecting changes in the electrical signal at each microelectrode, and
(g) an electrolyte solution in contact with the plurality of microelectrodes and polymeric hydrogel pads, and the counter-electrode, wherein molecular interactions between the immobilized probe and the electrochemically active reporter-labeled target molecule are detected by detecting changes in the electrical signal in the presence or absence of the electrochemically active reporter-labeled target molecule
2. An apparatus for detecting single base extension of an oligonucleotide comprising an oligonucleotide array, wherein extension is effected by a polymerase and directed by a nucleotide sequence of a nucleic acid in a biological sample, the apparatus comprising a first electrode comprising an array of ohgonucleotides on a substrate, wherein the electrode comprises a conducting or semiconducting surface, a second, counter electrode comprising a conducting metal in contact with an aqueous electrolyte solution, and a third reference electrode in contact with the aqueous electrolyte solution, wherein each of the electrodes is electrically connected to a voltage source, and wherein the apparatus further comprises a reaction chamber containing a polymerase and a hybridization solution comprising an electrolyte, wherein each of the electrodes is in electrochemical contact therewith, the solution further containing a plurality of primer extension units comprising chain-terminating nucleotide species, wherein each different chain-terminating nucleotide species is labeled with a distinguishable electrochemical label capable of participating in a reduction/oxidation reaction at the surface of the first electrode under conditions whereby an electrical potential is applied to the electrodes, wherein each of the labeled chain-terminating nucleotide species has a specific reduction/oxidation potential, wherein a current is produced in the apparatus when a biological sample comprising a nucleic acid that hybridizes to an oligonucleotide contained in the oligonucleotide array is incubated in the reaction chamber under moderate to high stringency hybridization conditions and the nucleotide sequence of said hybridized oligonucleotide is extended by the incorporation of at least one of the chain-terminating nucleotide and a voltage is applied to the electrodes at a potential specific for the reduction/oxidation potential of the electrochemical label
3 The apparatus of claim 2 wherein the oligonucleotide array is an addressable array, and wherein the first electrode comprises a plurality of electrodes corresponding to each address of said addressable array, wherein a current is produced at a particular address of said addressable array after single base extension of an oligonucleotide at said address of the array with a chain terminating nucleotide species labeled with an electrochemical reporter when a voltage is applied to the electrodes at a potential specific for the reduction/oxidation potential of the electrochemical label
4 The apparatus of claim 2 wherein the chain-terminating nucleotide species are labeled with a transition metal complex
5 An apparatus for electrical detection of molecular interactions between an immobilized probe and a target molecule, comprising
(a) a supporting substrate,
(b) a plurality of microelectrodes in contact with the supporting substrate to which probes are immobilized,
(c) at least one counter-electrode in contact with the supporting substrate, (d) an AC/DC voltage source for producing electrical impedance at each microelectrode,
(e) an electrical detector for detecting changes in impedance at each microelectrode in the presence or absence of a target molecule, and
(f) an electrolyte solution in contact with the plurality of microelectrodes and the counter-electrode, wherein molecular interactions between the immobilized probe and the target molecule are detected by detecting changes in the electrical impedance in the presence and absence of the target molecule
6 An apparatus for electrical detection of molecular interactions between an immobilized probe and a target molecule, comprising (a) a supporting substrate,
(b) a plurality of microelectrodes in contact with the supporting substrate,
(c) a plurality of conjugated polymer films in contact with the microelectrodes and to which probes are immobilized,
(d) at least one counter-electrode in contact with the supporting substrate, (e) an AC/DC voltage source for producing electrical impedance at each microelectrode,
(f) an electrical detector for detecting changes in impedance at each microelectrode in the presence or absence of a target molecule, and
(g) an electrolyte solution in contact with the plurality of microelectrodes, plurality of conjugated polymer films, and the counter-electrode, wherein molecular interactions between the immobilized probe and the target molecule are detected by detecting changes in the electrical impedance in the presence and absence of the target molecule
7 An apparatus for electrical detection of molecular interactions between an immobilized probe and a target molecule, comprising (a) a supporting substrate,
(b) a plurality of microelectrodes in contact with the supporting substrate,
(c) a plurality of polymer gel pads in contact with the microelectrodes and to which probes are immobilized,
(d) at least one counter-electrode in contact with the supporting substrate, (e) an AC/DC voltage source for producing electrical impedance at each microelectrode,
(f) an electrical detector for detecting changes in impedance at each microelectrode in the presence or absence of a target molecule, and
(g) an electrolyte solution in contact with the plurality of microelectrodes, plurality of polyacrylamide gel pads, and the counter-electrode, wherein molecular interactions between the immobilized probe and the target molecule are detected by detecting changes in the electrical impedance in the presence and absence of the target molecule
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US459685 | 1995-06-02 | ||
| US45850199A | 1999-12-09 | 1999-12-09 | |
| US09/458,533 US20020051975A1 (en) | 1999-12-09 | 1999-12-09 | Reporterless genosensors using electrical detection methods |
| US458501 | 1999-12-09 | ||
| US09/459,685 US6518024B2 (en) | 1999-12-13 | 1999-12-13 | Electrochemical detection of single base extension |
| PCT/US2000/033497 WO2001042508A2 (en) | 1999-12-09 | 2000-12-11 | Methods and compositions relating to electrical detection of nucleic acid reactions |
| US458533 | 2003-06-09 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| EP1238114A2 true EP1238114A2 (en) | 2002-09-11 |
Family
ID=27412734
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EP00993326A Withdrawn EP1238114A2 (en) | 1999-12-09 | 2000-12-11 | Methods and compositions relating to electrical detection of nucleic acid reactions |
Country Status (5)
| Country | Link |
|---|---|
| EP (1) | EP1238114A2 (en) |
| JP (1) | JP2003516165A (en) |
| AU (1) | AU2907201A (en) |
| CA (1) | CA2393733A1 (en) |
| WO (1) | WO2001042508A2 (en) |
Families Citing this family (33)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6071699A (en) | 1996-06-07 | 2000-06-06 | California Institute Of Technology | Nucleic acid mediated electron transfer |
| US6824669B1 (en) | 2000-02-17 | 2004-11-30 | Motorola, Inc. | Protein and peptide sensors using electrical detection methods |
| GB0118931D0 (en) * | 2001-08-02 | 2001-09-26 | Oxford Biosensors Ltd | Voltammetric ion-selective biosensor |
| DE10210051B4 (en) | 2002-03-07 | 2005-10-13 | Siemens Ag | Device for the electrochemical detection of a nucleotide sequence, analysis cassette for such a device and method for producing such an analysis cassette |
| DE10224567B4 (en) * | 2002-06-03 | 2014-10-23 | Boehringer Ingelheim Vetmedica Gmbh | Sensor arrangement and method for operating a sensor arrangement |
| DE10228260A1 (en) * | 2002-06-25 | 2004-01-22 | Bayer Ag | Method and device for the impedimetric detection of one or more analytes in a sample |
| GB2391867A (en) * | 2002-08-13 | 2004-02-18 | Smartbead Technologies Ltd | Analysis system using coded supports |
| KR100858080B1 (en) * | 2002-11-12 | 2008-09-10 | 삼성전자주식회사 | How to detect PCR amplification products that measure electrical signals |
| WO2004044570A1 (en) * | 2002-11-14 | 2004-05-27 | Toyama Prefecture | Method of detecting hybridization |
| DE10259819B4 (en) | 2002-12-19 | 2006-07-13 | Siemens Ag | Method for PCR amplification and detection of nucleotide sequences |
| WO2005016115A2 (en) | 2003-01-23 | 2005-02-24 | Montana State University | Biosensors utilizing dendrimer-immobilized ligands and their use thereof |
| AT413214B (en) * | 2003-01-24 | 2005-12-15 | Sy Lab Vgmbh | MEASUREMENT ARRANGEMENT AND METHOD FOR DETECTING A DNA SEQUENCE |
| CN1784497A (en) * | 2003-03-05 | 2006-06-07 | 萨斯喀彻温大学技术公司 | Nucleic acid mismatch detection |
| WO2005001122A2 (en) * | 2003-06-27 | 2005-01-06 | Adnavance Technologies, Inc. | Electrochemical detection of dna binding |
| DE10327756B4 (en) * | 2003-06-18 | 2005-12-29 | november Aktiengesellschaft Gesellschaft für Molekulare Medizin | Method for real-time quantification of a nucleic acid |
| KR100590569B1 (en) * | 2004-02-14 | 2006-06-15 | 삼성전자주식회사 | Method for real-time detection of Polymerase Chain Reaction |
| US20080227651A1 (en) * | 2004-03-25 | 2008-09-18 | Yanxiu Zhou | Cyclic voltammetry (CV) for identifying genomic sequence variations and detecting mismatch base pairs, such as single nucleotide polymorphisms |
| WO2005093418A1 (en) * | 2004-03-26 | 2005-10-06 | Toto, Ltd. | Method of specifically detecting test substance by using photocurrent and electrodes, measurement cell, measurement device and buffer solution to be used therefor |
| WO2005095991A1 (en) | 2004-04-01 | 2005-10-13 | Nanyang Technological University | Addressable chem/bio chip array |
| KR100613612B1 (en) | 2004-04-27 | 2006-08-18 | 삼성전자주식회사 | Apparatus and method for detecting biocombination using inductance device and capacitance device |
| EP1848823A4 (en) | 2005-01-21 | 2008-06-25 | Univ Rochester | METHODS OF SEPARATING SINGLE-STRANDED, LONG-LONG SINGLE NUCLEIC ACID NUCLEIC ACID NUCLEIC ACID, AND ASSOCIATED BIOMOLECULAR ASSAYS |
| WO2009041917A1 (en) * | 2007-09-28 | 2009-04-02 | Agency For Science, Technology And Research | Method of electrically detecting a nucleic acid molecule |
| NZ610129A (en) | 2010-10-04 | 2014-08-29 | Genapsys Inc | Systems and methods for automated reusable parallel biological reactions |
| US9399217B2 (en) | 2010-10-04 | 2016-07-26 | Genapsys, Inc. | Chamber free nanoreactor system |
| US9184099B2 (en) | 2010-10-04 | 2015-11-10 | The Board Of Trustees Of The Leland Stanford Junior University | Biosensor devices, systems and methods therefor |
| US8585973B2 (en) | 2011-05-27 | 2013-11-19 | The Board Of Trustees Of The Leland Stanford Junior University | Nano-sensor array |
| US9926596B2 (en) | 2011-05-27 | 2018-03-27 | Genapsys, Inc. | Systems and methods for genetic and biological analysis |
| CN106591103B (en) | 2011-12-01 | 2021-06-04 | 吉纳普赛斯股份有限公司 | System and method for efficient electronic sequencing and detection |
| EP2971141B1 (en) | 2013-03-15 | 2018-11-28 | Genapsys, Inc. | Systems for biological analysis |
| WO2015089238A1 (en) | 2013-12-11 | 2015-06-18 | Genapsys, Inc. | Systems and methods for biological analysis and computation |
| EP3556864B1 (en) | 2014-04-18 | 2020-12-09 | Genapsys, Inc. | Methods and systems for nucleic acid amplification |
| US10544456B2 (en) | 2016-07-20 | 2020-01-28 | Genapsys, Inc. | Systems and methods for nucleic acid sequencing |
| CA3076378A1 (en) | 2017-09-21 | 2019-03-28 | Genapsys, Inc. | Systems and methods for nucleic acid sequencing |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB8530715D0 (en) * | 1985-12-13 | 1986-01-22 | Unilever Plc | Microchemical testing |
| US5001048A (en) * | 1987-06-05 | 1991-03-19 | Aurthur D. Little, Inc. | Electrical biosensor containing a biological receptor immobilized and stabilized in a protein film |
| CS274231B1 (en) * | 1988-12-05 | 1991-04-11 | Jan Rndr Krejci | Regenerable enzyme sensor with exchangeable membrane system |
| US5776672A (en) * | 1990-09-28 | 1998-07-07 | Kabushiki Kaisha Toshiba | Gene detection method |
| US5849486A (en) * | 1993-11-01 | 1998-12-15 | Nanogen, Inc. | Methods for hybridization analysis utilizing electrically controlled hybridization |
| IL103674A0 (en) * | 1991-11-19 | 1993-04-04 | Houston Advanced Res Center | Method and apparatus for molecule detection |
| RU2041261C1 (en) * | 1993-08-11 | 1995-08-09 | Институт молекулярной биологии им.В.А.Энгельгардта РАН | Method for manufacturing of matrix for detecting of mismatches |
| JPH10509025A (en) * | 1994-08-26 | 1998-09-08 | アイジェン, インコーポレイテッド | Biosensor and method for electrogenerated chemiluminescent detection of nucleic acids adsorbed on solid surface |
| US6207369B1 (en) * | 1995-03-10 | 2001-03-27 | Meso Scale Technologies, Llc | Multi-array, multi-specific electrochemiluminescence testing |
| US5981268A (en) * | 1997-05-30 | 1999-11-09 | Board Of Trustees, Leland Stanford, Jr. University | Hybrid biosensors |
| CA2300268A1 (en) * | 1997-08-12 | 1999-02-18 | Robert D. Macphee | Electrochemical reporter system for detecting analytical immunoassay and molecular biology procedures |
| DE19741716A1 (en) * | 1997-09-22 | 1999-03-25 | Hoechst Ag | Recognition system |
| US6048692A (en) * | 1997-10-07 | 2000-04-11 | Motorola, Inc. | Sensors for electrically sensing binding events for supported molecular receptors |
| AU765597B2 (en) * | 1998-05-06 | 2003-09-25 | Clinical Micro Sensors, Inc. | Electronic detection of nucleic acids using monolayers |
-
2000
- 2000-12-11 CA CA002393733A patent/CA2393733A1/en not_active Abandoned
- 2000-12-11 JP JP2001544379A patent/JP2003516165A/en active Pending
- 2000-12-11 WO PCT/US2000/033497 patent/WO2001042508A2/en not_active Ceased
- 2000-12-11 EP EP00993326A patent/EP1238114A2/en not_active Withdrawn
- 2000-12-11 AU AU29072/01A patent/AU2907201A/en not_active Abandoned
Non-Patent Citations (1)
| Title |
|---|
| See references of WO0142508A3 * |
Also Published As
| Publication number | Publication date |
|---|---|
| WO2001042508A9 (en) | 2002-05-30 |
| WO2001042508A3 (en) | 2002-03-14 |
| WO2001042508A2 (en) | 2001-06-14 |
| CA2393733A1 (en) | 2001-06-14 |
| AU2907201A (en) | 2001-06-18 |
| JP2003516165A (en) | 2003-05-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP1238114A2 (en) | Methods and compositions relating to electrical detection of nucleic acid reactions | |
| US20030209432A1 (en) | Methods and compositions relating to electrical detection of nucleic acid reactions | |
| AU771571B2 (en) | The use of microfluidic systems in the electrochemical detection of target analytes | |
| US20020090649A1 (en) | High density column and row addressable electrode arrays | |
| WO2002031463A9 (en) | High density column and row addressable electrode arrays | |
| EP1075656B1 (en) | Detection of a target in a sample | |
| JP3548159B2 (en) | Binding promotion method for analyte detection | |
| US20050023155A1 (en) | Protein and peptide sensors using electrical detection methods | |
| JP2004515231A (en) | Apparatus and method for multiplexing biochips | |
| JP2007187677A (en) | Biochip multiplexing device and method | |
| KR20040074066A (en) | Mesoporous permeation layers for use on active electronic matrix devices | |
| CA2393766A1 (en) | Column and row addressable high density biochip array | |
| JP2002525577A (en) | Signal detection method for analyte detection | |
| JP2003517156A (en) | Compositions and methods for performing biological reactions | |
| US20030138845A1 (en) | Protein and peptide sensors using electrical detection methods | |
| AU2001236625A1 (en) | Detection and differentiation of bacteria using electrical detection methods | |
| CA2471339A1 (en) | Method and device for the quantitative electrical detection of analytes | |
| KR100355778B1 (en) | Electrochemical detection of acid hybridization | |
| AU2004202695A1 (en) | The use of microfluidic systems in the electrochemical detection of target analytes |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
| 17P | Request for examination filed |
Effective date: 20020708 |
|
| AK | Designated contracting states |
Kind code of ref document: A2 Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR |
|
| AX | Request for extension of the european patent |
Free format text: AL;LT;LV;MK;RO;SI |
|
| STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN |
|
| 18D | Application deemed to be withdrawn |
Effective date: 20050701 |